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Liver resection offers curative treatment to a number of malignant conditions. It has 
traditionally been associated with poor post-operative outcomes. More recently a 
mortality rate of less than five per cent has become established but morbidity remains 
high. Enhanced Recovery After Surgery (ERAS) has become established practice in 
a number of surgical specialties and has shown improvement in post-operative 
outcomes. ERAS has been introduced for liver resection however practice is less well 
established and liver surgery has several complexities that need to be accommodated 
in order to optimise post-operative care. The following thesis aims to identify areas 




Systematic review and meta-analysis were performed to identify areas that required 
clarification and were lacking in sufficient evidence to guide practice. A randomised 
controlled trial was performed to compare established areas of practice. Prospective 
observational studies were performed when exploratory investigation was required. 
Retrospective analysis of a prospectively collected database was performed to 
identify risk factors for post-operative morbidity. Patients included in the above trials 
underwent liver resection at the Royal Infirmary of Edinburgh, UK, between 




Post-operative analgesia after liver resection was identified as being an area that was 
controversial. Continuous wound infiltration was shown to offer improved recovery 
times when compared to epidural with no significant associated disadvantages. After 
retrospective review of 603 liver resections, extended resection was observed to be 
associated with high morbidity rates. It was hypothesised that post-operative 
nutritional requirements might be higher in these patients. This was not found to be 
the case but post-operative energy requirements were found to be difficult to predict 
after liver resection, suggesting the benefits of real-time monitoring of energy 
expenditure. Finally acetaminophen metabolism was suspected of being altered after 
major resection. An observational study suggested that despite altered metabolism, 
glutathione deficiency was not observed after major resection and so liver volume 
was not a contra-indication to acetaminophen administration. 
 
Summary 
Liver resection offers a complex set of conditions on which to base an enhanced 
recovery protocol. Current ERAS literature does not completely address these issues. 
This thesis has investigated several aspects of care unique to liver surgery in an 
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1 Introduction 
 
1.1 The Physiological Response To Surgery  
 
Abdominal surgery results in initiation of a number of physiological and metabolic 
responses. [1] After the initial surgical incision and for several days afterwards, a 
stimulation of the inflammatory response occurs. This is a well-orchestrated 
activation of the sympathetic, endocrine and immunological systems resulting in the 
release of catecholamine and norepinephrine from the hypothalamus and adrenal 
medulla respectively. This leads to the characteristic physiological outcome of 
increased heart rate and a rise in circulatory pressure. [2] 
 
Surgical trauma results in activation of neuronal afferents at the surgical site that 
travel via the dorsal root to the hypothalamus. The endocrine organs subsequently 
release a number of hormones via the hypothalamo-pituitary-adrenal (HPA) axis 
(Figure 1). These include insulin and glucagon, antidiuretic hormone (ADH), cortisol 
and adrenocorticotropic hormone (ACTH). The net result of this is catabolism of 
fats, proteins and glycogen and retention of salt and water to satisfy energy 
requirements and cardiovascular stability. [2] 
 
As a result of injury to tissue and cells, the immune response is also stimulated. This 
is a complex combination of innate (neutrophils, macrophages and complement) and 
specific (B cells, T cells and Natural Killer cells) cellular and humoral responses. 
Enhanced Recovery After Liver Surgery 
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This results in chemokines and cytokines being released early on from damaged 
leukocytes and endothelial cells and they, amongst other factors, stimulate and 

















Figure 1. The hypothalamo-pituitary-adrenal axis 
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The inflammatory response is the result of an interaction between pro-inflammatory 
and anti-inflammatory mediators (Figure 2). Its magnitude is associated with the 
extent of the traumatic insult. Inflammatory mediators include the cytokines 
interleukin 6 (IL6), IL1 and tumour necrosis factor alpha (TNFα). Other factors 
released from migratory neutrophils include nitric oxide, histamine and 
phospholipase-A2. [3] 
 
The end physiological result of the immune response is increased blood flow to the 
affected area, blood vessel dilatation, increased vessel permeability and adhesion and 
migration of phagocytic cells to the point of injury. Complement cascade and the 
coagulation pathways are also stimulated as well as growth factors that result in 
healing, tissue repair and removal of necrotic cells and toxins. [3] 
 
Should the inflammatory response be overwhelming, a systemic inflammatory 
response syndrome (SIRS) may occur, in which excessive fluid redistribution to the 
extra vascular space, haemodynamic instability and excessive muscle catabolism can 
result in multi-organ dysfunction syndrome (MODS). [4] The inflammatory response 
is normally attenuated by anti-inflammatory mediators, namely IL10, that are 
released to counterbalance the pro-inflammatory mediators to provide a balanced 
response capable of optimising healing. [4] Similarly, should excessive anti-
inflammatory mediators persist, immunosuppression may occur increasing host 
susceptibility to infection. [4]
Enhanced Recovery After Liver Surgery 
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 Figure 2. The inflammatory response 
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1.2 Inflammatory Mediators And Clinical Outcome 
 
The impact of the inflammatory response on patient outcome has been investigated 
extensively and is well recognised as being associated with clinical course. TNFα is 
an early mediator of the inflammatory response. It peaks at around 12 hours after 
surgery and remains elevated for over 72 hours (Figure 3). [5] TNFα is released by 
T-cells and macrophages that are widely present in peritoneal tissue. [4] TNFα 
stimulates coagulation, adhesion molecules and glucocorticoids as well as 
haemodynamic change and muscle catabolism. [4] TNFα at increased levels has been 
found in patients with anastomotic leakage following colorectal surgery after meta-
analysis [6] and a small observational study found low TNFα levels are associated 
with uncomplicated post-operative recoveries. [7] 
 
IL1 is a pro-inflammatory cytokine. It is released soon after TNFα from 
macrophages and endothelial cells. There are two subtypes of IL1 – IL1α and IL1β. 
IL1β is detected in the circulation where its functions include activation of the 
coagulation cascade, release of adhesion molecules and glucocorticoids. Its release is 
also associated with haemodynamic instability. [4]  
 
IL6 is released in response to surgical trauma. It is mainly released from endothelial 
cells and peaks at around 12 hours and remains elevated for several days post-
operatively. Its functions include activation of the acute phase response and 
activation of neutrophils, which can prolong the inflammatory process. [4] Not only 
Enhanced Recovery After Liver Surgery 
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has it been found to be associated with the extent and duration of the surgical insult 
but is also associated with post-operative morbidity. [8] A meta-analysis of five 
RCTS showed that glucocorticoid administration reduced complications and resulted 
in correspondingly low IL6 in patients following liver resection. [9] 
 
Figure 3. Pro-inflammatory cytokine dynamics 
Figure reproduced from Sammour et al [3] with permission from Springer.  
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IL8 is a pro-inflammatory cytokine and neutrophil activator. [4] It is associated with 
increased risk of multi-organ failure after trauma [10] and is predictive of poor 
outcomes in patients with acute pancreatitis. [11] Prospective RCTs have shown that 
a reduction of IL8 by either methylprednisolone [12] or silvestat [13] resulted in IL8 
attenuation and associated improvements in clinical course following major surgery. 
 
In contrast to the above factors, IL10 is described as an anti-inflammatory cytokine. 
Animal studies have shown increased IL10 levels to reduce mortality [14] and IL10 
deficient mice to have increased mortality following peritonitis. [15] Although 
randomised trials are lacking, low IL10 levels were shown in an observational 
prospective trial to be associated with post-operative complications following major 
abdominal surgery. [16] IL10 works in concert with antagonists to TNFα and IL1 to 




The Damage Associated Molecular Pattern molecules (DAMPs) are nuclear and 
cytoplasmic proteins that are released from cells following tissue damage. A subset 
of DAMPs, the alarmins, has increasingly been shown to play a crucial role in the 
molecular stimulation of the sterile systemic inflammatory response process. [18] 
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Numerous alarmins have been identified and studied. Specifically High Mobility 
Group Box 1 (HMGB1) is increasingly gaining importance as the major stimulant of 
innate immunity in sterile inflammation. [19] 
 
Once HMGB1 has been released from damaged cells at the point of injury it acts on 
endothelial cells via the Receptor for Advanced Glycation End Products (RAGE) 
resulting in release of adhesion molecules (ICAM1, VCAM1), cytokines and tissue 
plasminogen activator. [20] 
 
Prospective observational studies have shown high levels of HMGB1 to be 
associated with increased mortality rates following major trauma. [19] After major 
gastrointestinal surgery HMGB1 is associated with prolonged duration of SIRS and 
pulmonary dysfunction. [21] HMGB1 has also been reported as associated with 
increased operative time and blood loss and those with post-operative morbidity after 
abdominal surgery were found to have higher HMGB1 levels than those without. 
[22] Patients undergoing oesophagectomy were also found to have higher levels of 
HMGB1 in those who suffered post-operative morbidity. [23] Anti HMGB1 
antibodies when utilised in murine model studies resulted in improved survival 
following haemorrhagic shock, [24] limb fracture [25] and sepsis. [26] In human 
studies HMGB1 inhibitors such as sivelstat, a neutrophil elastase inhibitor, have been 
shown to improve clinical outcomes following major GI surgery in a controlled trial. 
[23] HMGB1 is released early in the post-operative period (from incision) and peaks 
at post-operative day (POD) two to three. [22] As described above, high early levels 
Enhanced Recovery After Liver Surgery 
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are strongly associated with adverse outcome in the post-operative course and 
therefore attenuation of this mediator has been recommended by investigators as an 
area of exploitation in an attempt to improve post-operative outcomes.[27] 
 
1.4 Enhanced Recovery After Surgery 
 
Enhanced Recovery After Surgery (ERAS) is a concept that has increased in 
popularity over the past decade. It was introduced initially in colorectal surgery and 
is responsible for improvements in post-operative length of stay and morbidity in this 
field. [28] Since then its use has extended to multiple surgical specialties including 
orthopaedic, [29] oesophagogastric [30] and breast surgery. [31] 
 
The underlying principle of ERAS is the application of a multimodal peri-operative 
protocol to attenuate the inflammatory response and optimise patient rehabilitation 
following major surgery. [32] This is in an effort to prevent the problems associated 
with an exaggerated inflammatory reaction to surgery such as poor healing, infective 
complications and multi-organ dysfunction. [33] This approach, combined with 
intensive post-operative optimisation of mobility, gut function and analgesia [34] 
contributes to expediting recovery and minimising morbidity. 
 
ERAS protocols were originally described by Kehlet in 1997 [32] and focused on 
pre-operative, intraoperative and post-operative factors that could be managed and 
Enhanced Recovery After Liver Surgery 
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optimised by a series of multi-disciplinary interventions (Figure 4). Individual 
protocols vary depending on the procedure and have been altered over time. 
However the underlying principles of enhanced recovery surgery broadly aim to 
minimise complications, optimise rehabilitation and reduce the impact of the surgical 
insult on the patient. This is achieved by suppression of the inflammatory response, 
targeting and preventing individual complications, promotion of rehabilitation and 
providing optimum nutrition to achieve a patient-centred recovery. [32] 
 
 
Figure 4 Elements of Enhanced Recovery After Surgery 
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1.4.1 ERAS Society Recommendations (Colorectal Surgery) 
 
A significant proportion of investigation of ERAS care has been undertaken in the 
context of colorectal surgery. The current best evidence assessing individual ERAS 
care components in the colorectal literature has been reported by the ERAS Society 
and is summarised below. [36] The level of evidence supporting the 
recommendations below is high or if not, is strongly recommended by the ERAS 
Society.  
 
1.4.2 Pre-operative Factors 
 
The ERAS Society [36] advises against the conventional practice of prolonged 
fasting of patients pre-operatively prior to surgery. Clear fluids up until two hours 
before induction of anaesthesia is not associated with increased risk of aspiration 
pneumonia according to a large meta-analysis of 22 RCTs [37] and is therefore 
recommended to avoid pre-operative dehydration.  
 
Routine bowel preparation is also advocated against in a move away from traditional 
surgical practice. A large meta-analysis found no benefit in administering bowel 
preparation [38] in terms of anastomotic leak and, in view of the potential 
disadvantages with this practice, is not recommended. 
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Further recommendations by the ERAS Society based on large meta-analyses include 
avoidance of pre-anaesthetic medication [39] to prevent post-operative sedation and 
increase speed of rehabilitation and administration of peri-operative prophylactic 
antibiotics [40] to reduce post-operative wound infections. 
 
Moreover clear fluids containing carbohydrates drunk up to two hours pre-
operatively can counter-act the mediation of the inflammatory response by reduced 
insulin resistance. The evidence supporting this is less conclusive, however a 
randomised trial showed a reduction in post-operative morbidity after carbohydrate 
loading and improved recovery times after abdominal surgery. [41] 
 
1.4.3 Intra-operative Factors 
 
Intra-operative care components are centred around the surgical approach and the 
anaesthetic management of the patient. In order to attenuate the inflammatory 
response to surgery minimisation of surgical trauma is paramount to ERAS care 
principles. Laparoscopic surgery has been shown to reduce length of stay (LOS) in 
two large RCTS [42, 43] and laparoscopic approach is advised when possible and 
where the expertise is present. [36] 
 
Anaesthetic management is centred around control of pain and fluid management 
intra-operatively and in the immediate post-operative period. Regional anaesthesia in 
combination with general anaesthesia is recommended by the ERAS society for open 
Enhanced Recovery After Liver Surgery 
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colorectal surgery as it improves post-operative pain, reduces post-operative nausea 
and vomiting (PONV), increases post-operative mobility and is associated with a 
reduction in morbidity and modulation of the stress response. [36] These 
recommendations are made on the basis of large meta-analyses comparing epidural 
to systemic opiates. [44-46]  
 
Furthermore fluid administration should be delivered according to pre-specified 
physiological targets, ideally with monitoring of cardiac output to prevent fluid 
overload. Although a meta-analysis comparing fluid restriction to standard fluid 
administration failed to show a difference in outcomes, [47] goal directed fluid 
therapy assessed with oesophageal Doppler was shown after meta-analysis to 
improve morbidity and length of stay. [48] 
 
1.4.4 Post-operative Factors 
 
ERAS principles advocate a target driven approach to post-operative patient care 
which is dependent on multi-disciplinary input. Enteral nutrition is advised in the 
colorectal literature as soon as the patient is able to take oral diet and is supported by 
a meta-analysis showing a reduction in LOS and septic complications, and was not 
associated with increased anastomotic leaks when compared to conventional care. 
[49] Oral nutritional supplementation provided pre- and post-operatively has been 
shown to improve functional recovery in one RCT. [50] Adequate nutrition prevents 
muscle catabolism, insulin resistance and allows modulation of the inflammatory 
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response [51] and supplementation is of particular benefit in pre-operatively 
malnourished patients. [52] 
 
Optimum post-operative analgesia and prevention of ileus and PONV are goals of 
ERAS protocols and avoidance of excessive morphine administration is seen as 
central to achieving these goals. With this in mind a multimodal, opiate avoiding 
analgesic regimen is recommended. [36] This can be achieved by post-operative 
regional analgesia maintained for up to 72 hours with high level evidence advocating 
post-operative epidural analgesia being shown to reduce PONV, ileus and opiate use. 
[45] In addition to this, antiemetics are recommended and are superior to placebo, 
[53] as is dexamethasone. [54] No benefit is seen after meta-analysis when assessing 
nasogastric tube placement and this is not recommended. [55] 
 
The avoidance of prolonged bed rest and increased mobilisation is another key 
component of ERAS care recommended by the ERAS Society. Although no benefits 
have been shown by RCT for enforced mobilisation, [56] prolonged immobilisation 
has been shown in a retrospective analysis to be associated with prolonged LOS. [57] 
 
1.4.5 ERAS Outcomes  
 
The aim of ERAS is to minimise the impact of the operation in order to allow the 
most efficient recovery. As a result a natural marker of success of ERAS has 
traditionally been the length of time spent in hospital. In the largest meta-analysis of 
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38 trials of different surgical procedures (predominantly colorectal surgery) Nicolson 
et al showed a significant reduction in LOS in the ERAS group [58]. When looking 
at individual surgical procedures meta-analyses have been performed assessing 
oesophagectomy, [30]  pancreatic resection, [59] and colorectal surgery. [60] Similar 
length of stay reduction was reported in these fields of surgery for ERAS care. 
 
An initial concern during initial implementation of ERAS care components was the 
safety of ERAS protocols and the resultant potential to increase complication rates as 
a result of alteration of traditional surgical practices. Again this has proven not to be 
the case on the basis of the current literature. Nicolson et al [58] showed significant 
reductions in morbidity in 22 trials of mixed operation type. Similar significant 
reductions have also been shown following oesophagectomy [30] colorectal surgery 
[60] and pancreatic resection. [59] No significant differences have been observed 
between ERAS protocols and conventional care in terms of mortality. 
 
As a result enhanced recovery principles have become seen as standard of care in 
certain procedures, most notably colorectal surgery where there is a wealth of 
supporting literature. However individual care components are not universally agreed 
upon and not all surgical procedures are as well researched as colorectal surgery, 
affording areas to optimise.  
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1.5 Liver Surgery 
 
Liver resection has become a routine procedure worldwide with increasing numbers 
of resections being performed annually. Liver resection offers the only curative 
option for a number of primary and secondary liver cancers and long-term cure is 
becoming increasingly common. [61] 
 
1.5.1 Indication For Resection of the Liver 
 
The liver is commonly affected by malignancy and both primary and secondary 
tumours can affect the liver. [62] The most common primary liver tumours are 
hepatocellular carcinoma (HCC) and cholangiocarcinoma. The most common 
secondary tumour is a metastasis from colorectal cancer.  
 
1.5.1.1 Hepatocellular Carcinoma 
 
HCC is the commonest primary liver tumour and represents 7.9% of all tumours. 
[63] In northern Europe the incidence is <5 per 100000 people whereas in areas of 
high incidence such as China and South East Asia HCC is reported in 20 per 100000 
people. [63] Its incidence is increasing in the western world but decreasing in areas 
with traditionally high levels of HCC. [63] 
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In patients without cirrhosis, liver resection for HCC results in a five year survival 
rate of 50%. [64] 50% of patients with non-cirrhotic liver will recur within two years. 
[64] Re-resection is often indicated in these patients with similar long term outcomes 
to primarily resected patients. [64]  Five year survival rates for patients with cirrhosis 
who undergo resection for HCC is 45% however the recurrence rates has been 




Cholangiocarcinoma is cancer of the bile ducts and is a relatively rare malignancy 
accounting for 2% of all malignancies reported worldwide. [65] However it is the 
second most common primary liver malignancy. [65] Approximately 1500 people a 
year die in the UK from cholangiocarcinoma. [65] 
 
The only treatment option for a potential cure is surgical resection and often a radical 
surgical approach is required. However only around one third of patients are found to 
have resectable disease at presentation [65] and 50% of those who make it to 
laparotomy are subsequently found to be irresectable at operation. [66] 
 
Cholangiocarcinoma surgery has notoriously poor outcomes. The four year 
recurrence rate is reported as up to 56%. [67] Complete resection of 
cholangiocarcinoma is associated with five year survival rates of between 20 and 
Enhanced Recovery After Liver Surgery 
Introduction  18 
40% for perihilar cholangiocarcinoma. [68] Intrahepatic cholangiocarcnoma has been 
associated with five year survival of 61% but the majority of centres again report 
between 20 and 40%. [68] 
 
1.5.1.3 Colorectal Liver Metastases 
 
The most common tumour encountered in the liver and the most common hepatic 
secondary tumour is a metastasis from a colorectal primary. Colorectal 
adenocarcinoma is the third most common newly diagnosed cancer in the UK. 
Between 2008 and 2010 58 new cases per 100000 men and 37 new cases per 100000 
women were diagnosed in the UK. [69] 25% of these patients present with 
synchronous liver metastases and a further 25% develop metachronous liver 
metastases over their follow up period after colonic resection. Of these 15% will go 
on to have resection of the liver metastasis. [70] 
 
1.5.2 Morbidity and Mortality After Liver Resection 
 
Morbidity after liver surgery remains a major consideration.  Large retrospective 
analyses of liver resection cohorts over the past decade have consistently shown 
mortality rates of under five per cent [71-73]. Mortality rates have decreased from 
around ten per cent [74] to more acceptable levels mainly as a result of centralisation 
of liver resection to large volume centres, [75] advancement of techniques to reduce 
post-operative hepatic failure, [76-78] and reduction in operative blood loss. [79] 
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Morbidity rates however have consistently been reported at levels between 22 and 45 
per cent. [71-73, 80] Common hepatic complications include bleeding, bile leak, 
liver failure and intra-abdominal sepsis. These complications result in significant 
compromise to patients’ recovery after liver resection and result in increased length 
of stay, reduced satisfaction and increased risk of mortality. Furthermore general 
complications such as pneumonia, thromboembolic disease and acute kidney injury 
(AKI) are also prevalent following liver resection [71-73, 80]. 
 
Rates of liver failure have been reported between 2.6 and 5.7 per cent. [71, 81] Liver 
failure can result in multi-organ dysfunction and is a significant contributor to 
increased LOS and post-operative mortality. [72] Bile leak is a further significant 
cause of morbidity and mortality after liver resection. Rates of between 3.6% [82], 
3.7 [71] and 4.8% [81] have been reported in large retrospective cohort studies. Bile 
leak adds to length of stay and is associated with sepsis, liver failure and mortality. 
[83] Intra-operative and post-operative haemorrhage is a further complication related 
to resection of the liver parenchyma. Rates of between 0.5 and 6.8 per cent [71, 84, 
85] are reported. Not only is bleeding itself a complication associated with poor 
outcomes and re-laparotomy but peri-operative blood transfusion is associated with 
other causes of morbidity and mortality. [86] Similarly general complications such as 
pneumonia, UTI and thromboembolic disease not only increase length of stay but 
also are associated with reduced disease free and overall survival after resection for 
malignant disease. [87]  
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Enhanced recovery protocols have resulted in improved peri-operative complication 
rates in numerous surgical specialties [30, 58, 59]. With the increasing performance 
of liver resections at high volume centres and the increasing complexity of liver 
resectional surgery, the application of ERAS protocols to liver resectional surgery 
seems a favourable option when attempting to improve outcomes. 
 
Enhanced recovery protocols were initially introduced to liver resectional surgery in 
2006. [88] Debate remains regarding the optimal ERAS protocol for liver surgery. 
Although the basic principles of enhanced recovery surgery can be applied to liver 
resection surgery, this operation offers several unique facets of complexity that need 
to be considered when implementing surgical intervention and peri-operative care. 
These will be discussed below. 
 




The liver is a vascular organ and receives inflow of blood from both the portal vein 
and hepatic artery. The right, middle and left hepatic veins drain blood from the liver 
into the inferior vena cava (IVC) and back into the heart. As well as this, a system of 
bile ducts drains bile from the hepatocytes into the duodenum via the biliary tree and 
common bile duct.  
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The ability of liver tissue to function is dependent on receiving inflow from the 
portal vein and hepatic artery and having bile and blood drained away by the biliary 
tree and hepatic veins respectively. Resectability is defined as the removal of tumour 
involved liver with R0 resection (surgical resection margin clear of tumour), leaving 
at least two segments with the corresponding inflow, outflow and biliary drainage. 
[89]  
 
The liver is divided into segments according to the functional branching of the 
hepatic inflow and biliary drainage combined in a biliary triad. The standard surgical 
anatomical description of the liver was first described by Couinaud [90] who defined 
the segmental anatomy according to the distribution of the portal vein branches. The 
liver is divided up first of all into two hemilivers: the left and the right. The 
hemilivers are divided into segments according to the portal vein branches as well as 
their arterial inflow and biliary drainage. There are eight segments in total. Segments 
one to four comprise the left hemiliver and segments five to eight make up the right 
hemiliver. The two hemilivers are divided by the middle hepatic vein. Each 
hemiliver is further divided into sections. The following description is the Brisbane 
terminology [91] which is more surgically relevant although does stray from 
Couinaud’s anatomical definition. The right liver is divided into the anterior 
(segments five and eight) and posterior (segments six and seven) sections. The right 
hepatic vein divides the right anterior and posterior sections.  The left hemiliver is 
divided into the medial and lateral sections. The left medial section comprises 
segment four and the left lateral section is made up of segments two and three. These 
sections are divided by the left hepatic vein. The remaining segment of the left 
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hemiliver is segment one, or the caudate lobe, which lies between the IVC and the 
portal vein and has its own drainage via short hepatic veins into the IVC.    
 
1.5.3.2 Underlying Liver 
 
As well as the technical resectability of a tumour, the condition of the underlying 
liver parenchyma is also a consideration when assessing patients prior to liver 
surgery. Patients with underlying cirrhosis are at potentially increased risks of 
complications and mortality. Cirrhosis is a particular concern when operating on 
patients with HCC due to the direct relationship between the two. The Model of End-
Stage Liver Disease (MELD) is a strong predictor of outcome following liver 
resection for patients with cirrhosis and high MELD scores are associated with 
mortality rates of up to 14% after liver resection. [92] 
 
Chemotherapy-related liver injury (CRLI) is a potential concern prior to liver 
resection particularly for patients with colorectal liver metastases who might have 
had either adjuvant chemotherapy following the bowel operation or neoadjuvant 
chemotherapy for a primarily unresectable or resectable liver tumour. Many of the 
chemotherapy regimens used can lead to pathological evidence of steatosis, 
steatohepatitis and sinusoidal obstruction syndrome and can lead to higher rates of 
post-operative complications. [93] 
 
Enhanced Recovery After Liver Surgery 
Introduction  23 
However peri-operative chemotherapy has been shown in a large RCT to provide a 
benefit to patients who underwent liver resection for primarily resectable disease in 
terms of an increased recurrence free survival. [94] Despite no difference being 
observed in overall survival [95] chemotherapy, namely folinic acid, fluorouracil and 
oxaliplatin (FOLFOX4), is recommended for primarily resectable disease in view of 
these data. [70] This is a further facet of care that can contribute to post-operative 
morbidity following liver resection. 
 
Assessment of liver parenchyma can be made from radiological investigations such 
as the appearance of the liver on CT or MRI scan as well as by virtue of historical 
biopsies or laparoscopic assessment. However, often consideration and pre-emption 
of the possibility of poor functional reserve is factored into the pre-operative work 
up. 
 
1.5.3.3 Biliary Obstruction 
 
Further consideration should be given to any obstruction of the biliary system prior 
to resection. Patients with jaundice have been observed to suffer significantly higher 
morbidity rates following major resection [96] and efforts should be made to relieve 
obstruction (most commonly secondary to cholangiocarcinoma) prior to surgery in 
an effort to reduce complications such as abscess formation and bile leak.  
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1.5.3.4 Resection Extent 
 
Deciding on which operative strategy to take involves consideration of size and 
location of the tumour. Small peripheral tumours are often amenable to localised 
non-anatomical resection without disruption to the inflow or drainage of the 
anatomical segment (referred to as an atypical resection). Larger or more centrally 
located tumours are not amenable to atypical resection and require formal anatomical 
resection of the involved segments.  
 
Consideration of the underlying tumour pathology must be made when considering 
surgical approach. When considering HCC, the performance of an anatomical 
resection has been shown by meta-analysis to offer superior overall survival and 
disease free survival than non-anatomical atypical resections. [97] In contrast to this 
no difference was observed in survival rates when anatomical and non-anatomical 
resections are compared for colorectal liver metastasis (CLM) resections. [98]   
 
Hilar cholangiocarcinoma resection will often require extended resection and radical 
excision of the biliary tree. The biliary system then requires to be reconstructed by 
means of a Roux-en-Y hepatico-jejunosotomy. Such procedures are technically 
challenging, prolonged and associated with significantly higher post-operative 
morbidity rates of up to 72 per cent [99] and mortality rates of up to 14.3 per cent. 
[66] The differences in surgical technique, when resecting hilar cholangiocarcinomas 
in particular, compared to other resections include the decision to perform a portal 
Enhanced Recovery After Liver Surgery 
Introduction  25 
vein resection and a recent meta-analysis found this to be related to improved 
survival rates in patients with portal vein involvement. [100] It is also recommended 
that the caudate lobe be resected routinely in resection of cholangiocarcinoma as this 
is associated with better long term results. [101] 
 
The resection margin is an important consideration however the precise margin that 
is acceptable remains controversial and is often determined by anatomical 
considerations of the procedure. Incomplete resection (R1) defined as tumour 
occurring within 1mm of the resection margin is associated with poor long term 
outcome following resectional liver surgery without neoadjuvant chemotherapy, 
although no difference between R0 and R1 survival outcome was observed in those 
who did receive neoadjuvant chemotherapy in a retrospective analysis of 264 
patients. [102] However a meta-analyses looking at CLM [103] has shown that 
resection margins of more than one centimetre are associated with better survival 
outcome than margins of less than one centimetre although these results were not 
replicated for HCCs. [104] Therefore underlying liver pathology as well as 
individual patient factors need to be incorporated into the decision determining the 
appropriate surgical approach. 
 
Resection of the left or right hemiliver normally leaves adequate remnant liver and 
often only involves the sacrifice of one hepatic vein and branch of the hepatic artery 
and portal vein. However, once resection goes beyond the hemiliver and becomes an 
extended resection, careful consideration of the remaining future liver remnant (FLR) 
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is critical. Twenty-five per cent of the functioning liver is regarded as the minimum 
predicted FLR. [105] However, this also depends on the functioning of the remaining 
liver parenchyma. Should the underlying liver be suspected to be sub-optimal, such 
as in cirrhotic livers or livers affected by chemotherapy, a FLR of 30-40% is 
indicated [105] and pre-operative interventions to increase the volume of the FLR 
may need to be employed.  
 
Several options are available should adequate oncological clearance not be perceived 
to be reached by orthodox resections. Such circumstances might be reached if the 
resection would leave less than 25 per cent of the liver volume, the functioning 
parenchyma is suspected to be compromised or the distribution of the tumours 
involves both lobes and would not be amenable to clearance by resection of a 
hemiliver. 
 
Possible options for irresectable tumours include conversion chemotherapy, which 
can downsize tumours into the resectable criteria. This has proven to be an effective 
approach with improved long-term results and increased number of resectable 
patients. [106] 
 
Portal vein embolisation (PVE) involves the involved liver being excluded via 
embolisation of the corresponding branch of the portal vein and hypertrophy of the 
FLR being induced to increase liver volume. PVE is associated with long term 
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survival outcomes similar to patients undergoing extended resections without PVE. 
[76] Hypertrophy after PVE takes between four to six weeks.  
 
A further option, either with or without PVE, is termed two-stage resection where 
bilobar disease is resected first by clearance of one lobe, followed by a staged 
interval to allow for regeneration and then clearance of the other lobe. This approach, 
although relatively new in practice has resulted in superior long-term survival 
compared to chemotherapy alone. [77] 
 
A recent development is known as Associating Liver Partition and Portal Vein 
Ligation (ALPPS). This technique employs a surgical split of the liver along the 
falciform ligament in conjunction with a portal vein ligation. This induces the left 
side of the liver to hypertrophy and the affected right side to atrophy prior to a 
second stage procedure to remove the affected hemiliver around seven days later. 




Liver resection is notorious for its potential to cause excessive intra-operative 
bleeding. Much research has focused on minimisation of intra-operative bleeding. 
Not only is significant bleeding itself intrinsically related to poor outcome and is 
associated with peri-operative mortality, [107] it is also associated with the 
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development of other peri-operative complications, particularly infective 
complications. [86] 
 
Central venous pressure (CVP) optimisation during parenchymal resection has been 
shown to be associated with reduced estimated blood loss (EBL). [108] Methods of 
CVP reduction are varied. By using anaesthetic methods of intra-venous infusion 
(IVI) reduction, vasodilators and/or diuretics to maintain a CVP of less than five 
mmHg then significantly reduced EBLs and length of stay have been observed [109].  
 
Intra-operative use of in-flow occlusion is used to reduce blood loss. The technique 
involves the clamping of the portal vein and the hepatic artery (the Pringle 
manoeuvre). This leads to ischaemia of the liver if applied for prolonged periods that 
can potentially lead to post-operative morbidity. [110, 111] The common protocol for 
complete inflow occlusion is to apply occlusion for ten minute periods with 
intermittent five minute intervals of non occlusion during liver transection if 
required. 
 
Additional surgical techniques to reduce blood loss are total vascular hepatic 
exclusion (TVHE). This involves clamping of the hepatic veins and the IVC above 
and below the liver, in combination with a Pringle manoeuvre. Similarly selective 
vascular hepatic exclusion (SVHE) is also employed and this involves clamping the 
hepatic veins but the inflow and IVC are still patent.  A meta-analysis [112] did not 
show any benefit of SHVE or THVE in terms of morbidity and mortality compared 
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to Pringle alone, and Pringle was associated with a significantly lower morbidity 
when compared to THVE.  
 
1.5.4 Inflammatory Mediators and Outcomes After Liver Surgery 
 
Liver resection, in common with other forms of abdominal surgery, results in a 
similar inflammatory response with mediation from cytokines as well as endocrine 
and sympathetic responses. Liver resection however has some specific differences 
that are unique to this type of surgery.  
 
Kupffer cells can result in a highly exaggerated inflammatory response when 
stimulated due to resection. [113] Liver transection results in disruption and injury to 
the liver parenchyma resulting in Kupffer cell damage and release of inflammatory 
mediators.  
 
Portal triad clamping in an attempt to reduce intra-operative blood loss involves the 
clamping of the hepatic artery and the portal vein. As a result in-flow to the liver is 
stopped for a period of time. This process can result in an ischaemia/reperfusion 
injury to the liver whereby hypoxic damage can occur. This results in a further 
stimulation of the cytokine mediated response. [114]  
 
The liver is also unique in its ability to regenerate following resection. This is a well- 
orchestrated process that results in cell proliferation and tissue formation. However it 
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is initiated by the cytokine cascade that, in turn, stimulates growth factors and 
hepatocyte regeneration. [115] Therefore an appropriate inflammatory response is 
important not only to avoid immunosuppression but also to ensure adequate liver 
functioning after liver resection. 
 
Attempts to attenuate the inflammatory response after liver resection have been made 
by several investigators. A meta-analysis of RCTs shows that when perioperative 
steroids are administered in patients undergoing liver resection a reduction in IL6 
and CRP, a raise in IL10 and an improvement in clinical outcomes including 
morbidity are observed. [116] 
 
1.6 Summary and Required Work 
 
Major surgery results in a stimulation of the inflammatory response in order to 
preserve function and promote healing. However, as a result of this process, 
compromises to recovery can occur. Enhanced recovery after surgery is a 
multifaceted care process that has proven to be effective at reducing post-operative 
morbidity and expediting recovery. It aims to attenuate the impact of surgery and the 
inflammatory response to allow recovery to be optimised.  
 
Liver surgery is indicated as a curative option for a number of malignant conditions. 
Indications for surgery and the numbers of resections being performed are 
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increasing. Due to the complex nature of liver surgery it has several aspects of care 
that are not encountered in other aspects of abdominal surgery. These unique 
complexities of liver surgery mandate consideration when attempting to optimise 
outcome after hepatic resection. For this reason the general ERAS literature is not 
necessarily translatable to liver resection surgery. Therefore it is crucial to scrutinise 
the liver ERAS literature in order to establish current practice and determine the 
areas where improvements are required in order to minimise post-operative 
morbidity after liver surgery. The following chapter investigates in detail the current 
evidence assessing enhanced recovery after liver surgery. 
 
1.7 Chapter Publications 
 
Principles of Liver Surgery. Michael J Hughes & Stephen J Wigmore. Surgery 
2014;12:643-647 
 
Malignant Liver Tumours. Michael J Hughes & Ewen M Harrison. Surgery 
2014;12:655-660 
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2 Enhanced Recovery Following Liver Surgery: A Systematic 




Enhanced Recovery After Surgery (ERAS) programmes aim to improve post-
operative outcomes. They are increasingly being utilised in hepatic surgery. This 
review aims to evaluate the impact of ERAS on outcomes following liver surgery 
and identify areas where improvements can be made. EMBASE, Medline, PubMed 
and the Cochrane database were searched for trials comparing outcomes of patients 
undergoing liver surgery utilising ERAS principles with conventional care. The 
primary outcome was post-operative complications within 30 days. Secondary 
outcomes included length of stay, functional recovery, and adherence to the ERAS 
protocols. Nine articles were included in the review, of which two were RCTs. The 
overall complication rate was: ERAS 25% (range 11.5%-46.4%); conventional care: 
31% (range 11.8%-46.2%). Significantly reduced overall complication rates 
following ERAS care were demonstrated by the two RCTs following meta-analysis, 
(OR 0.49, 95%CI 0.28, 0.84; p=0.01) The median length of stay for ERAS patients 
reported by the studies was 5 (range 2.5-7) days compared with 7.5 (range 3-11) days 
for non-ERAS patients. Recovery milestones, where reported, were improved 
following ERAS care. The adoption of ERAS protocols improves morbidity and 
length of stay following liver surgery. ERAS programmes need to accommodate the 
unique properties of liver surgery in order to optimise post-operative outcomes.  
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2.2 Introduction 
 
ERAS programmes were introduced initially in colorectal surgery, where they have 
been associated with improvements in post-operative length of stay and morbidity. 
[28] They have since been adopted by multiple specialties including orthopaedic 
surgery [29], oesophagogastric surgery [30] and breast surgery. [31] 
 
The underlying principle of ERAS is a multimodal peri-operative protocol to 
attenuate the inflammatory response and potentiate patient rehabilitation following 
major surgery. [32] The intention is to prevent the problems associated with an 
exaggerated inflammatory reaction to surgery such as poor healing, infective 
complications and organ dysfunction. [33] This approach, incorporating intensive 
optimisation of mobility, gut function and analgesia [34] contributes to expediting 
recovery and minimising morbidity. 
 
ERAS programmes have been shown to reduce post-operative morbidity rates 
following a variety of surgical procedures. [28] Liver resections have traditionally 
been associated with high mortality and morbidity rates. With current surgical and 
peri-operative management mortality rates of less than five per cent can be achieved. 
[71] However, morbidity rates remain high at between 22 and 45 per cent. [71, 73, 
81, 117]  Adopting ERAS protocols may facilitate further improvement in surgical 
outcomes in hepatic resection. 
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Recently a number of publications have examined the application of ERAS 
programmes to hepatic surgery. This review aims to evaluate the impact of these 
programmes on morbidity and recovery rates following liver surgery and identify 
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2.3 Methods 
 
This study was conducted according to the PRISMA guidelines for meta-analysis. 
[118] A literature search was performed independently by two researchers of 
EMBASE, Medline, PubMed and the Cochrane databases in May 2013. 
 
The databases were searched from 1966-2013 with the following key terms: 
“enhanced recovery”, “fast track”, “ERAS” and “liver”, “hepatobiliary”, “hpb”. All 
abstracts were reviewed for relevance. Relevant full text articles were subsequently 
reviewed.  
 
All trials assessing enhanced recovery following liver surgery were included. It was 
required that the protocol be clearly stated and that it contain at least four items of 
care considered to be contributory to an enhanced recovery programme. [119] 
Exclusion criteria included: children aged 16 years and below; non-standardised care 
pathway and comparison of ERAS protocols in both arms of the study. 
 
All studies included in the final analysis were assessed by two independent 
reviewers. Study quality and bias was assessed independently using the Downs and 
Black score. [120] Data was extracted directly from the papers as directed by data 
extraction forms. 
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Primary outcome was the occurrence of any complication occurring within 30 days 
post-operatively. The following markers were assessed as secondary outcomes: 
length of stay (LOS); time to the achievement of functional recovery; readmission 
rate and adherence to ERAS protocol. 
 
The meta-analysis was performed using Review Manager (RevMan ver 5.2. The 
Nordic Cochrane Centre, Copenhagen). Dichotomous data were analysed by fixed 
effects odds ratio. Heterogeneity was assessed by using I2 and X2 and adjudged to be 
significant if I2 >50 per cent and/or p<0.05. Statistical significance was set at p<0.05. 
When continuous quantitative data were not distributed normally, meta-analysis was 
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2.4 Results 
 
2.4.1 Study Characteristics 
 
257 papers were identified. The PRISMA diagram is shown in Figure 5. Nine studies 
were included for review. [88, 121-128]  
Enhanced Recovery After Liver Surgery 
Enhanced Recovery Following Liver Surgery: A Systematic Review and Meta-analysis  38 
 
Figure 5. PRISMA diagram 
 
In open hepatic surgery there were two RCTs [122, 124], two prospective [123, 126] 
and one retrospective [121] cohort studies, and two case control papers. [88, 128] 
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Two case control trials compared laparoscopic ERAS protocols with laparoscopic 
conventional care. [125, 127] 
 
The trials included spanned the period 2008 to 2013. A total of 522 patients 
underwent liver resection with an ERAS protocol and 316 followed a conventional 
care pathway following liver resection. Patient age was reported between the groups 
as ERAS: median 60 years (range 48.4 – 64) and conventional care: median 53.8 
years (range 45-67). The majority of the operations were for colorectal liver 
metastases or hepatocellular carcinoma. Details of participant characteristics are 
shown in Table 1. All studies explicitly described an ERAS protocol. A median of 11 
ERAS items were utilised (range 8 - 19). The individual components utilised in the 
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   Van Dam et al [88] Sanchez Perez et al [125]     Stoot et al [127]          Jones et al [122] 
 ERAS C ERAS C ERAS C ERAS C 
Number 61  100 26 17 13 13 46  45 
Age (years) 62 (24-82)  60 (20-81) 58 (29-77)  52 (29-84) 55 (34-82) 45 (26-70) 64 (27-83) 67 (27-84) 
ASA n(%) 
  I 
  II 
  III 
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Male  35(57.3) 51(51.0) 15(57.7)  10(58.8) 3(23.1)  2(15.4) 31(67) 23(51.1) 
Quality 20/32  18/32  19/32  31/32  
ERAS = Enhanced Recovery After Surgery; C = Conventional Care; NA=Not assessed. Statistically significant results (p<0.05) are highlighted in bold. § = 
POSSUM scores significantly greater in ERAS group, *mean±sd. Data are presented as n(%) or median (range).  
 Table 1. Patient characteristics 
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 Mackay [123] Schultz et al 
[126] 
     Lin et al [128] Connor et al [121]      Ni et al [124] 
 ERAS ERAS ERAS C ERAS ERAS C 
Number 12 100 56 61 128 80 80 
Age (years)  60 (43-74) 64 (16-91) 57(23-73) 55 (22-81) 63 (35-82) 48.4 ±15.6* 50.1 ±21.8* 
ASA n(%) 
  I 
  II 
  III 
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Male n (%) 8(66.7) 63(63.0) 31(55.4) 34(55.7) NA 66(82.5) 59(73.8) 
Quality 18/32 22/32 21/32  21/32 27/32  
ERAS = Enhanced Recovery After Surgery; C = Conventional Care; NA=Not assessed. Statistically significant results (p<0.05) are highlighted in bold; 
§§n=129, *mean±sd.   Data are presented as n(%) or median (range).  
Table 1 contd. Patient characteristics   
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Care Component Van Dam 
et al [88] 
Sanchez Perez et 
al [125] 
Stoot et al 
[127] 
Jones et al 
[122] 




Schultz et al 
[126] 
Lin et al 
[128] 




  X X  X X  X X X 
Avoid bowel prep    X  X   X X 
Carb. drinks up to two 
hours pre-op 
X  X X  X X   X X 
Avoid anaesthetic pre-
med 
X  X X  X   X X 
DVT prophylaxis    X      X 
Antibiotic prophylaxis    X   X    X 
Standard anaesthetic 
protocol 
X   X X      X 
Ileus avoidance X  X X  X  X    
NGT avoidance X X X X  X  X  X  
Intra-op warming X   X      X 
Minimisation of pre-op 
fluids 
X X X X  X X  X X X 
Avoid routine drains X  X X X  X  X  X X 
Early removal of IDC X X X X  X X X  X X 
Multimodal analgesic X X X X X X X X X 
Early feeding X  X X X  X X  X X X 
Early mobilisation X X X X  X X  X X X 
X=component included, NGT = nasogastric tube, IDC = indwelling catheter, DVT= Deep vein thrombosis. 
Table 2. ERAS components present in protocol 
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2.4.2 Complications 
 
All nine studies assessed complication rates (Table 3). [88, 121-128] The overall 
morbidity rate was: ERAS 25% (range 11.5% - 46.4%); conventional care: 31% 
(range 11.8%-46.2%). Ni et al [124] observed a significantly reduced overall 
complication rate in the ERAS group (Figure 6) and meta-analysis of the two RCTs 
assessing overall complication rates shows significantly fewer complications 
following ERAS surgery (I2 0%; OR 0.49, 95% CI 0.28, 0.84; p=0.01). Both Jones et 
al [122] and Ni et al [124] reported significantly fewer non-surgical complications in 
the ERAS arm (Jones et al: ERAS 7% versus conventional care 27% p=0.02; Ni et 
al: ERAS 12.5% versus conventional care 25%; p=0.04) but showed no statistically 
significant difference in liver specific complications (Jones et al: ERAS 15% versus 
conventional care 11%, p=0.612; Ni et al: ERAS 17.5% versus conventional care 
21%, p=0.55).  
 
 
Figure 6. Morbidity rates for ERAS versus conventional care.
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ERAS – Enhanced Recovery After Surgery; C – Conventional Care; LOS – Length of Stay; IQR – Interquartile Range; RCT – Randomised Controlled 
Trial; NA – Not Assessed.  Statistically significant results (p<0.05) are highlighted in bold.  
Table 3. Study outcomes 
Author Design n LOS (Days) 




Median (IQR) or 
mean±sd 
Readmission n (%) Morbidity n (%) 
  
Case control 
ERAS C ERAS  C  ERAS C ERAS  C  ERAS  C 
Van Dam et al [88] 61 100 6 (3-82)  8 (4-68) NA NA 8(13.0)  10(10.0)  25(41.0)  31(31.0)  
Sanchez-Perez et al [125] Case control 26 17 2.5 (1-39)  3(1-22)  NA NA 1(3.8)  1(5.8)  3(11.5)  2(11.8)  
Stoot et al [127] Case control 13 13 5 (3-10)  7 (3-12)  3 (1-7)  5 (2-8)  0 (0) 0 (0) 2 (15.4) 2(15.4) 
Jones et al [122] RCT 46 45 4 (3-5) 7 (6-8) 3 (3-4)  6 (6-7) 2 (4.3)  0 (0) 8 (17.4)  14 (31.1) 
Ni et al [124] RCT 80 80 6.9 (±.8) 8.0 (± 3.7) 5.2 (±2.3)  6.7 (±2.9)  NA NA 24(30.0)  37(46.2) 
Mackay [123] Prospective 
cohort 
12 - 4 (2-7)  - NA - NA - 3(25.0) - 
Schultz et al [126] Prospective 
cohort 
100 - 5 (minor)  
6 (major) 
- NA - 6(6.0) - 25(25.0) - 
Lin et al [128] Case control 56 61 7 (3-26)  11 (4-37) NA NA 4 (7.1)  2(3.3) 26(46.4)  27 (44.3) 
Conner et al [121] Retrospective 
review 
128 - 4 (2-111)  NA - 14(10.9) - 34 (26.6) - 
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2.4.3 Length of Stay 
 
The median length of stay for ERAS patients reported by the studies was 5 (range 
2.5-7) days compared with 7.5 (range 3-11) days for non-ERAS patients. The three 
cohort studies reported median LOS of 4 [121, 123] and 5 [126] days. All four 
studies comparing ERAS open liver surgery to conventional open liver surgery 
showed a significantly reduced LOS in the ERAS groups. [88, 122, 124, 126] Neither 
of the two laparoscopic studies [125, 127] identified a reduced LOS. However, Stoot 
et al [127] reported reduced time to achieve functional recovery. Functional recovery 
was only reported by three studies [122, 124, 127] which all showed reduced time to 
recovery following ERAS care. Five [88, 122, 125, 126, 128] of the nine trials 





Three of the studies reported rates on adherence to the protocol. [88, 122, 123] Jones 
et al [122] reported a 100% adherence in all 19 ERAS categories except early 
removal of IDC. Mackay & O’Dwyer [123] reported prolonged use of IV fluid 
administration beyond the first post-operative day in 25% of patients. Van Dam et al 
[88] reported on abdominal drain insertion (n=1), nasogastric tube insertion (n=3) 
and epidural analgesia (95%). 
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2.5 Discussion 
 
This review investigated the effects of ERAS protocols on recovery following liver 
resection. Three previous reviews [119, 129, 130] have been performed in this area, 
which concluded that safety and feasibility were satisfactory with reduced length of 
stay not resulting in increased morbidity or mortality. However these reviews 
included studies other than purely ERAS versus conventional care, did not report any 
RCTs and reviewed only two studies comparing open ERAS versus open 
conventional care. Since these reviews five studies have been published including 
two RCTs. Therefore in light of this new evidence it is important to review the 
current recommendations. 
 
This review was limited as a result of the small number of RCTS, preventing 
meaningful meta-analysis. The majority of studies were observational thus reducing 
the power of the review and preventing optimal quantitative comparison. However 
all trials were procedure specific and compared ERAS with conventional recoveries 
and this review represents the current best available evidence. 
 
In concordance with the previous reviews on this subject, [119, 129, 130] the current 
review observed that length of stay can be reduced by ERAS programmes, a result 
that was seen in all of the comparative studies in open liver resection. However, in 
contrast to the previous reviews, and in line with previous ERAS literature [28] it has 
also demonstrated that complication rates in hepatic surgery can also be reduced by 
Enhanced Recovery After Liver Surgery 
Enhanced Recovery Following Liver Surgery: A Systematic Review and Meta-analysis  47 
ERAS protocols, with meta-analysis of both published RCTs showing a significant 
reduction in overall complication rates. 
 
This reduction was not repeated in the non-RCT studies. This may be related to study 
design and power. Also, morbidity as an outcome measure has its limitations, with 
reporter bias and inconsistent complication classifications potentially contributing to 
morbidity rate variation.  However it is of note that Ni et al [124] had the youngest 
population of all the studies and both RCTs had relatively fitter populations. 
Advanced age and ASA level are both independent predictors of morbidity following 
abdominal surgery [131] and it is possible that younger and fitter populations of 
these studies progressed better in an enhanced recovery protocol. Furthermore, Jones 
et al [122] employed an ERAS programme incorporating 19 components – more than 
any other trial, and the protocol compliance was exceptionally high, a key 
consideration in the conduction of ERAS programmes. [132] 
 
Adherence was poorly reported with only three trials commenting on this. The main 
areas of reported poor compliance were IV fluid restriction, IDC removal and early 
mobility. Within the colorectal ERAS literature compliance is often not recorded or 
may be as low as 5% for some elements. [132] Higher rates of compliance are 
associated with reduced length of stay. [132] Compliance is an area that has potential 
for improvement in ERAS protocols following liver surgery. 
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Although the rates of general complications were observed to have been reduced in 
the two randomised trials, no difference in liver specific surgical complications was 
observed. Liver resection offers a unique set of post-operative circumstances due to 
the process of liver regeneration, anatomical complexity of biliary drainage and 
intra-operative vascular inflow control and transient impairment of liver function 
following resection. When scrutinising the included ERAS protocols, such 
components were not consistently addressed and so it is not surprising that the ERAS 
approach did not reduce surgical complications in these patients.  
 
Whilst the majority of the ERAS protocols focussed on pre- and post-operative 
considerations, opportunities exist where intra-operative care can be optimised. 
Minimising blood loss can help to reduce post-operative complications. [71, 73, 117] 
Raised CVP has been shown to be associated with intra-operative blood loss during 
liver resection [109]. In this review only two trials [88, 121] commented on titration 
of IV fluid according to CVP. Jones et al [122] used goal directed fluid therapy 
guided by cardiac output monitoring to prevent fluid overload although this was done 
in the early post-operative period. It would appear in liver surgery that ERAS 
protocols should incorporate both intra-operative and post-operative components to 
maximise their gains. 
 
Areas that were not explored by the included studies included the use of thoracic 
epidural. Although recommended in colorectal ERAS literature [36] its use has been 
questioned in liver surgery [133] as it is associated with fluid overload and increased 
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red cell transfusion. There is evidence suggesting that epidurals may impair recovery 
in liver surgery, and that alternate analgesic methods should be considered. [134, 
135] However, the evidence base is not clear or conclusive and controversy regarding 
this facet of care remains.  
 
Analgesia after liver resection is also complicated by a potentially small liver 
remnant that may be a contra-indication to administering acetaminophen. [136] 
Acetaminophen is routinely utilised as the backbone of ERAS analgesic regimens but 
in major hepatic resections it is often withheld for fear of inducing liver damage, 
increasing opiate requirements. Evidence addressing this issue is limited to a small 
observational study. [136] Further evaluation of analgesia for liver surgery within the 
context of an ERAS programme is required to establish optimum practice. 
 
This review has highlighted the benefits of the application of enhanced recovery 
principles following liver surgery. However, the evidence supporting these principles 
stems from the colorectal literature. Resectional liver surgery comes with its own set 
of unique conditions that must be acknowledged when attempting to optimise the 
outcomes of patients following liver surgery. In order to maximize the potential 
benefit of such programmes future research should aim to establish peri-operative 
care plans specific to liver surgery and accommodate the unique requirements of this 
operation.  
 
Enhanced Recovery After Liver Surgery 
Enhanced Recovery Following Liver Surgery: A Systematic Review and Meta-analysis  50 
Length of stay is not an ideal outcome to judge the success of an ERAS programme 
due to the multifactorial aspects of patients being able to leave hospital. [137] 
Functional recovery was infrequently assessed in the included studies. When this was 
reported, ERAS protocols resulted in either parity or improvement of these 
outcomes. Functional recovery has been suggested as more meaningful than simple 
LOS in assessing the success of an enhanced recovery protocol [119] and should 
form the measurement of success in future programmes. 
 
In summary the evidence investigating ERAS following liver surgery is limited with 
only two RCTS. However, postoperative length of stay is reduced when compared to 
conventional care. Overall and general complication rates seem to be reduced 
although surgical morbidity remains high and as yet is not affected by ERAS 
protocols following liver surgery. Future research should concentrate on peri-
operative care components specific to liver surgery, such as optimal analgesic 
regimens and intra-operative manipulations to reduce blood loss, rather than simply 
transferring components from the colorectal literature. The following two chapters 
will investigate the literature assessing these two aspects of care during liver surgery. 
 
2.6 Chapter Publication 
 
Enhanced Recovery Following Liver Surgery: a systematic review and meta-
analysis. Hughes MJ, McNally S, Wigmore SJ. HPB (Oxford). 2014;16:699-706.  
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Post-operative analgesia following liver resection remains controversial. The 
traditional standard of care of thoracic epidural is increasingly questioned due to 
perceived associated complications and delays to recovery. Evidence supporting 
alternative analgesic techniques is emerging however best practice is not yet 
established. This review aimed to evaluate the literature to assess the optimum 
analgesic technique following liver resection. A systematic review was conducted of 
trials evaluating analgesic methods in open liver surgery. Primary outcome was the 
post-operative complication rate. Secondary outcomes were length of stay and pain 
scores. Fourteen trials matching the inclusion criteria were analysed. No difference 
was observed in systemic complication rates between analgesic modalities. Epidural 
was associated with prolonged length of stay when compared with continuous wound 
infiltration and intrathecal morphine. Epidural offered equivalent or superior pain 
scores when compared to alternative techniques. In summary, current evidence 
suggests alternative analgesic modalities may provide favourable recovery outcomes 
following liver surgery compared to epidurals but consistent evidence is limited. 
Epidurals provide superior pain relief to alternatives but this does not translate into 
reduced length of stay or complication rate following liver surgery. 
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3.2 Introduction 
 
Liver surgery is commonly performed worldwide and its indications have increased in 
recent years. Overall mortality has now been reported at levels of less than five per 
cent [81], when performed in high volume centres. However complication rates 
remain high at levels reported between 22 and 45%. [71, 73, 117] 
 
Efforts to improve complication rates have focussed on optimising post-operative 
care. Enhanced Recovery After Surgery (ERAS) programmes, by way of initiating 
early mobilisation, early feeding and a multi-disciplinary goal directed care package 
have contributed to improved post-operative morbidity rates. [28] Pain control is a 
vital component of the post-operative care of these patients and crucial when 
attempting to achieve ERAS recovery milestones. [36] Traditionally an epidural has 
been advocated as the routine, optimal choice of analgesic modality following liver 
surgery, [88, 138] although in recent years this has been questioned. [139] 
 
Criticisms of epidurals cite the associations with hypotension, post-operative 
intravenous fluid overload [140] and increased rates of blood transfusion. [141] 
Furthermore high failure rates, [142] risks of urinary retention [143] and epidural 
haematoma [144] and infection [145] contribute to delays to post-operative recovery. 
When compared to other abdominal procedures, liver surgery patients have reported 
post-operative coagulopathy rates of over 50% making epidural haematoma an even 
greater consideration. [146] Furthermore, liver resection is ideally performed under 
hypovolemic conditions and increased intra-operative IV fluid administration 
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associated with neuraxial blockade can further complicate post-operative recovery. 
[147] Therefore choice of analgesic technique is particularly pertinent following liver 
surgery and can have significant effects on outcome. 
 
In the absence of superior alternatives such negative side effects have been tolerated 
in favour of the excellent pain relieving components in an effort to optimise post-
operative recovery outcomes. [36] However, new analgesic techniques are being 
developed and used in open abdominal surgery and liver surgery and support for such 
techniques is growing. [148]   
 
ERAS following liver surgery has grown in popularity. [119] Therefore the effect of 
analgesic modality on surgical outcomes is coming under scrutiny. Debate continues 
as to the optimal analgesic modality following liver surgery in terms of overall post-
operative outcome. [133] Therefore this review aims to systematically evaluate the 
literature comparing all analgesic modalities following liver surgery and assess the 
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3.3 Methods 
 
This review was conducted in accordance with the PRISMA guidelines. [118] A 
literature search of Medline, EmBase, OVID and PubMed from November 1966 to 
September 2013 was performed independently by two reviewers. The following 
search terms were used: “liver resection” or “hepatic resection” or “hepatectomy” and 
“epidural” or “opiate” or “opioid” or “spinal” or “intrathecal” or “wound catheter” or 
“continuous infiltration” or “local infiltration” or “transversus abdominis plane” or 
“TAP block” or “patient controlled analgesia” or “on-q”. 
 
Two researchers independently performed the literature search and all articles were 
scrutinised and irrelevant publications excluded. All relevant publications were 
reviewed and compared with the pre-determined inclusion criteria independently. 
Each paper was then assessed for quality by the two reviewers using the Downs and 
Black score. [120]  
 
The following data were extracted directly from the papers: patient demographic 
details, type of operation, analgesic regimen details, complication rates, length of stay 
(LOS), pain scores at rest and on movement at 24 hours post-operatively and in 
hospital mortality rates. If specific data were not presented, statistical or non-
statistical differences were extracted where reported.  
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3.3.1 Inclusion and Exclusion Criteria 
 
Papers assessing any analgesic modality in open liver surgery were included. Papers 
examining analgesia in other hepatic procedures were excluded (laparoscopic 
resections, liver transplant recipients, hepatic ablations). Papers examining the effect 
of epidural on fluid balance and coagulopathy were also excluded. Papers comparing 
different configurations of the same analgesic technique in both study arms were also 





The primary outcome was overall systemic complication rate within 30 post-operative 
days. All complications, medical and surgical, were included in a composite manner. 
Local complications were also examined.  Secondary outcomes were LOS and pain 




A qualitative descriptive analysis was performed to compare outcomes of the included 
trials. In order to allow for appropriate comparison of analgesic techniques, studies 
that compared similar techniques were reviewed together. Statistically significant 
differences in outcomes were sought. A difference was considered significant if the 
quoted p value was <0.05.  
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3.4 Results 
 
Fourteen studies were included in the review [134, 135, 149-160] as shown in the 
PRISMA diagram (Figure 7) and Tables 4 and 5. Nine of the trials were RCTs, [135, 
150, 152-156, 158, 159] four were retrospective studies [134, 151, 157, 160] and one 
was a prospective non-controlled study. [149] The selected articles reached a high 
scientific level with a median Down’s and Black score of 26 (range 16-30). 
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Figure 7. PRISMA diagram 
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Table 4. Study analgesia regimens   
 
Study Design Operation Modality 1 Regimen 1 Modality 2 Regimen 2 Downs 
and 
Black 






Epidural T10-T12 0.1% bupivacaine and 0.1% 
meperidine until pain suitable for 




Demand pump with IV 
morphine. 
24/32 









T7-T10 placement, postoperative 
infusion of 0.1% bupivacaine and 
0.015mg/ml hydromorphone at 
5ml/hr (with 3ml bolus, 20 minute 




bolus at 0.2-0.4mg with 
5min lockout and 4hr max 
of 10mg. 
Or morphine 1mg/ml bolus 
of 1-2mg with 5 min 
lockout and 4 hour max of 
40mg. 
23/32 






Epidural 0.0625% bupivacaine + 
3.3microg/ml fentanyl 
 
IV opiates IV PCA morphine and IV 
morphine 
16/32 




Epidural T7-8 0.1% bupivacaine and 2mcg/ml 
fentanyl at 7-10ml/hr 
CWI 20ml bolus of 0.25% 
bupivacaine; Dual Catheter 
0.375% levobupivacaine at 
4mls/hr in musculofascial 
layer for 48hrs 
30/32 
CWI = Continuous Wound Infiltration, PCA= Patient Controlled Analgesia, ITM= Intrathecal Morphine, ITP= Interpleural analgesia, 
PVB = Paravertebral Block 
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Table 4 contd. Study analgesic regimens. 
Study Design Operation Modality 1 Regimen 1 Modality 2 Regimen 2 Downs 
and 
Black 
Chan et al 
[150] 
RCT Liver resection Placebo Dual limb catheter to 
musculofascial layer, 20ml 0.9% 
saline to musculofascial layer prior 
to closure; then 4ml/h for 68h 
CWI Dual limb catheter to 
musculofascial layer, 20ml 
0.25% ropivacaine to 
musculofascial layer prior 








Liver resection CWI Dual limb wound catheter. 1 limb 
in TA plane, 2nd limb posterior to 
rectus muscle. 10 ml bolus of 
0.25% bupivacaine then 0.25% 
bupivacaine at 3ml/hour for 72h 
 
- - 21/32 
Lee et al 
[154]  





Dural puncture of L3-4/L4-5 and 
injection of 400 microg of 
morphine sulphate. At end of 
operation 1500microg of fentanyl 
in 100ml normal saline commenced 
at 1ml/hr plus 15microg bolus 
fentanyl PCA with 15min lockout.  
CWI Dual limb catheter. 1st  limb 
to TA plane and 2nd limb to 
preperitoneal space in 
midline. Bolus of 10mls 
0.75% ropivacaine given 
then 300ml of 0.5% 
ropivacaine delivered at 
4ml/hr for 72hrs.  
29/32 
CWI = Continuous Wound Infiltration, PCA= Patient Controlled Analgesia, ITM= Intrathecal Morphine, ITP= Interpleural analgesia, PVB = 
Paravertebral Block  
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Table 4 contd.  Study analgesic regimens. 
Study Design Operation Modality 1 Regimen 1 Modality 2 Regimen 2 Downs 
and 
Black 






Epidural 0.125% bupivacaine and fentanyl 
2mcg/ml 0.1ml/kg/hr weaned 
after 72 hrs 
ITM 300microg morphine and 
oral gabapentin (1200mg 





et al [152]  
RCT Liver 
resection 
Epidural T9-T11 ropivacaine 0.2% 6-8 ml 
and morphine 2mg pre-op; post-
op infusion of ropivacaine 0.2% 
5-7ml/h 
ITM Dural puncture at L3-L5; 









Intraoperative epidural infusion of 
0.5% bupivacaine at 3ml/hr plus 
preoperative intrathecal injection 





injection of 0.5mg 
morphine plus sham intra-
operative epidural 
30/32 







Sham intrathecal injection (skin 
punctured but not advanced 
beyond subcutaneous tissue). 
PCA morphine - 0.05mg/kg at 
7min intervals if pain >60mm on 




L2/3 or L3-4 lumbar 
puncture and injection of 
morphine 0.5mg and 
15mcg fentanyl 
27/32 
CWI = Continuous Wound Infiltration, PCA= Patient Controlled Analgesia, ITM= Intrathecal Morphine, ITP= Interpleural analgesia, PVB = 
Paravertebral Block  
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Table 4 contd. Study analgesic regimens. 
 
 
Study Design Operation Modality 1 Regimen 1 Modality 2 Regimen 2 Downs 
and 
Black 
Ko et al 
[153]  
RCT Living donor 
hepatectomy 
ITM + IV PCA 
fentanyl 
Dural puncture of L3-4/L4-5, 
400microg morphine sulphate 
in 4ml 0.9% saline injected + 
IV PCA fentanyl 15microg/l, 
1ml bolus, lockout time of 
15mins and baseline rate of 
1ml/hour 
IV PCA fentanyl IV PCA fentanyl 
15microg/l, 1ml bolus, 
lockout time of 15mins 




et al [159]  
RCT Liver resection ITP Levobupivacaine 0.125% at 




Morphine 1mg bolus 
with 5 min lockout and 





RCT Living donor 
hepatectomy 
PVB Pre-operative bilateral thoracic 
paravertebral injection at T7-8 
of  25mls bupivacaine 0.25% 
with epinephrine 1:200000 
Placebo Pre-operative bilateral 
thoracic paravertebral 
injection at T7-8 of 
25mls 0.9% NaCl 
25/32 
CWI = Continuous Wound Infiltration, PCA= Patient Controlled Analgesia, ITM= Intrathecal Morphine, ITP= Interpleural analgesia, PVB = 
Paravertebral Block  
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Table 5. Demographic and pathological characteristics of included studies 
 Page et al [157] Clarke et al [151] Yong et al [160] Revie et al [135] Chan et al [150] Basu et al [149] 












NA Age (mean±sd) 
ASA n(%) 
  I 
  II 
  III 




















  ≥3 segments 




















  CLM 
  HCC 
  Cholangiocarcinoma 
  Benign 





















Male n (%) 140(54.7)/37(33.3)  28(41.2)/76(48.1)  NA 19(61.3)/17(51.5)  17(77.3)/19(86.4) NA 
NA=Not assessed, CWI = Continuous Wound Infiltration, PCA= Patient Controlled Analgesia, HCC = Hepatocellular carcinoma, CLM= Colorectal 
Liver Metastasis. Statistically significant differences are highlighted in bold. Data are presented as n(%) unless stated otherwise.*median (range) 
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 Lee et al [154] Koea et al [134] De Pietri et al [152] Mondor et al [155] 
 ITM/CWI Epidural/ITM Epidural/ITM Epidural+ITM/ITM 
Number 21/19 50/50 25/25 22/22 
Age (mean±sd) 35.6±11.0/30.5±8.7 61(28-83)/60(23-79)* NA  61.0±8.0/58.0±11.0 
ASA  
  I 
  II 
  III 
  IV 
 















 ≥3 segments 













  CLM 
  HCC 
  Cholangiocacinoma 
  Benign 

















Male n(%)  15(71.4)/12(63.2)  27(54.0)/24(48.0)  NA 15(68.2)/14(63.6)  
NA=Not reported, CWI = Continuous Wound Infiltration, ITM= Intrathecal Morphine, Statistically significant differences are highlighted in 
bold. §(≥/<4 segments) §§(≥/<2 segments). Data are presented as n (%) unless stated otherwise, *median (range).   
Table 5 contd. Demographic and pathological characteristics of included studies. 
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 Roy et al [158] Ko et al [153] Weinberg et al [159] Moussa [156] 
 ITM/placebo ITM/PCA ITP/PCA PVB/Placebo 
Number 10/10 20/20 25/25 12/12 
Age (mean±sd) 60.0±8.0/58.0±9.0 31.6±10.4/26.7±6.8 56(19-84)/58(23-77)* 32.8±9.3/34.3±8.2 
ASA  
  I 
  II 
  III 















  ≥ 3 segments 








Hepatic resection weight: 





  CLM 
  HCC 
  Cholangiocarcinoma 
  Benign 













Male n(%)  5(50.0)/5(50.0) 17(85.0)/13(65.0) 10(40.0)/11(44.0)  9(75.0)/10(83.3) 
NA=Not reported, CWI = Continuous Wound Infiltration, PCA= Patient Controlled Analgesia, ITM= Intrathecal Morphine, ITP= Interpleural 
analgesia, PVB = Paravertebral Block. Statistically significant differences are highlighted in bold. §(≥/<4 segments) §§(≥/<2 segments). Data are 
presented as n (%) unless stated otherwise, *median (range). 
Table 5 contd. Demographic and pathology characteristics of included studies. 
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3.4.1 Study Characteristics 
 
All studies included adult patients only. Two distinct sections emerged in that nine of 
the studies assessed liver resection for benign or malignant tumours [134, 135, 149, 
150, 152, 155, 157-159] and five trials assessed patients following living donor 
hepatectomies. [151, 153, 154, 156, 160] The demographic details of the included 
trials are summarised in Table 5. The main differences between the liver resection 
patients and the living donors were the age ranges and the ASA levels with the living 
donors representing a younger, fitter population who had not received chemotherapy. 
Two of the liver resection studies incorporated an enhanced recovery protocol. [134, 
135] Six of the studies excluded patients with pre-existing chronic pain issues or were 
taking regular opiates. [150, 152-155, 159]  
 
Multiple analgesic methods were assessed in combination. These were epidural, 
systemic opiates (PCA), continuous local anaesthetic wound infiltration (CWI), 
intrathecal analgesia (ITM), paravertebral block (PVB) and interpleural analgesia 
(ITP). (127, 128, 142, 143, 145, 148, 150-152) No more than one RCT per 
comparison of analgesic technique was available and this prevented meta-analysis. 
The details of the analgesic regimens assessed are summarised in Table 4 and the 
outcomes are displayed in Table 6. 
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NS=non significant, NA=Not assessed, CWI = Continuous Wound Infiltration, PCA= Patient Controlled Analgesia, ITM= Intrathecal Morphine, 
ITP= Interpleural analgesia, PVB = Paravertebral Block, VAS= Visual Analogue Score. Statistically significant differences are highlighted in bold. 
LOS data presented as mean±s.d. or median (range) unless otherwise stated. Pain scores presented as VAS 0-100, mean ±s.d. or median (IQR) 
unless otherwise stated. §(VAS1-10) 
Table 6. Study outcomes




Length of Stay (days) Pain Scores at rest at 24hrs Pain Scores on movement at 
24hrs 
 Epidural PCA Epidural PCA Epidural PCA Epidural PCA Epidural PCA 
Page et al [157] 256 111 61 (23.8) 19 (17.1) 10.0±7.1 10.0 ±9.3 NA NA NA NA 
Clarke et al [151] 68 158 NA NA 6.6±1.7 6.5 ±1.7 2.2±0.5 2.6± 0.3 NA NA 
Yong et al [160] 6 31 NS NS NA NA NS NS NS NS 
 ITM PCA ITM PCA ITM PCA ITM PCA ITM PCA 
Ko et al [153] 20 20 NA NA 10.8±2.8 10.7±2.9 16 (4-36) 36 (32-48) 40 (21-50) 56 (40-70) 
Roy et al [158] 10 10 NA NA NA NA 23 (range 55) 30 (range 75) 48(range 80) 50 (range 50) 
 CWI Placebo CWI Placebo CWI Placebo CWI Placebo CWI Placebo 
Chan et al [150] 22 22 NA NA 8.2±3.1 9.7±5.8 20.0±14.0 36.0±14.0 30.0±15.0 50.0±18.0 
Basu et al [149] 10 - 4(40.0) - 8 (7-15) - NA - NA - 
 
Weinberg et al [159] 
ITP PCA ITP PCA ITP PCA ITP PCA ITP PCA 
25 25 5(20.0) 6(24.0) 8.4±3.5 9.0±4.8 22±38 22.0±39.0 42.0 ±7.0 50.0 ±34.0 
 PVB Placebo PVB Placebo PVB Placebo PVB Placebo PVB Placebo 
Moussa [156] 12 12 NA NA NA NA Median 1§ Median 4§ NA NA 
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NS=non significant, NA=Not assessed, CWI = Continuous Wound Infiltration, PCA= Patient Controlled Analgesia, ITM= Intrathecal Morphine, 
ITP= Interpleural analgesia, PVB = Paravertebral Block, VAS= Visual Analogue Score. Statistically significant differences are highlighted in bold. 
LOS data presented as mean±s.d. or median (range) unless otherwise stated. Pain scores presented as VAS 0-100, mean±s.d. or median (IQR) unless 
otherwise stated. §(VAS 1-10). 
Table 6 contd. Study outcomes.




Length of Stay (days) Pain Scores at rest at 24hrs Pain Scores on movement 
at 24hrs 
 Epidural CWI Epidural CWI Epidural CWI Epidural CWI Epidural CWI 
Revie et al [135] 31 33 18 (58.1) 16(48.5) 6.0 (3-42) 4.5(2.5-64) 1.3±1.3§ 2.6±1.2§ 3.2±1.9§ 4.8±1.9§ 
 
Lee et al [154] 
ITM CWI ITM CWI ITM CWI ITM CWI ITM CWI 
21 19 7 (33.3) 6 (31.6) 15±7.2 17.9 ±11.6 20 (20-32.5) 30 (20-37.5) 40 (30-50) 50 (40-57.5) 
 Epidural ITM Epidural ITM Epidural ITM Epidural ITM Epidural ITM 
Koea et al [134] 50 50 11 (22.0) 8 (16.0) 6.8±1.2 4.7±0.9 Median 2§ Median 1§ NA NA 
De Pietri et al [152] 25 25 NA NA NA NA 19.0±2.0 23.0±4.0 20.5±3.5 24.0±2.0 
 
 





















22 21 NA NA 8.0±3.2 10.2±6.0 0 (0-11) 12(0-30) 16 (6-26) 36(24-50) 
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3.4.2 Epidural Versus Alternatives 
 
Seven trials compared epidural to an alternative analgesic regimen. Epidural was 
compared to PCA, [151, 157, 160] CWI, [135] ITM [134, 152] and in one trial was 
combined with ITM and compared to ITM alone. [155] 
 
Morbidity 
Four trials reporting complication rates compared epidural to either systemic opiates, 
[157, 160] CWI, [135] or ITM. [134] No difference was observed in complication 
rates between epidural and any of the alternatives.  
 
Pain Scores 
Two studies comparing epidural to ITM, [134, 152] and one comparing epidural to 
PCA [160] showed no superiority of epidural in terms of resting or dynamic pain 
scores.  However improved pain scores were observed in the epidural group 
comparing epidural to CWI, [135] PCA [151] and when epidural was combined with 
ITM and compared to ITM alone. [155] None of the trials reported on long term pain 
outcomes. 
 
Length of Stay 
Five trials [134, 135, 155, 157, 160] assessed LOS. Two trials found LOS to be 
significantly longer in the epidural groups compared to CWI [135] and ITM [134] and 
two [157, 160] did not find a significant difference between epidural and PCA groups. 
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Mondor et al [155] did not report a significant difference between epidural and ITM 
versus ITM alone. 
 
3.4.3 CWI Versus Placebo 
 
Chan et al [150] compared CWI to placebo and found no difference in complication 
rate, improved pain scores in the CWI group and no difference in LOS. Basu et al 
[149] assessed 10 patients and found a complication rate of 40% in one of the first 
studies assessing CWI feasibility. 
 
3.4.4 ITM Versus PCA or Placebo 
 
Two trials assessed ITM with placebo [158] or PCA. [153] Both studies found 
significantly improved pain scores in the ITM group when compared to placebo [158] 
or PCA. [153] Of these only Ko et al [153] went on to assess complication rate and 
LOS and found no significant difference between ITM and PCA. 
 
3.4.5 ITP and PVB Versus PCA or Placebo 
 
One study assessed ITP versus PCA [159] and one study assessed PVB versus 
placebo. [156] Both studies observed improved pain scores in the intervention arm of 
the study. Weinberg et al [159] also assessed LOS and complication rates but did not 
observe a significant difference between the two groups.  
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3.4.6 Local Complications 
 
Seven trials commented specifically on complications as a direct result of the pain 
killing modality i.e. local anaesthetic toxicity or epidural haematoma. [135, 149, 150, 
152, 155, 158, 159] None of these trials reported any incidence of these occurring. Of 
the trials that included wound catheters, no significant difference in wound 
complication rate was observed in any of the trials. [135, 149, 150, 154] 
 
Five studies assessing ITM [152, 153, 155, 158] and ITP [159] commented 
specifically on respiratory depression and of these studies only Weinberg et al [159] 
reported a significantly increased rate of respiratory depression following IV PCA 
compared to interpleural analgesia (PCA morphine n=24%; ITP n=0%, p=0.02).
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3.5 Discussion 
 
This review reports that no analgesic method was associated with improved 
complication rates; epidurals were associated with increased length of stay when 
compared to ITM and CWI and epidurals demonstrated improved or equivalent pain 
scores compared to all other techniques. However the large number of different 
modalities assessed and methodological limitations prevented appropriate meta-
analysis or definitive recommendations.  
 
The included trials represent typical patients and conditions facing the surgical and 
anaesthetic teams involved in major resections for predominantly malignant tumours 
in patients of ASA grade I-III. The patients undergoing living donor resection were 
younger and fitter than the patients undergoing liver tumour resection and so would 
be perceived as being less likely to suffer post-operative morbidity, however similar 
rates of morbidity and LOS emerged when comparing liver resection to living donor 
patients and so the recommendations of this review apply to both patient groups.  
 
One previous review [133] assessed the safety and efficacy of epidurals and found 
that the effects of fluid administration, failure rates and coagulopathy could delay 
recovery and questioned the routine use of epidurals following liver resection. This 
present review therefore aimed to systematically assess not only epidurals but also the 
effect of all analgesic modalities on outcomes following liver resection to establish if 
a superior modality has emerged. Comparisons between all epidural and non-epidural 
based analgesic techniques were included to reflect the direction of recent practice 
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and research. The present review primarily focused on the impact of the analgesic 
modality on patient recovery outcomes after liver resection in an attempt to clarify the 
role of all analgesic modalities in future ERAS protocols. 
 
Epidurals were shown to provide superior or equivalent pain relief in all the trials that 
reported on epidurals. Current expert opinion holds that epidural analgesia provides 
superior post-operative pain relief, both resting and dynamic, when compared with 
systemic opiates in large meta-analyses. [44, 45] The evidence that we found 
comparing pain scores between these modalities following liver surgery was much 
more limited with only two retrospective studies, [151, 160] one of which concurred 
with the evidence base and reported reduced pain scores for the epidural [151] and a 
second study that reported equivalent scores for the PCA opiates. [160] However in 
this study only six patients were included in the epidural group thus reducing the 
power of the study and potentially introducing a type two error. Therefore the 
evidence supporting epidural as being superior to opiates is not abundant in this field 
of surgery and the results are inconclusive. 
 
Continuous wound infiltration has increased in popularity with evidence showing its 
efficacy compared to placebo in open abdominal surgery, [161] which was the case in 
this review. It has also been shown in a meta-analysis to be comparable to epidural in 
terms of analgesic properties in open abdominal surgery. [162] In this review however 
CWI received higher pain scores compared with epidural in the only RCT comparing 
these two modalities. [135] The reason for this apparent reduced analgesic efficacy 
following liver surgery is unclear although the subcostal incision used for liver 
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resection potentially provides a greater challenge for wound catheters compared to 
laparotomy wounds. Wound catheter position and placement is a factor that can 
radically alter the efficacy of the technique and variation in placement and 
configuration can result in variability of observed analgesic effect. More work in this 
area is required to establish optimum practice. 
 
Therefore when assessing analgesic capabilities of the various analgesic techniques, 
the current evidence available comparing modalities after liver surgery is 
heterogeneous, equivocal and lacking in consistent RCTs. Therefore when 
considering pain scores, the current available evidence is insufficient to guide 
practice.   
 
A shorter length of stay was demonstrable with the use of ITM [134] and CWI [135] 
when compared to epidurals. Similarly epidurals did not reduce hospital stay when 
compared to systemic opiates alone [151, 157] or when used in combination with ITM 
and compared to ITM alone. [155]  
 
Epidurals have historically been shown to be associated with similar length of stay in 
other areas of open abdominal surgery when compared to systemic opiate 
administration. [163] When alternatives to systemic opiates alone are compared to 
epidurals, i.e. CWI and ITM, equipoise or superiority in terms of duration of hospital 
stay have been demonstrated following open abdominal surgery, particularly in the 
setting of an enhanced recovery post-operative protocol. [164-166] Absence of an 
epidural potentially allows for a speedier recovery. Reduced IV fluid administration, 
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earlier removal of urinary catheter and reduced hypotension, with reduction of 
systemic opiates, are attractive features of non-epidural based analgesia such as CWI 
and ITM and this review suggests that these techniques could contribute to reduced 
length of hospital admission after liver resectional surgery.  
 
However, no difference in LOS was observed in any other trial in this review, [150, 
151, 153-155, 157-159] including three further trials [151, 155, 157] comparing 
epidurals with alternative modalities to systemic opiates. Therefore definitive 
conclusions cannot be made regarding the effect of epidurals on LOS based on the 
current evidence and further research is required to clarify this. 
 
The primary outcome of this review, and a critical outcome following major surgery, 
was morbidity rate. No significant advantage was observed in systemic complication 
rates when epidural analgesia was compared to systemic opiates, wound catheters or 
ITM groups.  
 
Epidurals have traditionally been associated with reductions in post-operative 
complication rates, particularly pulmonary, cardiovascular and gastrointestinal 
complications when compared to systemic opiates. [167, 168] Minimisation of post-
operative pain can result in increased respiratory capacity and ability to mobilise 
without limitation. Avoidance of systemic opiates reduces rates of ileus and epidural 
related attenuation of the inflammatory response is associated with improved 
physiological outcomes. [36]   
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The often described disadvantages of epidurals such as high failure rate, [142] 
hypotension, increased IV fluid administration [140] and epidural haematoma risk 
[146] have often been accepted because of the perceived superiority in terms of 
analgesia outweighing the disadvantages and leading to a superior recovery and a 
reduction in post-operative morbidity. [36] However CWI and ITM can potentially 
avoid such epidural related problems whilst delivering effective opiate sparing pain 
relief to minimise complications in a similar manner to epidural analgesia. [164-166] 
This review shows that such evidence in the context of liver surgery is currently 
limited, but suggests equipoise between epidurals, CWI and ITM in terms of post-
operative morbidity thereby offering a realistic alternative to epidurals in this setting.  
 
Of note, however, is that none of the trials reporting complication rates, apart from 
Koea et al, [134] reported the rates of underlying liver disease or neoadjuvant 
chemotherapy. Such factors are contributory to post-operative complication rates and 
recovery time following liver resection. [169-171] Moreover, patients suffering from 
chronic pain conditions were frequently excluded from the included trials, and no 
assessment of chronic post-operative pain was reported. Therefore in order to 
determine accurately the effects of a modality on overall recovery and to eliminate 
potentially confounding factors such as these, accurate reporting is mandated in order 
to establish the generalisability of the baseline data. 
 
It is also critical to appreciate the importance of a multi-disciplinary enhanced 
recovery programme complementing the post-operative analgesic technique and 
achieving optimum recovery outcomes. Enhanced recovery programmes represent 
optimal post-operative care and contribute to reductions in morbidity rates. [28] 
Enhanced Recovery After Liver Surgery 
Analgesia After Liver Surgery: A Systematic Review of the Literature  76
Moreover, implementation of these standards allows for simple comparison and 
evaluation of the effect of the variable technique. It also allows comparison of 
outcomes between trials. The trials not commenting specifically on their post-
operative recovery pathways make determination of the impact of the analgesic 
technique on recovery difficult. It is also important to be able to determine if 
significant suboptimal variations occurred within and between groups as well as 
between trials to assess the impact of confounding factors on outcome rather than 
analgesic technique. Therefore, in order to answer the question of optimum analgesic 
modality after liver surgery, ERAS protocols need to be incorporated into the study 
design. In this review only two of the studies included such a pathway [134, 135] and 
so potential systematic variation in the non-ERAS trials makes categorical 
conclusions inappropriate.  
 
Despite these limitations, the review raises important issues. Wound catheters and 
intrathecal opiates appear to have the potential to offer faster rehabilitation with no 
compromise to morbidity rates when compared to epidurals. This raises the possibility 
of there being a benefit to not using an epidural following liver surgery. When 
considering other published studies looking at ERAS protocols following liver 
surgery [88, 122, 126, 128] all have incorporated epidural placement as the analgesic 
method of choice. In this review the reported LOS for Revie et al [135] and Koea et 
al [134] were both less than 5 days - the shortest admission times of all the included 
trials.  Both these trials utilised an ERAS protocol and the short discharge times 
reflect this practice. Considering these findings this review suggest that epidurals may 
not be the most appropriate analgesic technique to incorporate into liver resectional 
ERAS programmes. The evidence suggesting this as yet consists of only two trials 
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[134, 135] and so this cannot be treated as a definitive recommendation. There is 
however a clear need to examine this issue further if outcomes are to be optimised and 
definitive recommendations made. As ERAS programmes have been shown to have 
procedure specific qualities, it will necessitate RCTs comparing epidurals and 
alternative analgesic techniques, including combination techniques, within the context 
of a liver surgery ERAS regimen. 
 
In summary, no analgesic modality resulted in improved complication rates. Epidurals 
provided equivalent or improved pain scores compared to CWI, ITM and PCA. 
Epidurals were associated with prolonged length of stay when compared to CWI and 
ITM, but not PCA. Future research should focus on epidurals versus alternative 
techniques within an enhanced recovery protocol to establish optimum practice. 
 
3.6 Chapter Publication 
Effect of analgesic modality on outcome following open liver surgery: a systematic 
review of postoperative analgesia. Hughes M, McNally S, McKeown DW, Wigmore 
S. Minerva Anestesiol. 2015;81:541-56.  
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Liver resection under low central venous pressure (CVP) has become standard 
practice. However the benefits beyond reduction of blood loss are not well 
documented. Moreover the precise method to achieve CVP reduction is not 
established. A systematic review and meta-analysis of RCTs was performed to assess 
the effects of CVP on clinical outcome and to identify the optimum method of CVP 
reduction. EMBASE, Medline, PubMed and the Cochrane database were searched for 
trials comparing low CVP surgery with controls. The primary outcome was post-
operative complications within 30 days. Secondary outcomes included estimated 
blood loss, blood transfusion rates and length of stay. Sub-group analysis was 
performed to assess CVP reduction method on outcome. Eight trials were identified. 
No difference was observed in morbidity rate between low CVP and control groups 
(OR=0.96 [95% CI 0.66, 1.40] p=0.84, I2=0%,). Estimated blood loss (WMD= -
308.63mls [95% CI -474.67, -142.58] p=0.0003, I2=73%) and blood transfusion rates 
(OR 0.65 [95%CI 0.44, 0.97] p=0.04, I2=37%) were significantly lower in the low 
CVP groups. Neither anaesthetic nor surgical methods of bleeding control were 
associated with reduced post-operative morbidity. In summary, low CVP surgery is 
associated with reduction in blood loss however this is not translated into an 
improvement in post-operative morbidity. Optimum method of CVP reduction has not 
been identified. 
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4.2 Introduction 
 
Liver resectional surgery is often the only chance of curative treatment for a number 
of primary and secondary tumours. It is complex surgery although mortality rate in 
high volume centres should be considered to be less than five per cent. [71] Morbidity 
rates are reported at up to 45%. [73] 
 
Enhanced recovery protocols after liver surgery have increased in popularity in recent 
years and several studies have highlighted not only the feasibility and safety of fast 
track liver protocols [119] but reduction in length of stay and morbidity rates post-
operatively. [172] Morbidity rates, however, remain significant and peri-operative 
protocols require optimisation in order to minimise complications. [172] 
 
It has frequently been reported that blood loss during liver resection is associated with 
increased post-operative morbidity rates. [73, 86, 117] Endeavours to reduce intra-
operative blood loss have included efforts to reduce central venous pressure (CVP) 
during liver resection. Low CVP parenchymal transection has become an accepted 
practice during liver surgery. [117] However a review of the initial available data 
questioned the outcome benefit of low CVP surgery beyond reduction of blood loss. 
[79] Moreover new techniques are being introduced to reduce CVP, of which the 
efficacy is not well established. Therefore this review aims to evaluate the current 
literature to assess the effect of CVP reduction on clinical outcome after liver 
resection and assess the techniques used to achieve this.  
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4.3 Methods 
 
This study was conducted according to the PRISMA guidelines for meta-analysis 
conduct. [118] The protocol was registered prospectively on the PROSPERO database 
for meta-analyses (registration number CRD42014007651).  
 
A literature search was performed independently by two researchers of EMBASE, 
Medline, PubMed and the Cochrane databases in December 2013.  The databases 
were searched from 1966 -2013 with the following terms: “central venous pressure” 
or “CVP” and “liver resection” or “liver surgery” or “hepatic resection” or “hpb”. 
 
All abstracts were reviewed for relevance by two independent investigators. Relevant 
full text articles were subsequently reviewed and critiqued.  
 
4.3.1 Inclusion Criteria 
 
Studies that fulfilled the eligibility criteria were RCTs that compared significantly 
different CVPs or compared a low CVP group to a control group and reported on 
patient outcomes (morbidity, estimated blood loss and length of stay) following open, 
elective liver resection.  
 
4.3.2 Exclusion Criteria 
 
Non-RCTs were excluded. Trials that did not report significantly different CVPs 
between groups, did not compare low CVP with a control group or did not report 
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outcomes of EBL and/or morbidity rate were excluded. All reviews were excluded. 
Irrelevant studies, letters, case reviews, paediatric populations and animal studies 





The intervention investigated was the reduction of intra-operative CVP. This was 
defined as either any statistically significantly difference in CVP between groups or a 
“low CVP” group compared to a control group. Where multiple recordings of CVP 




The comparator group comprised the groups where significantly higher intra-
operative CVP was reported or the “high CVP” group. The comparator group should 
either demonstrate a significantly higher CVP (mmHg), regardless of absolute CVP 
value and regardless of technique used to achieve CVP, or reflect the “uncontrolled 
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4.3.5 Outcomes 
 
4.3.5.1 Primary Outcome 
 
Primary outcome was a composite end-point of the occurrence of one or more 
systemic complication within 30 days of liver resection. Derangement of specific 
blood tests were not included in the overall complication rate. 
 
4.3.5.2 Secondary Outcome 
 
Further comparisons were made between low CVP groups and control groups. The 
mean CVP (mmHg/cm H20) during the operation or, if given, during transection was 
compared between groups. Estimated Blood Loss (EBL) in millilitres was extracted 
from the data as was length of stay (LOS) which was recorded in days. CVP lowering 
protocols were also recorded and compared. 
 
4.3.6 Subgroup Analysis 
 
Subgroup analysis was performed according to technique of CVP reduction: 
anaesthetic methods (IVI restriction, epidural, vasodilators and/or diuretics) and 
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4.3.7 Data Extraction 
 
Abstracts were reviewed for relevance and suitability for inclusion by two 
independent investigators.  Full text articles were reviewed, and data were extracted 
using pre-designed data extraction forms. If data were not presented in a format 
conducive for data synthesis, the authors were contacted using the published 
correspondence details.  In the event of no response, an attempt to contact authors was 
made by repeat email, followed by letter and/or phone call. Where no author response 
was received medians and ranges were converted to mean/standard deviation using 
methods described by Hozo et al. [173]. The Cochrane bias risk assessment tool was 
used to assess study quality. [174]  
 
4.3.8 Statistical Analysis 
 
Statistical analysis was performed using Review Manager (RevMan ver 5.2. The 
Nordic Cochrane Centre, Copenhagen). The following outcomes were treated as 
dichotomous data and were analysed using pooled odds ratios: major complication 
rate and intra-operative blood transfusion requirement. The following outcomes were 
treated as continuous data and were analysed with a weighted mean difference 
(WMD): estimated blood loss and length of stay. Statistical significance was set at 
p<0.05. Heterogeneity was assessed by using I2 and X2 and adjudged to be significant 
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4.4 Results 
 
4.4.1 Included Trials 
 
The PRISMA diagram of included trials is shown in Figure 8. Eight RCTs were 
identified as meeting the inclusion criteria with a total of 339 patients with lower CVP 
than 342 control patients. [109, 175-181] Patient demographics and indications for 
hepatic resection are displayed in Table 7. Bias assessment scores for included trials 
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Figure 8. PRISMA diagram
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Table 7. Study characteristics.  
 Wang et al 2006 [109] Liu et al 2005 [178] Liu et al 2008 [179] El-Khaboutley et al 2004 [175] 
 Ex (n=25) Con (n=25) Ex (n=30) Con 
(n=30) 
Ex (n=23) Con (n=23) Ex (n=20) Con (n=20) 
Male 19(76.0) 21(84.0) NA NA 14(6.9) 16(69.6) 11(55.0) 12(60.0) 
Age (years) 45.3±14.6 46.0±12.1 NA NA 45.4±13.0 43.0±13.0 49.9±10.4 52.3±7.1 
Indication 
  CLM 
  HCC 
  Cholangiocarcinoma  
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Operating time (mins) 229.6±67.3 246.0±112.4 NA NA 156.9±38.5 162.8±60.6 164.0±42.0 190.1±24.0 
Transection time (mins) NA NA NA NA NA NA NA NA 
Ex= experimental group, Con = Control groups, NA = not assessed, NS=no significant difference, CLM=Colorectal Liver Metastasis, HCC= 
Hepatocellular Carcinoma; § major resection, ** >2 segments, ***>1 segment, ∞ =mean (s.e.m), *median (IQR). Data are otherwise presented 
as n(%) and mean±s.d. or median (range). Significantly different results (p<0.05) are highlighted in bold. 
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Table 7 contd. Study characteristics  
 
 Figueras et al 2005 [176] Zhu et al 2012 [181] Rahbari et al 2011 [180] Kato et al 2008 [177] 
 Ex (n=41) Con (n=39) Ex (n=96) Con (n=96) Ex (n=65) Con (n=63) Ex (n=43) Con (n=42) 
Male 28(68.3) 31(79.5) NS  37(56.9) 42(66.7) NA  
Age (years) 62.0±11.0 61.8±13.0 NS  57.2±10.9 59.2±12.1 65 (28-82) 67 (38-79) 
Indication 
  CLM 
  HCC 
  Cholangiocarcinoma  


































  Cirrhosis 
  Steatosis 
 
21(51.2) 




















Resection extent  



















219.0±45.0  207.0±48.0 161.8(36.1)∞ 172.0(46.2)∞ 145.0 (111.5-212.5)* 155.0(120.0-221.0)* NA NA 
Transection time 
(mins) 
65.0±25.0 60.0±26.0  NA NA 7(4-19) 9(5-19) 55(15-108)  49(7-157) 
Ex= experimental group, Con = Control groups, NA = not assessed, NS=no significant difference, CLM = Colorectal Liver Metastasis, HCC = Hepatocellular 
Carcinoma; §§ steatosis %, ** >2 segments, ***>1 segment. ∞ =mean (s.e.m) *median (IQR), data are otherwise presented as n (%) and mean±s.d. or median 
(range).  Significantly different results (p<0.05) are highlighted in bold. 
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Wang et al 2006 [109] + + + - + + + 
Liu et al 2005 [178] + + - - + ? + 
Liu et al 2008 [179] + + + ? + + + 
El-Khaboutley et al 2004 [175] + ? ? ? + + + 
Rahbari et al 2011 [180] + + + - + + + 
Zhu et al 2012 [181] + + ? ? + + + 
Kato et al 2008 [177] + ? ? ? + + + 
Figueras et al 2005 [176] + ? ? ? + + + 
+=present; -=absent; ?=unclear 
Table 8. Bias assessment table.  
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Three relevant RCTs were excluded. Ryu et al [182] maintained a low CVP in both 
groups and observed the effect of milrinone on the operative field without reporting 
EBL or complication rate; Sand et al [183] assessed the effect of patient position and 
positive end expiratory pressure (PEEP) on CVP and did not assess EBL, morbidity 
or LOS; and Lin et al [184] incorporated five randomised groups and assessed EBL 
as volume per transection area and did not report morbidity or LOS. It was felt that 
this was not meaningfully comparable to the other included studies and so excluded 
from the quantitative analysis. 
 
4.4.2 Evaluation of Intervention 
 
Exact CVP was not reported in two trials. [109, 179] In the six trials that did report 
CVP [175-178, 180, 181], the CVP was significantly reduced in the low CVP group 
(n=291) compared to the control groups (n=294) (WMD -2.37 mmHg [95%CI -4.11- 
-0.63] p=0.008, I2=92%). No difference in in-flow occlusion time was observed in 
the low CVP group (n=223) compared to the control group (n=227) in the trials that 
reported using it (WMD 0.21mins [95%CI -1.47 - 1.88] p=0.81, I2=23%). [109, 176, 
180, 181] 
 
Details of the trial protocols used are shown in Table 9. Four trials utilised 
anaesthetic methods to reduce CVP [109, 175, 178, 179], three trials [177, 180, 181] 
used IVC clamping to reduce CVP and one trial [176] performed a RCT comparing 
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complete in-flow occlusion with selective in-flow occlusion and observed a 
significant difference in CVP between the two groups. 
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IVI – Intravenous infusion, GTN – Glycerine trinitrate, PEEP – peak end expiratory pressure. Statistically significant (p<0.05) CVP 
differences highlighted in bold. *mean (s.e.m.) data otherwise presented as mean±s.d. or median (range) 












Wang et al 2006 [109] IVI, Head tilt, GTN, 
Furosemide, 
Y 2-4 IVI Y NA 
Liu et al 2005 [178] IVI, head tilt, GTN, 
isoflurane, fentanyl 
N 3.6±0.4 IVI N 8.9±2.1 
Liu et al 2008 [179] IVI, head tilt, GTN, 
furosemide, 
transfusion Hb <80g/L 
N 2-4 IVI N NA 
El-Khaboutley et al 
2004 [175] 
GTN, IVI Y 3.0±0.1 IVI Y 6.9±2.8 
Rahbari et al 2011[180] IVC clamp, epidural Y 4.0±3.2 Epidural, IVI, opioids, 
GTN, furosemide, 
reduced PEEP, epidural 
fentanyl 
Y 2.6±1.8 
Zhu et al 2012 [181] IVC clamp Y 4.3(0.9)* GTN, head tilt, 
furosemide, IVI 
Y 4.7(0.5)* 
Kato et al 2008 [177] IVC clamp, IVI, N 4(0-13) IVI N 6(1-14) 
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4.4.3 Primary Outcome: Morbidity Rate 
 
Five studies [109, 175, 176, 180, 181] with a total of 490 patients (low CVP n=243, 
control n=247) reported overall systemic complication rates between groups. There 
was no difference in overall morbidity rate between low and high CVP surgery 
(OR=0.96 [95% CI 0.66, 1.40] p=0.84, I2=0%, Figure 9).  
 
 
Figure 9. Post-operative morbidity rate 
 
4.4.3.1 Primary Outcome: Subgroup analysis 
 
Subgroup analysis was performed according to the method of CVP reduction 
(anaesthetic/surgical). Only two trials using anaesthetic methods to reduce CVP 
[109, 175] reported complication rates and no difference was detected (OR=0.6 
[95%CI 0.22, 1.63]; p=0.31, I2=0%). The two trials [178, 179] not included in the 
quantitative analysis that did not report complication outcomes did not report any 
significant differences in post-operative renal functioning between the two groups. 
Sub-group analysis of the two trials comparing IVC clamping (n=161) versus no IVC 
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clamping (n=159) [180, 181] and reporting complication rates did not report a 
significant difference in morbidity rate (OR 1.06 [95%CI 0.68, 1.66] p=0.80, I2=0%).  
 
4.4.4 Secondary Outcomes 
 
4.4.4.1 Estimated Blood Loss 
 
Seven trials [109, 175-179, 181] comprising 553 patients (Low CVP 276, Control 
277) reported EBL (Figure 10). There was a significant reduction in EBL in the low 
CVP group compared with the control group (WMD= -308.63mls [95% CI -474.67, -
142.58] p=0.0003, I2=73%). Subgroup analysis [109, 175, 178, 179] demonstrated 
that anaesthetic measures to reduce CVP (n=98) led to a significantly reduced EBL 
compared to control (n=98) (WMD = -406.26mls [95%CI -490.77, -321.76] 
p=<0.00001, I2=52). Sub-group analysis of two trials comparing IVC clamping 
(n=139) with no IVC clamping (n=138) [177, 181] showed no significant difference 
in EBL between the intervention and control groups (WMD = -88.70mls, [95%CI -
268.02, 90.7] p=0.33, I2=0%). 
 
 
Figure 10. Estimated blood loss 
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4.4.4.2 Intra-operative Transfusion Requirement 
 
Intra-operative blood transfusion requirements were reported in seven trials [109, 
175, 176, 178-181] including 681 patients (low CVP n=339, control n=342). 
Significantly fewer blood transfusions were required in patients in the low CVP 
group compared with the control group (OR 0.65 [95% CI 0.44, 0.97] p=0.04, 
I2=37%, Figure 11).  
 
 









Enhanced Recovery After Liver Surgery 
CVP and Liver Resection: A Systematic Review and Meta-analysis 95 
4.4.4.3 Length of Stay 
 
Length of stay was reported in 4 of the 8 trials [109, 176, 177, 181] with 407 patients 
(low CVP n=203, control n=204). No significant difference was observed between 
the low CVP group and control group (WMD -1.75 days [95% CI -5.84, 2.34], 
p=0.40 I2=64%, Figure 12).  
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4.5 Discussion 
 
This review provides an assessment of the effect of CVP on outcomes after liver 
resection and has shown that low CVP surgery reduces EBL. This does not, however, 
correspond to improved outcomes in terms of morbidity or hospital stay.   
 
Two other reviews have assessed the effect of CVP reduction on EBL. [79, 108] 
Gurusamy et al [79] and Li et al [108] analysed three and five studies respectively 
comparing low CVP with high CVP and found a significant reduction in blood loss 
during low CVP surgery. This current review includes a further three RCTs assessing 
high and low CVP, [176, 180, 181] discriminates between anaesthetic and surgical 
methodology and investigates quantitatively the effect of CVP reduction not only on 
EBL but also morbidity. This review further demonstrates the beneficial effects of 
lower CVP during transection when compared to higher CVPs in terms of intra-
operative blood loss and blood transfusion rates. This consolidates the data from the 
previous reviews.   
 
As well as the previous reviews of RCTs, retrospective series exist which have 
shown low CVP to be safe and associated with satisfactory EBL and outcomes [185-
188] and the few comparative studies comparing CVP of greater than five mmHg 
with CVP of less than five mmHg during liver transection [186, 189, 190] 
retrospectively concluded that those patients undergoing resection with CVP greater 
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than five mmHg suffered higher EBL. These published series have often guided 
practice and low CVP surgery is regarded as standard practice. 
 
However controversy does still remain regarding the evidence base for this issue 
with several trials [191-193] reporting that CVP is not associated with reduced EBL 
or predictive of EBL following regression analysis. Chibber et al [191] performed a 
sub-group analysis of CVP greater and less than five mmHg from their cohort (all 
using the same protocol) and did not observe a difference in blood loss in living 
donor patients.  
 
Moreover, two of the included trials in the current analysis [176, 177] did not show a 
significant reduction in EBL and Zhu et al [181] showed a mean reduction by only 
150 mls despite achieving significant reductions in CVP. The reason for the modest 
reduction in EBL seen in these three included trials is potentially explained by the 
methodology. The overall difference in CVP between these groups was low. Zhu et 
al [181] and Rahbari et al [177] had a “control group” as a low CVP group achieved 
by standard techniques compared to the IVC clamping group. Therefore the 
comparisons in the meta-analysis were not all uncontrolled high CVP versus low 
CVP (although mean CVPs in these groups were statistically significant). When CVP 
difference was larger a more significant difference in EBL was observed. [175, 178] 
This finding is suggestive of the importance of well-controlled CVP and does not 
identify benefits associated with ultra-low CVP. 
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It is well established that high blood loss intra-operatively has a negative effect on 
peri-operative complication rates and reduction in EBL leads to improved post-
operative outcomes [73, 117]. The overall meta-analysis, however, revealed no 
significant difference in complication rates between low CVP and control groups.  
 
An explanation for this might be the modest reduction in EBL reported by several of 
the trials [176, 177, 181] which could have potentially influenced the analysis. The 
reported difference in EBL in these trials was around 100-200mls less than the 
control group. This is much less than compared to the other included trials. [109, 
175, 180] Intuitively it can be appreciated why a large drop in EBL could contribute 
to an improved outcome and a modest reduction would not necessarily translate into 
an enhanced post-operative course.  
 
However it is also important to consider the methodology of the techniques used to 
reduce CVP and their impact on outcome. Three of the trials compared IVC 
clamping to reduce CVP compared with no IVC clamping. The potential hazards of 
IVC clamping have not been fully investigated. A negative effect on hepatic and 
renal function has not been routinely observed, [180, 194] however significantly 
higher rates of thromboembolic events [180] were reported. Such complications 
could negate the benefit of low CVP and low blood loss surgery. Considering the 
lack of benefit gained by this technique in terms of EBL and outcome when 
compared to standard practice, it is therefore reasonable to question the benefit of 
this technique over standard anaesthetic methods of CVP reduction. 
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A potential explanation for the negative result from the anaesthetic studies is the 
small numbers in the included RCTs. Only two of the anaesthetic trials reported 
systemic complication rates. These both showed non-significant improved outcomes 
in the low CVP groups, which may have resulted from an under powered analysis of 
secondary outcomes. Even after meta-analysis, no significant difference was noticed. 
Although this was trending towards reduced morbidity rates, a potential type two 
error in this analysis cannot be excluded.  
 
However, the two trials included in the meta-analysis [109, 175] did not report 
significant differences in complication rates and the two trials excluded [178, 179] 
that did not report overall complication rates did not report significant differences in 
renal or hepatic function despite significant reductions in EBL. Therefore a clinical 
benefit to low CVP surgery is not definitively presented by the evidence.   
 
Another explanation for the similar morbidity rates between groups is the potentially 
detrimental impact of the individual techniques used to reduce CVP by anaesthetic 
methods. [109, 175, 178, 179] IV fluid restriction during the transection phase, GTN 
and furosemide were utilised frequently by the included studies. These simple 
methods help to maintain a state of hypovolaemia and vasodilation to reduce back 
pressure on the hepatic veins to reduce venous bleeding during hepatic transection. 
Although evidence of renal dysfunction in these groups has not been established  
[187] there is a lack of prospective evidence for the efficacy and safety of each 
individual component of such CVP lowering protocols. 
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Only Ryu et al, [182] Page et al [157] and Sand et al [183] have performed 
assessments of single anaesthetic techniques in low CVP surgery. These studies did 
not fulfil the criteria for inclusion into the meta-analysis.  
 
Sand et al [183] investigated the benefit of positional change with or without PEEP 
on CVP during liver resection, finding a head up tilt to be successful in reducing 
CVP. Several studies in this review performed positional change to reduce CVP. 
[109, 178, 179, 181] Sand et al [183] found that the CVP rose in the head down 
position but fell in the head up position. However when taking into consideration that 
hepatic vein pressure measured at the time did not change regardless of position and 
head up tilt is associated with gas embolism and haemodynamic instability, [195] 
positional change is advised against.   
 
Ryu et al [182] assessed the effect of milrinone on CVP and the operative field. 
Milrinone was suggested as beneficial due to its inotropic as well as vasodilatory 
effect that would prevent the haemodynamic instability of fluid restriction or 
vasodilation with nitrates. The results were favourable although the study only 
assessed living donors and so its effect on patients with significant co-morbidities is 
not yet established. 
 
Another technique that was utilised sparingly by the included trials was epidural. 
Neuraxial blockade provides vasodilation and subsequent CVP reduction and its 
inclusion as part of CVP lowering protocols is often advocated. [186] This was 
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utilised by Rahbari et al [180] in the control group, which achieved significantly 
reduced CVP compared to the IVC clamping group. In the published non-
randomised trials this has become a controversial matter with two trials not showing 
an effect on blood loss when using an epidural in the CVP lowering protocol [157, 
191] and several others finding its absence associated with improvements in EBL 
and morbidity. [189, 190, 196] The advocates of epidural would welcome its 
inclusion peri-operatively due to the perceived improvement in recovery. [36] 
However this has become a controversial topic of late due to increased concerns 
being voiced related to coagulopathy secondary to liver resection affecting epidural 
removal, [144] increased IV fluids due to epidural related hypotension [157] and 
increased post-operative transfusions of red cells. [157] Such disadvantages are often 
accepted due to perceptions of improved overall outcomes and CVP reduction. 
However this concept is increasingly being challenged as improved alternatives to 
epidurals are becoming more widespread and enhanced recovery protocols improve 
speed of recovery often without the need for epidural. [134, 135] Moreover the 
ability to comment on the specific role of epidural on CVP is limited due to the lack 
of trials assessing this specifically. This is therefore an area that warrants prospective 
investigation to clarify the effect of epidural on CVP and outcome following liver 
resection. 
 
An additional point to consider is the effect of in-flow occlusion. All but Kato et al 
[177] combined IVC clamping with in flow occlusion. This could potentially result 
in a deleterious effect on outcome due to potential ischaemia associated liver injury. 
[197] This suspicion is further supported by three RCTs [110, 111, 176] whereby 
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selective in flow occlusion rather than complete in-flow occlusion was associated 
with significantly reduced post-operative morbidity. All maintained a CVP of less 
than five mmHg, there was no difference in blood loss but Ni et al [111] and Fu et al 
[110] reported a reduction in morbidity in the selective Pringle groups when 
compared to the Pringle groups. This therefore points to other areas of protocol 
optimisation to consider when CVP has been optimised below five mmHg.  
 
The main limitation of this review is the heterogeneity of the included studies. The 
anaesthetic studies assessed a CVP of over five with a CVP of less than five mmHg. 
The IVC clamping studies, despite significant differences in CVP, assessed a CVP of 
less than five mmHg in both groups. It is therefore unsurprising that little difference 
is seen in outcome. However the primary aim of all the included trials was to assess 
the effect of CVP lowering. Therefore these trials represent the current status of 
RCTs assessing this concept.  
 
In summary this review and meta-analysis shows that low CVP surgery effectively 
results in reduced blood loss and transfusion requirement during liver resection. 
However no improvement in clinical outcomes are associated with this and this may 
be affected by methodology. IVC clamping does not seem to improve outcome over 
low CVP surgery achieved by standard CVP lowering techniques. The optimum 
technique to achieve CVP reduction is not known with controversies existing 
regarding IVC clamping, correct anaesthetic technique and potential disadvantages 
of using the Pringle manoeuvre. Prospective, randomized trials are required to 
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establish precise protocol components when attempting to optimise outcomes 
following liver resection.
 
4.6 Chapter Publication 
 
Central Venous Pressure and Liver Resection: A Systematic Review and Meta-
analysis. Accepted for publication HPB (London) June 2015.   
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5 Summary of Evidence 
  
Enhanced recovery after liver surgery has shown some improvement in overall 
morbidity but has not resulted in decreased surgical morbidity.  In the published 
trials comparing ERAS protocols with standard care, the majority of trials have 
utilised epidural analgesia following resection. However the available evidence 
assessing analgesia after liver resection has not identified a clear optimum analgesic 
modality to enhance recovery after liver surgery in terms of morbidity. Moreover it is 
suggested that epidural might actually delay recovery compared to non-opiate 
alternatives, namely, continuous wound infiltration. Secondly an argument for the 
use of epidurals during liver resection is their ability to provide a low CVP during 
transection in order to minimise blood loss. However low CVP surgery has not 
shown an improvement in post-operative morbidity, potentially as a result of 
techniques used to achieve low CVP during transection. The evidence supporting the 
specific benefit of epidural on this facet of resection is not available. Therefore the 
following chapter will describe a trial investigating analgesic modalities after liver 
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6 The Effects of Local Infiltration Versus Epidural Following 




Analgesia after liver surgery remains controversial. A previous randomised trial of 
continuous wound infiltration versus epidural analgesia after liver surgery showed 
earlier discharge in the continuous wound infiltration (CWI) group but superior early 
post-operative pain scores in the thoracic epidural analgesia (TEA) group. This trial 
aims to determine the efficacy of CWI plus abdominal nerve blocks compared to 
epidural after liver resection. A randomised controlled trial of 100 patients 
undergoing open liver resection was performed from December 2012 to June 2014. 
Patients were randomised to receive either wound catheter and nerve block (CWI) or 
thoracic epidural analgesia (TEA) for 48 hours post-operatively. Primary outcome 
measure was functional recovery time. Secondary outcome measures were pain 
scores, complication rates, inflammatory mediators and CVP during transection.  44 
patients received TEA and 49 received CWI.  Functional recovery time was 6.5 IQR 
5-9.75 days (TEA) versus 5.75 IQR 4-7 (CWI) days (p=0.04). Pain scores were 
equivalent between the two groups and there were also no differences in morbidity, 
inflammatory response or CVP during transection. Increased opiate requirements 
were observed in the CWI group on the day of surgery and post-operative day one. 
CWI could be considered as first line analgesia after liver surgery. CWI offers a 
reduction in time to recovery. TEA does not offer an advantage over CWI in terms of 
attenuation of the inflammatory response or pain scores. 
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6.2 Introduction 
 
Pain control is a key principle of peri-operative care and a major factor when 
attempting to enhance recovery after surgery. [36] Thoracic epidural analgesia (TEA) 
has often been advocated as an optimum component of post-operative analgesia 
following abdominal surgery, particularly colorectal surgery. [36]  
 
Following introduction of enhanced recovery protocols after liver resectional surgery 
TEA has been incorporated as part of multi-modal analgesic regimens. [88, 122, 126, 
128] However, this has become controversial with opinion regarding the role of TEA 
after liver surgery being divided. [133, 139] Perceived disadvantages of TEA use 
include concern regarding increased IV fluid overload, [141] coagulopathy following 
liver resection increasing epidural haematoma rate, [146] a failure rate of up to 25% 
[142] and an increase in blood transfusion requirements. [157] 
 
Alternative modalities are becoming more popular with continuous wound 
infiltration (CWI) being used in an increasing number of centres. [135, 149, 150, 
154] High level evidence investigating CWI after liver resection is limited with only 
one small randomised controlled trial [135] comparing TEA with CWI. Despite this 
trial showing an improvement in recovery time, consensus agreement has not been 
reached with limited evidence guiding practice. [198, 199]  
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Potential reasons for this are the superior analgesic properties of TEA compared to 
CWI [135] and opiates [45] being shown. TEA is also seen as being able to attenuate 
the inflammatory response to surgery [200, 201] and this is one of the reasons why it 
has been recommended to be used as part of an ERAS programme. [36] Also TEA is 
often advocated during liver surgery to aid in CVP reduction to facilitate hypotensive 
parenchymal transection. [186]  
 
The aim of this study was to perform a randomised controlled trial comparing TEA 
with CWI following liver surgery in order to establish if superiority exists between 
these modalities in terms of recovery after surgery. A RCT [135] was previously 
conducted by the investigating unit comparing CWI and TEA reporting superior 
early pain scores in the TEA group compared with CWI. In order to overcome this 
and prevent a delay in establishing effective analgesia in the CWI group, in this trial 
a greater volume of local anaesthetic was delivered as a transversus abdominis and 
rectus sheath nerve block at the same time as the wound infiltration catheters were 
being placed.  Moreover in order to comprehensively assess the influence of the 
analgesic modality on the response to surgery an evaluation of clinical outcomes, 
inflammatory response mediators and physiological response (intra-operative CVP) 
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The trial was approved by the South East Scotland Research Ethics Committee and 
the trial protocol was published prior to commencement (clinicaltrials.gov, 
NCT01747122). Recruitment was conducted from December 2012 and follow up 
was completed by August 2014. 
 
6.3.2 Patients  
 
All patient listed to undergo an open liver resection at the Royal Infirmary of 
Edinburgh, UK, were approached to discuss participating in the trial. After an initial 
discussion patients were given written trial information at the pre-admission clinic 
approximately four weeks prior to admission for resection. Written informed consent 
was obtained on the day of surgery or sooner if appropriate. 
 
Patients were excluded prior to randomisation if they were to undergo a laparoscopic 
or combined procedure, had a contra-indication to epidural or wound catheter, 
deranged liver function tests, were below the age of 18 years of age or did not have 
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6.3.3 Perioperative Care 
 
Patients were admitted on the morning of surgery having fasted for six hours and 
taken clear fluids up to two hours prior to surgery. After consenting to the trial 
patients were randomised on the morning of surgery to receive either TEA or 
continuous wound infiltration combined with abdominal nerve block. Sequential, 
opaque sealed envelopes were pre-filled by an independent adjudicator and opened 
after consent had been obtained. Randomisation was stratified according to extent of 
resection - either major resection (three or more segments) or minor resection (less 
than three segments). Neither participant nor the trial team were blinded to the 
randomisation. 
 
Patients randomised to TEA underwent a standardised anaesthetic protocol by the 
same group of anaesthetists experienced in liver resection surgery. In the anaesthetic 
room prior to induction of anaesthesia, participants received a thoracic epidural 
puncture at the level of T8-T9. Four millilitres of 2% lignocaine was administered as 
a test dose followed by 10mls levobupivacaine with 100mcg fentanyl to establish 
epidural block.  An infusion of 0.1% levobupivacaine with 2mcg/ml fentanyl was 
then started.  
 
All patients underwent induction of anaesthesia with propofol, atracurium and 
fentanyl (1-2 mcg/kg). Maintenance of anaesthesia was achieved by desflurane or 
sevoflurane. At induction patients routinely received a central venous catheter in the 
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right internal jugular vein, radial arterial cannulation and a urethral catheter. Routine 
monitoring of CVP, invasive continuous blood pressure and mean arterial pressure, 
end tidal CO2, heart rate, oxygen saturation and urine output was performed 
throughout the operation.  
 
The peritoneal cavity was entered via a right subcostal incision that was extended if 
required superiorly in the midline. A full laparotomy was performed to ensure no 
contra-indications to resection were evident. Intra-operative ultrasound was 
performed by the operating surgeon to establish resectability and to formulate a final 
operative approach. Transection of the liver parenchyma was performed with 
Cavitron Ultrasonic Aspirator (CUSA, ValleyLab, Boulder, Colorado, USA) and 
monopolar diathermy. Resection was performed in accordance with the patients’ 
pathological, oncological and physiological requirements to ensure optimum short 
and long term outcomes. 
 
Peri-operative ERAS principles were adhered to with routine thromboprophylaxis 
administration and peri-operative antibiotics being administered immediately prior to 
incision. Intra-operative warming was routinely performed. As small an incision as 
required was used. Intra-peritoneal drains and nasogastric tubes were not routinely 
administered and intra-operative fluid management was restricted to 80-100mls/hour 
of crystalloid. 
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Patients randomised to receive CWI underwent the same induction and maintenance 
protocol. At the end of the operation an “on-Q” dual limb 12.5cm Painbuster 
(BBraun, Sheffield, UK) was inserted into the musculofascial layers of the 
abdominal wall. The lateral limb was placed between the transversus abdominis and 
internal oblique muscles and the medial limb was placed in the rectus sheath 
posterior to the muscle as described by Basu et al (2004) and Revie et al (2012). 
[135, 149] 
 
On closure of the wound the nerve block was performed by instilling a total of 40mls 
of 0.125% levobupivacaine into the transversus abdominis plane and the rectus 
sheath posteriorly via the wound catheter. The wound catheters were subsequently 
connected to an elastomeric reservoir containing 0.375% levobupivacaine that 
instilled at a fixed rate of 4ml/hr. This was kept in situ for 48 hours. 
 
6.3.4 Post-operative Care 
 
Patients were transferred from theatre to the recovery ward where they were 
extubated and monitored until observations and pain scores were satisfactory 
according to the unit protocol. They were subsequently transferred to the high 
dependency ward where they remained until they achieved discharge criteria and 
could be transferred to the general ward. Patients were managed according to an 
enhanced recovery protocol (Table 10) utilised in the investigating unit. [135]  
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Time Point Recovery Elements 
Day before surgery Normal oral nutrition until midnight 
No preanaesthetic medication 
DOS Short-acting IV anaesthetic agent 
No nasogastric drainage  
Warm IV fluids, and upper and lower body air-warming device 
Prophylactic antibiotics 
Avoidance of excessive IV fluids  
No routine drainage of the peritoneal cavity 
Epidural or CWI analgesia 
Patient mobilises to chair evening of surgery 
Restart oral intake of water/nutrition ad libitum 
POD 1 Arterial and central lines out 
Patient mobilises around bed 
Patient sits out of bed for 6 hours 
Discontinuation of intravenous fluids if haemodynamically stable and 
drinks more than 1 litre of fluid 
Normal diet 
Continue morphine PCA +/- wound catheter / TEA 
1000 mg paracetamol every 6 hours 
Transfer to general ward if possible 
POD 2 Morphine PCA +/- wound catheter /TEA down 
Continue mobilisation  
Patient to sit out of bed for 8 hours 
1000 mg paracetamol every 6 hours 
Urinary catheter out 
Normal diet 
Oral analgesia 
Transfer to general ward 
POD 3 Continue mobilisation 
Normal diet 
Check discharge criteria 
POD 4 Check discharge criteria  
Discharge 
Table 10. Enhanced Recovery Protocol 
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6.3.5 Outcomes 
 
6.3.5.1 Primary Outcome 
 
The primary outcome was functional recovery time. Patients were determined to be 
medically fit for discharge when they fulfilled the unit criteria: independently 
mobilising, eating and drinking with no requirement for IVI in the previous 24 hours, 
adequate pain control on oral analgesics, blood tests normal or returning to normal 
and patient willing to go home. Fulfilment of discharge criteria was determined by 
the senior clinician responsible for the patient, independent of the study team. This 
was reported as the time taken from the end of the operation to the time when all the 
recovery criteria were determined to have been achieved. This was assessed twice 
daily. Actual length of stay was also recorded but recovery criteria time was deemed 
a more accurate reflection of recovery time due to logistical difficulties of 
discharging patients on the day of recovery criteria fulfilment.  
 
6.3.5.2 Secondary Outcomes 
 
Pain Scores 
Pain scores were recorded by the nursing staff, independent of the trial and trained in 
pain score recording. Pain scores were recorded at 2, 6 and12 hours after closure of 
the incision and on post-operative day (POD) 1, POD 2 and POD 3 at 0900hrs. Pain 
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Complications were observed for twice daily. The type of complication was defined 
according to pre-determined complication criteria [202] and the severity of 
complication was graded according to the Clavien Dindo criteria. [203] The clinical 
team co-ordinated the diagnosis and management of complications and the 
investigating team observed twice daily for occurrence of a complication. Patients 
were reviewed in the out-patient clinic and morbidity within 30 days of discharge 
was documented also. 
 
Parameters of Recovery 
Patient recovery parameters were prospectively assessed.  Time to sitting, mobilising 
independently, drinking, eating, passing wind and moving bowels was prospectively 
observed. Independent mobilisation was defined as being able to weight bear and 
walk outwith the bed space without support from aids or assistants. 
 
The Inflammatory Response to Surgery  
Cytokine (IL1β, IL6, IL8, IL10, TNFα) and High Mobility Group Box 1 (HMGB1) 
levels were all assessed pre-operatively and at 24 hours and 72 hours after the 
incision was made.  
Enhanced Recovery After Liver Surgery 
Effects of Local Infiltration Versus Epidural Following Liver Resection II (LIVER II) 115 
Sample Preparation  
Cytokine measurement was obtained via analysis of plasma. Whole blood was 
collected from the patient by standard venepuncture into an EDTA tube and 
immediately transferred in ice to the laboratory and centrifuged at 1000 g for 15 
minutes at 4 degrees centigrade. The separated plasma was then aliquoted into 1.5 ml 
polypropylene tubes and immediately frozen and stored at -80 degrees. Sample 
preparation for HMGB1 analysis was different in that serum was required. Whole 
blood was extracted and was spun at 1000 g for 15 minutes. Serum aliquots were 
taken and stored at -80 degrees. Batch analysis was performed once all the samples 
had been obtained. 
 
Sample Analysis 
Cytokine analysis was performed via enzyme linked immunoassay (ELISA) 
procedure as per the manufactures instructions. The Milliplex human cytokine kit 
(Millipore Corp, St Charles, Missouri, USA) was used to obtain plasma levels of 
cytokines. High sensitivity analysis was performed to detect levels from a standard 
curve ranging from 0.13 pg/mL – 2000 pg/mL. Analysis of wells and microsphere 
identification and detection was performed via a Luminex 100 instrument (Luminex 
Corporation, Austin, Texas, USA).  
 
HMGB1 levels were obtained from a further quantitative sandwich ELISA (Shino-
Test Corporation, Japan). The standard curve was utilised to detect HMGB1 levels 
from a range of 0-80 ng/mL. 
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CVP Assessment 
CVP was monitored continuously intra-operatively. Mean CVP during transection 
was recorded as was highest and lowest CVP during the operation. Minimum MAP 
was recorded also. IV fluid and blood product administration was prospectively 
recorded until POD 2. 
 
6.3.6 Statistical Analysis 
 
Statistical analysis was performed with SPSS version 19 (IBM, Armonk, New York, 
USA). Based on unpublished retrospective data within the unit it was determined that 
a difference to functional recovery time of 1.5 days (with a standard deviation of 2.5 
days) with a significance of 0.05 and a power of 80%, would require 44 patients in 
each arm of the study to achieve this. 
 
Continuous data were compared with Mann Whitney U test or T-test depending on 
the distribution of the data. Paired data were compared with a paired t-test or 
Wilcoxon signed-rank analysis. Categorical data were compared with the Chi 
squared or Fishers exact test. Comparisons of multiple measures were performed 
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6.4 Results 
 
The trial was conducted from December 2012 to June 2014. A total of 100 patients 
were randomised. The CONSORT diagram is shown in Figure 13. 44 and 49 patients 
were included in the analysis for the primary outcome and clinical assessments in the 
TEA and CWI groups respectively. Two patients in the CWI group did not have 
POD 3 samples taken and so were excluded from inflammatory response analysis. 
One patient refused POD 3 bloods and another patient died on POD 3. Three patients 
were excluded after randomisation: one patient in the CWI group developed 
significant lactic acidosis during the procedure of unknown origin and it was elected 
to not place a wound catheter. One patient underwent CT scanning after 
randomisation, was found to have advanced disease and was deemed irresectable. A 
further patient developed a fever in the anaesthetic room and so an epidural was not 
sited. Both these patients were excluded at this point. One patient in each of the CWI 
and TEA groups did not have a functioning central line and so were excluded from 
the CVP analysis.  
 
Baseline characteristics were broadly similar with no significant differences observed 
between the two groups other than a significantly greater proportion of patients with 
normal liver in the TEA group (Table 11). Operative time was significantly longer 
and anaesthetic time was significantly shorter in the CWI group. No significant 
difference in EBL was observed (Table 12).  
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Assessed for eligibility (n= 188) 
Excluded  (n= 88) 
   Not meeting inclusion criteria (n= 42) 
   Declined to participate (n=36) 
   Other (n=10) 
Lost to follow-up (n= 0) 
Discontinued intervention (n=0) 
Allocated to CWI (n=50) 
 Received allocated intervention 
(n=49) 
 Did not receive allocated 
intervention (n=1) 
 Developed CI to CWI 
during operation (n=1) 
Lost to follow-up (n=0) 
Discontinued intervention (n=0) 
Allocated to TEA (n=50) 
 Received allocated intervention 
(n=48) 
 Did not receive allocated 
intervention (n= 2) 
 Operation cancelled due to 
disease progression (n=1) 
 Developed CI to TEA 
(n=1) 
 Resection not performed after 
laparotomy (n=4) 
Analysed  (n= 44) 







Analysed  (n= 49) 
 Excluded from analysis (n=0) 
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 TEA (n=44) CWI (n=49) 
Age (years) 62.6±11.1 62.8±12.1 
Male 29 (65.9) 28 (57.1) 
BMI (kg/m2) 27.7 ± 4.2 28.5±5.0 
ASA  
  I 
  II 










  CLM 
  HCC 
  Cholangiocarcinoma 
  Other malignant  













Size of tumour (mm) 47.6 ±44.8 45.2±44.0 
Number of tumours 1.4±1.2 1.7±1.2 
Background liver 
  Steatosis 
  Steatohepatitis 
  Sinusoidal dilatation 
  Cirrhosis 













Extent of Resection 
  Major resection 









23(52.3) 29 (59.2)  
BMI = Body Mass Index, ASA = American Society of 
Anesthesiologists, CLM= Colorectal Liver Metastasis, HCC = 
Hepatocellular Carcinoma.  a t-test, b 2 test, cFishers exact test. 
Data are presented as n (%) or mean±sd 
Table 11. Patient characteristics 
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 TEA (n=44) CWI (n=49) P value 
Operative time (min) 198 (141-250) 226 (171-306) 0.06a 
EBL (ml) 675 (452-1313 800 (475-1500) 0.41a 
Pringle time (min) 12 (0-27) 22 (2-34) 0.07a 
Transection time (min) 70 (42-100) 75 (48-110) 
30 (27-33) 
0.43a 
Wound size (cm) 31 (28-35) 0.25a 
Anaesthetic time (min) 50 (40-56) 35 (30-37) <0.0001a 
EBL = Estimated Blood loss. a Mann Whitney U test.  Data are presented as median 
(IQR) 
Enhanced Recovery After Liver Surgery 
Effects of Local Infiltration Versus Epidural Following Liver Resection II (LIVER II) 121 
6.4.1 Clinical Outcomes 
 
6.4.1.1 Functional Recovery Time 
 
The primary outcome of functional recovery time was reduced in the CWI group 
(CWI - 5.75 days, IQR 4-7; TEA – 6.5 days, IQR 5-9.75; p=0.04). As well as this the 
CWI group spent significantly less time in HDU (42 hours IQR 24-65) compared 
with TEA (46 hours IQR 42-66; p=0.04). Readmission rates were similar between 
the two groups (CWI 3 (6.1%), TEA 5 (11.4%); p=0.47). No differences were 
observed in achievement of recovery milestones (Table 13) or protocol compliance 
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 TEA (n=44) CWI (n=49) P value 
Recovery parameter  
  Passed wind 51 (23-79) 65 (34-78) 0.28a 
  Moved bowels 90 (55-120) 79 (65-101) 0.47a 
  Sitting 22 (20-36.5) 22 (19-24) 0.52a 
  Mobilisation 60 (44-85) 53 (39-72) 0.31a 
  First drink  6(4-14) 7(4-12) 0.68a 
  First meal  20(16-39) 20 (18-24) 0.99a 
Time to achievement of recovery milestones in hours.  Data are presented in median 
(IQR) hours. a Mann Whitney U test                                          
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ERAS compliance TEA (n=44) CWI (n=49) P value 








































































Data are presented as n (%). a 2 test bFishers exact test. 
Table 14. ERAS protocol compliance results 
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6.4.1.2 Morbidity 
 
A complication rate of 31(70.5%) was observed in the epidural group compared with 
a rate of 25 (51%) in the CWI group (p=0.06) (Table 15). No difference was 
observed in severity of morbidity between groups (Table 16). Three deaths occurred 
in the CWI group. No mortality was observed in the TEA group. Two deaths were as 
a result of multi organ failure following hepatic insufficiency and one was secondary 
to multi-organ failure on day 35 as a result of an ischaemic colon. A breakdown of 
individual complications observed is reported in Table 15. 
 
Individual complication type was recorded. All complications were reported 
including multiple complications in the same patient. Ten incidences of sustained 
hypotension related to epidural blockade were observed in the epidural group 
(p=0.03). Hypotension was defined as the requirement of an infusion of vasopressor 
to maintain adequate urine output, thus corresponding to a Clavien Dindo 
classification of two. Three patients in the CWI group required vasopressor support. 
This was in the context of multi-organ failure and all three of these patients 
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 TEA (n=44) CWI (n=49) P value 
Post-operative Outcome 
  All complications 31(70.5) 25(51.0) 0.06a 
  Mortality 0 (0) 3 (6.1) 0.24b 
Complication type    
  Bile leak 3 (6.8) 3 (6.1) 1.0b 
  Hematoma 0 (0) 2 (4.1) 0.5b 
  Collection/abscess 3 (6.8) 3 (6.1) 1.0b 
  Perforated DU 0 (0) 1 (2.0) 1.0b 
  Ischemic bowel 0 (0) 1 (2.0) 1.0b 
  Bleeding 1 (2.3) 2 (4.1) 1.0b 
  Wound   
dehiscence 
1 (2.3) 0 (0) 0.47b 
  Wound infection 3 (6.8) 2 (4.1) 0.66b 
  Hepatic Failure 4 (9.1) 4 (8.2) 1.0b 
  Hypotension  10 (22.7) 3 (6.1) 0.03b 
  LRTI 0 (0) 3 (6.1) 0.24b 
  UTI 1 (2.3) 2 (4.1) 1.0b 
  Urinary Retention 5 (11.4) 2 (4.1) 0.25b 
  Septicemia 1 (2.3) 0 (0) 0.47b 
  Ileus 5 (11.4) 4 (8.2) 0.73b 
  AKI 5 (11.4) 3 (6.1) 0.47b 
  Pneumothorax 1 (2.3) 1 (2.0) 1.0b 
  Colo-cutaneous                         
fistula 
0 (0) 1 (2.0) 1.0b 
  Arrhythmia 0 (0) 3 (6.1) 0.24b 
DU – Duodenal ulcer, LRTI – Lower Respiratory Tract Infection, UTI – Urinary 
Tract Infection, AKI – Acute Kidney Injury. a 2 test, bFishers exact test. Data are 
presented as n (%). 
Table 15. Post-operative morbidity and mortality 
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 TEA (n=44) CWI (n=49) P value 
Clavien Dindo Classification  
  0 13 (29.5) 21 (42.9)  
  1 10 (22.7) 6 (12.2)  
  2 15 (34.1) 10 (20.4)  
  3a 4 (9.1) 5 (10.2)  
  3b 0 (0) 3 (6.1)  
  4a 0 (0) 0 (0)  
  4b 2 (4.5) 1 (2.0)  
  5 0 (0) 3 (6.1) 0.19a * 
*Clavien Dindo grade ≥ 3 versus <3. If more than one complication observed per 
patient, highest Clavien Dindo complication reported. Data are presented as n (%).     
a 2 test 
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6.4.1.3 Pain Scores 
 
Pain scores were not significantly different between CWI and TEA at rest and on 
movement (Figure 14). The TEA group reported superior dynamic pain scores 
although this did not reach statistical significance. Both comparison of individual 
time points by t-test or comparison of all pain measurements repeated over the first 
three post operative days (by 2 way RM ANOVA) did not reveal a significant 
difference between pain scores. Peak dynamic pain scores were recorded 
immediately post-operatively for both CWI and TEA. Opiate consumption was 
greater in the CWI group until the first post-operative day. After that the epidural 
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 No significant difference observed after two way repeated measures ANOVA in 
pain scores at rest and on movement. Scores are recorded as mean±sd. 
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 TEA (n=44) CWI (n=49) P value 
Opiate consumption (mg) 
  Intra-operative  0 (0-1.9) 24.0 (20.0-38.0) <0.0001a 
  DOS  0 (0-22.6) 24.0 (14.0-51.0) <0.0001a 
  POD1  0 (0-34.5) 27.0 (16.0-47.0) <0.0001a 
  POD 2  18.5 (10.5-27) 12.0 (4.0-20.0) 0.02a 
  POD 3  15.0 (8.0-23.5) 8.0 (3.0-16.0) 0.02a 
DOS = day of surgery, POD = post-operative day. a Mann Whitney U test. Data are 
presented as median (IQR)  
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6.4.2 Inflammatory Response To Surgery 
 
Pro-inflammatory cytokines assessed were IL1β, IL6, IL8 and TNFα. One anti-
inflammatory cytokine (IL10) was assessed. HMGB1, a principle mediator of the 
inflammatory response, was also assessed. 
 
The pro-inflammatory mediators were all raised on POD1 and 3 compared to 
baseline in both groups except for IL1β (Table 18).  All mediators were raised in the 
CWI group compared with the TEA group on POD 1 but not significantly so (Table 
19). The levels then reduced by POD 3 but had not returned to baseline at this point 
as POD 3 cytokine levels remained significantly raised compared with the pre-
operative levels (Table 18). Two way RM ANOVA analysis of all three levels was 
performed to compare all measurements between groups. No significant difference 
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a paired t-test, b two way repeated measures ANOVA. * versus baseline. Data are 
presented as mean±s.d. 
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 TEA  (n=44) CWI  (n=47) P value 
IL10 (pg/mL) 96.2±125.0 169.2±599.7 0.43a 
IL1β (pg/mL) 0.8±0.7 2.7±13.5 0.36a 
IL6 (pg/mL) 165.6±278.4 190.1±219.7 0.64a 
IL8 (pg/mL) 12.8±12.0 15.0±13.1 0.41a 
TNFα (pg/mL) 6.5±6.5 6.0±6.0 0.72a 
HMGB1 (ng/mL) 6.2±4.1 8.4±10.5 0.19a 
a unpaired t-test. Data are presented as mean±s.d. 
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Mean±sd inflammatory marker levels. No significant difference was observed 
between groups and levels of inflammatory mediators after testing with two way RM 
ANOVA.  
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6.4.3 Haemodynamic Response 
 
Patients received intra-operative IV crystalloid according to protocol and at the 
discretion of the anaesthetist. There were no significant differences in patterns of 
fluid administration other than significantly greater IV crystalloid being administered 
to the epidural group (1618 mls IQR 1277-1908) compared to CWI (1450 mls IQR 
1200-1572) on DOS (p=0.02). Six patients in the TEA group and eight in the CWI 
group received a blood transfusion (p=0.72). There was a greater volume of 
crystalloid instilled in the CWI group (1315 mls IQR 320-1825) compared with TEA 
(779 mls IQR 285-2007) on POD 2 however this did not reach statistical significance 
(p=0.45) (Table 20). 
 
No difference was observed in CVP change during transection with a mean drop of 
6.0±2.7 mmHg and 6.2±3.0 mmHg in the TEA and CWI groups respectively during 
transection (p=0.65). Minimum mean intra-operative CVP observed was also similar 
in both groups (TEA 5.7±3.4 mmHg; CWI 5.7±2.7; p=0.99). Minimum MAP was 
however significantly lower in the TEA group (57.7±5.6 mmHg) compared with the 
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Measurements are in millilitres unless otherwise stated.   a Mann Whitney U test, 
bFishers exact test. Data are presented as median (IQR) or n (%).   
Table 20. Peri-operative fluid administration 
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 TEA (n=43) CWI (n=48) P value 
Highest CVP 11.6±4.6 11.9±3.4 0.75a 
Lowest CVP 5.7±3.4 5.7±2.7 0.99a 
Minimum MAP 57.7±5.6 61.2 ±7.8 0.01a 
CVP during transection   7.6±3.7 7.1±3.1 0.53a 
CVP reduction  6.0±2.7 6.2±3.0 0.65a 
CVP = central venous pressure, MAP = mean arterial pressure. Units are mmHg,        
a unpaired t-test. Data are presented as mean±s.d.  
Table 21. Intra-operative haemodynamic changes 
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6.5 Discussion 
 
This trial has shown that CWI offers an advantage in recovery time compared with 
epidural. No difference in resting or dynamic pain scores was observed. The 
inflammatory response was not noted to be attenuated to a greater degree in the TEA 
group and no advantage in terms of CVP reduction or EBL was observed.  
 
Epidurals are often advocated as important for enhanced recovery protocols due to 
the original perception of their role in improvement in recovery. [36] It has often 
been considered that a minimisation of pain leads to increased mobility, improved 
return of bowel function and prevention of complications.  However this does not 
seem to translate to reduced LOS. A large meta-analysis showed no reduction in 
LOS with epidurals compared to systemic opiates in a heterogeneous sample of 
recovery protocols. [163] Furthermore a recent meta-analysis looking at abdominal 
surgery [204] has shown that no difference in LOS was observed when all studies 
comparing epidural to either systemic opiates or CWI within an enhanced recovery 
protocol were compared. Moreover, two previous studies have shown epidural to 
prolong LOS within an enhanced recovery protocol after liver resection when 
compared with CWI [135] or intrathecal morphine injection. [134] Epidural is often 
advocated as an optimum analgesic modality following enhanced recovery protocols 
for liver resection. [88, 122, 126, 128] The current study represents the largest RCT 
comparing analgesic modalities following liver surgery and adds weight to the 
evidence that epidurals can actually prolong post-operative recovery time. 
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What has not been explored previously is why this might be. In this trial no 
significant differences were observed in recovery milestones and overall 
complication rates were not significantly different. However, TEA in this study was 
associated with a significantly increased HDU stay. Also significantly increased 
levels of hypotension were observed in the epidural group with ten patients requiring 
vasopressor infusion to maintain their systolic blood pressure above 90mmHg during 
their HDU admission. This will inevitably slow down post-operative recovery and 
prevents discharge from a high dependency environment. 
 
Higher rates of opiate consumption were observed in the CWI group on the day of 
surgery and POD1. However, surprisingly, opiate consumption rates were higher in 
the epidural group on POD2 (when the epidural was taken down) and POD 3 when 
both groups were prescribed oral analgesics. This may provide a further explanation 
as to why recovery time was prolonged in the epidural group. Increased opiate 
consumption after the epidural has been removed adds an obstacle to recovery and 
discharge that the CWI group did not have. Highest opiate consumption in the CWI 
group was on the day of surgery and this dropped thereafter, and as such, once the 
CWI was removed patients were able to move more seamlessly towards oral 
analgesics and discharge.   
 
Epidurals have historically been associated with improvements in certain 
complications such as pulmonary and cardiac complications following surgery. [167, 
168] However this evidence base is increasingly out-dated due to the lack of trials 
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including enhanced recovery protocols, comparisons of epidurals and systemic 
opiates only and heterogeneity of operation specialty and procedure. A more recent 
meta-analysis [204] compared epidurals versus all other analgesic modalities (PCA 
and CWI) in patients who all underwent enhanced recovery protocols following open 
abdominal surgery and no difference in complication rates was observed. This 
evidence is in agreement with the current trial that did not show a significant 
difference in overall morbidity rate, the inference being that a well constructed post-
operative enhanced recovery protocol should mitigate against preventable 
complications by providing optimum care to minimise complications and that an 
epidural is not mandated in order to achieve this. 
 
The overall complication rate of the current study is reasonably high when compared 
with current reported morbidity rates following liver resection [73] and reflects the 
prospective nature of the observation and reporting of all minor complications.  
 
Epidurals are traditionally associated with superior pain control however no 
significant difference was observed in this study.  Epidurals have consistently been 
shown to provide superior pain scores when compared to IV opiates. [45] However 
when compared to CWI the superiority has been blunted to an extent. A meta-
analysis comparing epidurals to CWI showed no significant difference in analgesic 
benefit following abdominal surgery. [162] This meta-analysis was limited by the 
heterogeneity of incisions and operations and included mostly lower abdominal or 
midline laparotomy procedures, the incisions of which do not incorporate a subcostal 
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element. Subcostal incision involves dermatomes up to T6 and require blockade of 
the transversus abdominis plane as well as the rectus sheath to ensure adequate 
analgesia. Therefore the results of a review assessing predominantly midline 
incisions are not directly translatable to a Makuuchi incision. A review of analgesia 
techniques following specifically liver surgery showed the improved analgesia scores 
after liver resection of CWI compared to controls [198] however only one previous 
RCT, also from our group, has compared epidural with CWI follow liver resection 
[135] and superior scores were noted in the epidural group, in accordance with 
similar trials comparing epidurals to alternative analgesic regimens [151, 155] after 
liver resection.  
 
In the first LIVER trial [135] the early pain scores were notably higher in the CWI 
group compared with the epidural group. In an effort to mitigate against this we 
incorporated a higher volume TAP and rectus sheath block in an attempt to improve 
pain scores in the immediate post-operative period. This seemed to have an effect as 
both early pain scores and overall pain scores were comparable to TEA in the current 
trial. Dynamic pain scores were observed to be superior in the epidural group 
although not significantly, however if the two way ANOVA RM was repeated with 
scores to POD 2 only then a significantly higher pain scores was observed in the 
CWI group, which suggests a potential for the epidurals to still provide relatively 
better dynamic analgesia although the mean pain scores were all in the “mild” 
category and the overall difference is not thought to represent a significant hindrance 
to clinical recovery as is shown by the equipoise in recovery parameters. 
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A potential argument for the use of epidurals over alternative analgesic modalities is 
the increased attenuation of the inflammatory response by epidurals. [36] However a 
significant rise in inflammatory markers was observed in both groups (except Il1β) 
thus implying no advantage in this respect in either group. Higher levels were seen in 
the CWI groups of the individual inflammatory markers on POD1, although this was 
not significant with either two way RM ANOVA or comparison of the two 
independent levels.   
 
Both epidural and CWI have been shown to attenuate the inflammatory response 
when compared to controls in a variety of abdominal surgical settings [200, 201, 
205-207] with a meta-analysis showing an association between attenuation of the 
inflammatory response and clinical outcome [116] and a potential argument for the 
use of TEA after abdominal surgery is the effect of TEA on the inflammatory 
response to surgery. [36] We have therefore shown that this is not necessarily the 
case. It is likely that CWI exhibits its own inflammatory response attenuation via the 
instillation of local anaesthetic to the afferent nerve fibres.  
 
A multitude of inflammatory mediators have been investigated in the past. More 
recently HMGB1 has emerged as a principle mediator of the inflammatory response, 
and moreover has been closely associated with clinical outcome in a variety of 
settings. [19, 21, 22, 27] Its inhibition by local anaesthetics has also been postulated 
in an in-vitro study [208] thus making this a particularly interesting mediator to 
quantify in the two study groups.  
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The third area of investigation of this trial was the effect of either TEA or CWI on 
intra-operative transection. No difference was observed in terms of CVP during 
transection between the CWI and TEA groups. The evidence assessing CVP 
reduction during liver surgery is lacking large RCTs comparing methods. No trial has 
assessed the effect of epidural alone on this care component. 
 
Epidural has been included in CVP lowering protocols along with IV fluid 
restriction, GTN, furosemide and patient positioning. These trials have shown 
significant improvements in EBL following CVP reduction by these methods [175, 
178, 179] when CVP was reduced from over five mmHg to below five mmHg 
however the impact and importance of TEA in these protocols is not clear due to the 
multi-modal nature of the intervention. Therefore in light of the findings of our 
recent trial, epidural may not offer an advantage in terms of CVP reduction and 
should not be considered mandatory to achieve low CVP. 
 
A retrospective study [141] showed a significantly increased volume of colloid and 
total fluids administered intra-operatively and post-operatively in patients who 
received epidurals when compared to those not receiving epidural. Excessive fluid 
administration is associated with increased complication rates and increased post-
operative LOS. [209, 210] One previous large retrospective analysis of TEA versus 
systemic opiates following liver resection also found increased RCC transfusion rates 
and increased intra-operative colloid in patients receiving epidural. [157]  
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The findings of the current study conflict with these previous studies in that we have 
not shown a significantly deleterious impact of epidural on EBL, transfusion rates or 
intra-operative fluid administration. In this study, intra-operative MAP was 
significantly reduced in the TEA group, and vasopressor infusions were required in a 
significant proportion of patients receiving TEA. This illustrates the effect of 
epidural on the sympathetic nervous system, which is implied as the mechanism of 
TEA associated hypotension and fluid overload. However, with the prospective 
implementation of an appropriately directed protocol in terms of intra-operative and 
post-operative fluid administration excessive administration of IV fluids and the 
adverse outcomes associated with IV fluid overload can be prevented. 
 
The results of the trial need to be considered in the context of its limitations. Firstly it 
was decided to run the trial as unblinded, which could be considered as a potential 
introduction of bias in the trial. The principle reason for running the trial in this way 
was to allow a realistic assessment of the advantages and disadvantages of the two 
analgesic methods. Blinding in this type of trial, as was done in our earlier LIVER 
study, [135] involves a sham procedure, either epidural or CWI. This is not 
necessarily effective in providing genuine blinding. Moreover blinding can alter 
normal usage of the analgesic technique, thus providing an untranslatable picture of 
each modality. The introduction of purely objective measures such as complication 
rate, length of stay and cytokine response allows for minimisation of any bias 
introduction. 
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Secondly, the timing of the assessment of the inflammatory mediators may 
potentially be misleading. A true peak is likely immediately post-operatively, and we 
are unable to categorically exclude a difference in early peaks. However a 24 hour 
assessment is reasonable and likely to capture a sustained difference in cytokine 
release. The 24 hour levels are also more important in this trial as the CWI was not 
inserted until the end of the procedure and so would likely have had no effect on 
cytokine response by the immediate post-operative time point.  
 
The majority of the secondary outcomes assessed in this trial did not show 
statistically significant differences. It is appreciated that the opportunity for a type 
two error is possible in this situation as the original powering of the study was 
performed to assess a difference in recovery time. However in a study of this size it 
is reasonable to infer that when no significant difference was observed, no obvious 




TEA did not show an advantage over CWI after liver resection. CWI patients showed 
improved recovery times with no difference in pain scores or complication rates. No 
advantage was shown by TEA in terms of the inflammatory response or intra-
operative CVP. In the era of enhanced recovery surgery epidurals need no longer be 
considered mandatory to achieve optimum outcomes when an appropriate post-
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operative protocol is implemented. CWI could be considered as a first line analgesic 
method after liver resection. 
 
6.7 Research Requirements Identified 
 
During the conduct of this trial it was observed that adherence to the ERAS protocol 
was variable and ensuring implementation of the ERAS care components often 
challenging. This raised questions regarding the obstacles preventing adherence and 
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7 Attitudes Of Patients And Care Providers To Enhanced 
Recovery After Surgery Programmes Following Major 




Enhanced Recovery After Surgery (ERAS) is a well-established pathway of peri-
operative care in surgery in an increasing number of specialties. In order to 
implement protocols and maintain high levels of compliance, continued support from 
care providers and patients is vital. This survey aimed to assess the perceptions of 
care providers and patients of the relevance and importance of the ERAS targets and 
strategies. Pre-operative and post-operative surveys were completed by patients 
undergoing major hepatic, colorectal or oesophagogastric surgery in three major 
centres in Scotland, Norway and The Netherlands.  Anonymous web-based and paper 
surveys were also sent to surgeons, anaesthetists and nurses experienced in 
delivering enhanced recovery protocols. Each questionnaire asked the responder to 
rate from 0-10 a selection of enhanced recovery targets and strategies in terms of 
perceived importance. 109 patients and 57 care providers completed the pre-
operative survey. Overall both patients and care providers rated the majority of items 
as important and supported ERAS principles. Freedom from nausea (median 10, IQR 
8-10) and pain at rest (median 10, IQR 8-10) were the care components rated highest 
by both patients and care providers. Early return of bowel function (median 7, IQR 
5-8) and avoiding pre-anaesthetic sedation (median 6, IQR 3.75-8) were scored the 
lowest by care providers. In conclusion, ERAS principles are supported by both 
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patients and care providers. This is important when attempting to implement and 
maintain an ERAS programme. Controversies still remain regarding the relative 
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7.2 Introduction 
 
Enhanced Recovery After Surgery (ERAS) protocols have become established 
practice in patients undergoing major resectional surgery. [148] The original success 
in colorectal cancer resections has been followed by its application in other fields 
including surgery for breast [31] and oesophagogastric cancer. [30]  
 
The main measurements of success of enhanced recovery programmes have been the 
reduced peri-operative morbidity and reduced post-operative length of hospital stay. 
[58] 
 
However, deviation from ERAS protocols is commonly reported and this is 
associated with prolonged length of stay. [57] As well as this, barriers to 
implementing fast track protocols are commonly encountered, [211] with reluctance 
by care providers to accept care strategies that differ from personally preferred 
practice being a major factor. [212] 
 
Patient acceptance is vital when attempting to achieve successful results with 
enhanced recovery approaches. Moreover, care provider support for enhanced 
recovery care components is critical in order to successfully implement post-
operative care pathways relying on multi-disciplinary team input. [212] 
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It is therefore necessary to explore the views of both patients and care providers 
regarding their personal priorities pertaining to recovery and the favoured strategies 
used to achieve these aims. This information is crucial to determine whether 
enhanced recovery programmes have the correct patient-centred approach to post-
operative recovery and the appropriate support of care providers in order to optimise 
implementation. 
 
This survey of patients and healthcare professionals was performed to investigate 












Enhanced Recovery After Liver Surgery 
Attitudes of Patients and Care Providers to Enhanced Recovery After Surgery Programmes 150 
7.3 Methods 
 
After satisfying the requirements of the respective institutional review boards a 
survey was carried out by the investigators across three Northern-European centres – 
Edinburgh (UK), Tromsø (Norway) and Maastricht (The Netherlands). These 
institutions are high volume tertiary referral centres experienced in delivering ERAS 
protocols in hepatic, colorectal and oesophagogastric surgery.  
 
The authors developed a questionnaire for the purpose of this survey. The 
questionnaire aimed to quantify the responders’ perception of the importance of 
individual enhanced recovery outcomes and strategies. 
 
The questionnaire was divided into two sections. The first assessed individual targets 
to be achieved during recovery following abdominal surgery (questions 1-8). These 
incorporated the major domains of ERAS principles [36] – pain control, gut function 
restitution, mobility, overall function and hospital discharge.  These items were 
identical for questionnaires given to care providers and patients. The second section 
assessed strategies on how to achieve the recovery targets specified in section one. 
The items chosen reflected common strategies utilised in enhanced recovery 
protocols as advocated by the best available evidence. [36] The patients were given 
four questions and the care providers were given 13 different questions relating to 
strategy.  
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The questions were formulated in English and then translated into Dutch and 
Norwegian. A further separate translation of the questions back into English was 
performed to ensure accurate translation. The questionnaire was trialled locally to 
ensure satisfactory comprehension by responders. 
 
Responders in each institution were given a standardised verbal explanation as to 
what the survey entailed and advice regarding how to complete the survey. They 
were asked to rate each component from 0-10 on an 11 point Likert scale, depending 
on how important they believed each component was. The scale used indicator 
statements of “not important” and “very important” at the relevant extremes of the 
scale to assist with scoring. An example was performed by the investigator with each 
responder to ensure comprehension and then the patient was left to complete the 
questionnaire unaided.  
 
The survey was conducted between November 2012 and November 2013. 
Consecutive patients scheduled for hepatic, colorectal or oesophagogastric surgery 
were approached and asked to complete a questionnaire on the morning of their 
operation or during out-patient work-up prior to surgery. This was repeated 
following surgery when the patient returned to the out-patient clinic two to four 
weeks later. Due to the exploratory nature of this survey a sample size calculation 
was not performed. However, it was determined that each centre would recruit a 
minimum of 35 patients to complete the questionnaire before and after surgery. The 
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exclusion criteria were an inability to comprehend the survey or unwillingness to 
participate. 
 
A random sample of senior surgeons, anaesthetists and nurses working in the centres 
involved in the care of these patient groups were also surveyed. This questionnaire 
was administered using an internet-based tool (Survey Monkey, Palo Alto, US; for 
Tromsø: Questback®) or an identical paper-based version depending on 
convenience.  
 
Results were collated and analysed with Excel 2010 (Microsoft Corp., Seattle, US) 
and presented as median and interquartile range (IQR). Statistical analysis was 
performed with R (R Foundation for Statistical Computing, version 2.9.0). Discrete 
variables were compared with Fishers exact or Chi-square tests where appropriate. 
Continuous data were assessed with Mann Whitney U test. Scores between care-
provider specialties were compared with the Kruskal-Wallis test. Statistically 
significant differences between pre-operative and post-operative patient scores were 
assessed by the Wilcoxon signed-rank test. Significance tests were adjusted for 
multiple comparisons using the Bonferroni correction.  
 
As we had devised a novel questionnaire, we undertook validation of the instrument. 
High internal consistency would be expected if responders scored items within the 
two sections (outcomes and strategies) similarly. Internal consistency of 
questionnaire components was determined with Cronbach’s alpha including 95% 
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bootstrapped confidence intervals. Cronbach’s alpha increases with greater inter-
correlation of questionnaire components and can be interpreted as an overall measure 
of internal consistency.   
 
Exploratory factor analysis was performed to assess the underlying structure of the 
questionnaire. The questionnaire had two sections, “attitudes to outcomes” and 
“attitudes to strategies”. It might be expected that answers to questions assessing 
each of these domains would be correlated. The factor analysis examined whether 
questions might cluster into alternative groupings representing different underlying 
concepts. Principal component analysis was performed and eigenvalues generated 
(representing the proportion of the variance explained by each additional new factor). 
Eigenvalues were plotted on a scree plot and a cut-off determined.  Maximum 
likelihood factor analysis was then performed with varimax rotation retaining the 








Enhanced Recovery After Liver Surgery 
Attitudes of Patients and Care Providers to Enhanced Recovery After Surgery Programmes 154 




One hundred and nine patients scheduled for major abdominal surgery were 
approached and participated in the pre-operative survey. Patients were included from 
all three centres – Edinburgh (n=38), Tromsø (n= 36) and Maastricht (n=35). The 
demographic and clinical characteristics of the patients are shown in table 22 and 23. 
Eighty-one per cent (88/109) of patients responded to the follow-up survey 
administered after surgery. The post-operative non-responders had higher ICU 
admission rates (29% vs 8%, p<0.05) and a higher proportion of oesophagogastric 
resections (24% vs 7% p<0.05) performed when compared to the patients who 
completed the post-operative questionnaire. Sixteen anaesthetists (median age 51, 
IQR 42-61), 23 nurses (median age 35, IQR 29-38) and 18 surgeons (median age 52, 
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Data are presented as median (range) or n (%) 
Table 22. Patient characteristics 
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CLM – Colorectal liver metastasis, HCC – Hepatocellular carcinoma. Data are presented as 
median (range) or n (%) 
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7.4.2 Questionnaire Validation 
 
The inter-correlation of items within the two parts of the questionnaire was good 
suggesting internal consistency: care providers outcomes α=0.89 (IQR 0.83-0.93), 
care providers strategies α=0.83 (IQR 0.75-0.89); patients outcomes α=0.96 (IQR 
0.79-1.00) and patient strategies α= 1.00 (IQR 0.34-1.00).  
 
An exploratory factor analysis was performed on the questionnaire components for 
care providers to assess underlying structure. Three factors were shown to provide an 
adequate fit. Items relating mainly to enhanced recovery outcomes loaded onto one 
factor and those relating to individual strategies to a second. Interestingly, four items 
(two outcomes and two strategies) – “to be completely free from pain at rest”, “to be 
completely free from pain on movement”, “using epidural analgesia for 48 hours” 
and “optimising fluid balance” – loaded onto a third factor, suggesting additional 
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Figure 16. Factor analysis of strategies and outcomes 
*Strategy factor 
 
7.4.3 Patient Outcomes 
 
The overall scores were high with the lowest median score being 8/10. The pre-
operative impressions of patients awaiting surgery were unchanged by the 
subsequent surgery, with no significant differences observed between pre- and post-
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operative scores (i.e p>0.05 for each comparison following adjustment for multiple 
comparisons), as determined by the Wilcoxon signed-rank tests (Figure 17).  
 
Patients scored freedom from nausea (median 10 IQR 8-10) and freedom from pain 
at rest (median 10 IQR 8-10) as the two most important factors. Achieving 
independent mobility was also scored highly by patients (median 9, IQR 8-10). Early 
discharge (median 9, IQR 6.5-10) and early return of bowel movements (median 9, 
IQR 7.25-10) received the lowest scores when taking the IQR into account (Figure 
17).  
 
7.4.4 Patient Strategy 
 
Patients highlighted pre-operative counselling (median 10, IQR 8.75-10) and 
avoiding infection in hospital (median 10, IQR 9-10) as a priority in achieving 
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7.4.5 Care Provider Outcomes 
 
Outcomes were in general scored highly by the care providers with all items being 
scored with a median of 7/10 or higher. The outcomes scored as most important by 
care providers were control of nausea (median 9, IQR 8-10) and being free from pain 
at rest (median 9, IQR 8-10) (Figure 18).  
 
Being able to move the bowels as soon as possible was scored the lowest (median 7, 
IQR 5-8) by the care providers. Also being discharged from hospital as soon as 
possible received lower scores (median 8, IQR 6-9) as did returning to daily 
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7.4.6 Care Provider Strategy 
 
The range of scores was more varied in this area of responses. The highest rated 
items of care strategy as scored by the care providers were: provision of pre-
operative counselling (median 10, IQR 9-10); promotion of early mobilisation 
(median 9.5, IQR 9-10) and optimisation of IV fluid administration (median 9, IQR 
8-10) (Figure 19).  
 
Avoiding wound drains (median 7, IQR 4.5-8.25), avoiding bowel preparation 
(median 7, IQR 4-8) and avoiding anaesthetic pre-medication (median 6, IQR 3.75-
8) were scored the lowest (Figure 19).  
 
Sub-group analyses using the Kruskal Wallis test were performed to compare scores 
of each item by individual specialties of care providers and between the care provider 
nationalities. Following adjustment for multiple comparisons no significant 
differences between care provider specialty nor nationality scores were observed. 
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7.5 Discussion 
 
This study investigated the opinions and perceptions of both providers and receivers 
of enhanced recovery protocols following major abdominal resectional surgery in 
three European countries. It is the first study of its kind.  
 
The novel questionnaire was designed for the purposes of this study and validated 
successfully. Good internal consistency was observed and the factor analysis 
performed revealed a logical separation of items into ERAS outcomes and strategies. 
This suggests consistent and distinct scoring patterns within these groups of 
questionnaire items indicating satisfactory validity of the items selected. These 
results also reflect the consistently high scores throughout the survey and overall 
support for the outcomes and strategies used in the questionnaire. 
 
The post-operative response rate of eighty-one per cent was satisfactory. The non-
responders underwent a greater proportion of oesophagogastric resections and fewer 
hepatic resections than those who completed the post-operative questionnaire. 
Although the ICU admission rate was higher in this sub-group, readmission and 
complication rates remained unchanged. This likely reflects a tendency for 
oesophagogastric resections to be managed initially in ICU routinely, which was not 
the case for hepatic resections, and their absence was not thought to adversely 
influence the post-operative responses observed. 
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Patients attributed high importance to all of the ERAS aims and strategies asked of 
them. This represents concordance between patients’ beliefs and current 
recommendations by ERAS experts and this finding should be used to encourage and 
develop ERAS implementation. 
 
Previous studies have also shown that compliance with ERAS protocols can be 
compromised resulting in deviation from care plans. [57] However, our results show 
that patient support for the ERAS process is high and therefore we suggest it is 
unlikely that lack of patient acceptance is the main cause of deviation from protocols. 
Moreover, we did not show a difference in patient opinion pre- and post-operatively, 
suggesting that patient support for such care plans does not change even after having 
gained experience of the care principles.  
 
A qualitative assessment of patient experience following ERAS surgery [213] found 
that decreased satisfaction was reported in a subgroup of patients who suffered a 
complication following discharge. Our survey sample included patients who suffered 
complications at rates that would be expected from these types of surgery. This did 
not cause significantly different pre-operative and post-operative patient scoring and 
so we do not concur with the view that the development of a complication negatively 
impacts on patients’ support for the ERAS principles.  
 
The clinicians also scored highly for the majority of targets and strategies and good 
inter-specialty agreement was observed, representing streamlined support for ERAS 
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principles. Opinions of different professional groups involved in delivering ERAS 
programmes has not been assessed before and represents a novel finding of the study 
and justification for continued implementation.  
 
However, although our scores were high there were some areas of relatively lower 
scoring. There was a broad range of scores for the importance of epidurals, 
particularly from surgeons (range 1-10). This reflects the controversy that surrounds 
routine epidural use. [139] The use of alternative analgesic modalities, such as 
intrathecal analgesia and continuous wound infiltration, has become increasingly 
popular. [134, 135] The UK Department of Health’s Enhanced Recovery Partnership 
Programme (ERPP) consensus opinion [148] has subsequently advocated less routine 
epidural use and increased alternative analgesic methods.  
 
Fluid balance optimisation was scored highly by care providers. Both inappropriate 
fluid restriction and excessive fluid administration have been shown to be associated 
with prolonged hospital stays [209] and increased post-operative morbidity [210] 
reflecting the importance of accurate fluid balance. Epidural use is associated with 
vasodilation and hypotension and can be associated with excessive intravenous fluid 
administration.[140] It may be that these perceived drawbacks associated with 
epidural use are contributory to its lower rating. Indeed the factor analysis identified 
epidural use, fluid balance and minimisation of pain as a distinct group separate from 
ERAS outcomes and strategies, reflecting an independent but uniform scoring pattern 
for these items by the care providers. 
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Strategies scored lowest overall by care providers were the avoidance of post-
operative abdominal drains, oral bowel preparation and pre-anaesthetic sedatives. 
There is high-level evidence in colorectal surgery advocating against drain insertion. 
[214] Similarly, there is good evidence suggesting no benefit of routine bowel 
preparation prior to abdominal surgery. [215] 
 
The stimulation of gut motility was also scored in the lower half of results, 
particularly by anaesthetists and, to a lesser degree, surgeons. Liberal laxative use to 
prevent constipation and achieve restoration of bowel function is often advocated as 
a preventative measure against post-operative ileus [216] and is a component of 
many enhanced recovery protocols. However the care provider responses were at 
odds with this evidence.  
 
These results may be partly due to of the presence of resections other than colorectal 
in the study population where there is less clear evidence for the benefits of drain 
avoidance and less relevance of bowel preparation and stimulation. However, the 
reluctance to abandon previously well-established practice despite evidence to the 
contrary is recognised in the literature. [137, 211] This is a potential obstacle to the 
implementation and continued establishment of ERAS principles and is a 
phenomenon that continues to be observed [217] and requires attention when 
addressing failing ERAS implementation. 
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Potential drawbacks to the study are the relatively small sample size and the post-
operative response rate. It is also acknowledged that due to the small sample size and 
the high concordance in the overall scoring it is not possible to determine which 
items are considered more important relative to each other. However it is possible to 
determine those items scored highest and lowest and an appropriate qualitative 
assessment of these items was performed. Additionally, the overall high internal 
consistency of the results suggests that the sample provides valid results and is an 
acceptable number for this descriptive analysis.  
 
The survey was performed on patients, for the most part, undergoing major open 
abdominal surgery for malignant disease processes. This therefore represents a 
population representative of the majority of ERAS recipients however is not strictly 
relevant to non-abdominal surgery.  
 
In conclusion, this novel study has shown good patient and multidisciplinary care 
provider approval for the principles of enhanced recovery care after surgery and 
supports on going development and implementation of such programmes. It 
highlights potential areas of concern for care providers, namely epidural use and 
fluid administration. Lastly, we identified several items scored as low priority by 
care providers where there is a strong evidence base to the contrary. This highlights a 
potential barrier to ERAS implementation and is an area that requires consideration 
and education if continued sustainability and development of ERAS programmes is 
to be achieved.  
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7.6 Research Requirements Identified 
 
The establishment of support for ERAS principles in this chapter is an encouraging 
finding. However, what is of concern is the morbidity burden associated with liver 
resection. This and the previous chapter reported morbidity rates of 45 per cent and 
over. The following chapter investigates this finding further and attempts to quantify 
overall morbidity rate for the investigating unit and identify factors associated with 
morbidity. 
 
7.7 Chapter Publication 
Attitudes of patients and care providers to enhanced recovery after surgery programs 
after major abdominal surgery. Hughes M, Coolsen MM, Aahlin EK, Harrison EM, 
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8 Short Term Outcomes After Liver Resection For Malignant And 




Post-operative morbidity following liver resection remains high and has not reduced 
significantly over the past decade. Recently Enhanced Recovery After Surgery 
protocols have been implemented effectively and suggest some benefits in terms of 
general morbidity. In order to improve the effectiveness of peri-operative care 
protocols, further investigation is required to identify factors associated with poor 
outcome after liver resection when enhanced recovery principles are applied. An 
analysis of a prospectively collated database of patients undergoing liver resection at 
the Royal Infirmary of Edinburgh, UK between January 2006 and September 2012 
was conducted. The primary outcome was morbidity rate. Data were collected on 
patient demographics, oncological, operative and pathological details and post-
operative outcomes including length of stay (LOS) and complication type. Univariate 
and multivariate analyses were performed to determine independent predictors of 
morbidity. 603 patients underwent liver resection during the study period. Morbidity 
and mortality rates were 34.3% and 1.5% respectively. Independent predictors of 
overall morbidity included age  (OR 1.02; 95%CI 1.007-1.037), major resection (OR 
1.835; 95% CI 1.224-2.751) and extended resection (OR 2.443; 95% CI 1.475-
4.047). The only predictor of major morbidity was extended resection (OR 4.079; 
95% CI 2.177-7.642). In summary, age is still associated with adverse outcome after 
liver resection despite the application of enhanced recovery principles. Extended 
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resection is associated with both major and overall morbidity and further 
investigation is required to establish post-operative care components to improve this. 
When determining optimum peri-operative care, factors associated with adverse 
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8.2 Introduction 
 
Liver resection offers definitive surgery for a number of malignant conditions. 
Traditionally liver resection has been associated with high post-operative mortality 
and morbidity rates. [218] With centralisation of services to high volume centres, 
mortality rate has steadily declined to an accepted rate of less than five per cent. [71] 
Morbidity rates, however, remain high at up to 45%. [73] Not only is peri-operative 
morbidity delaying discharge, causing patient suffering and leading to increased risk 
of mortality, it is also associated with decreased overall long term survival following 
surgery for malignant disease. [87]  
 
Therefore the minimisation of morbidity is fundamental to improving outcomes. 
Enhanced Recovery After Surgery (ERAS) programmes have been utilised 
extensively in colorectal surgery and have been shown to not only reduce hospital 
admission time but also reduce morbidity rates and are now established as standard 
of care. [28] In liver resectional surgery there has been increasing interest in ERAS 
protocols. [172] Not only is ERAS after liver surgery deemed safe and feasible but 
two recent RCTs [122, 124] have shown reduced general morbidity rates after liver 
resections.  
 
Predictors of morbidity have been assessed before, [73, 117] however, a recent 
assessment of predictors of outcome after resection of all tumour types, in a general 
population undergoing enhanced recovery multi-modal peri-operative care is lacking.  
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The investigating unit is experienced at providing enhanced recovery care after liver 
surgery. [88, 135, 219] In order to formulate successful post-operative ERAS 
protocols and continue to effectively reduce surgical complications it is critical to 
evaluate the factors associated with post-operative morbidity and determine areas of 
care that can be optimised after liver resection.  The aim of this study was to quantify 
outcomes and assess the predictors of morbidity after liver surgery when enhanced 
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8.3 Methods 
 
Approval from the NHS Lothian review board was obtained prior to commencing the 
data collection. All patients who underwent a liver resection between January 2006 
and September 2012 within the Royal Infirmary of Edinburgh, UK, were identified 
from the prospectively collated Lothian Surgical Audit database. The Caldicott 
Guardian approval was obtained and these principles of data management were 
adhered to. 
 
8.3.1 Peri-operative Protocol 
 
All patients undergoing liver resection underwent review in a multi-disciplinary team 
meeting where their radiological investigation was assessed by the surgical and 
radiological team in an attempt to ascertain resectability. This decision was made in 
concert with the oncology team and a decision made regarding pre-operative 
chemotherapy, further staging and suitability for surgery if appropriate.  
 
Peri-operative care at the Royal Infirmary of Edinburgh is based on a protocol first 
described by van Dam et al (2006) [88] and has been utilised in subsequent clinical 
trials. [135, 219]  Patients are routinely admitted to hospital on the day of surgery 
after having fasted from midnight. Patients are allowed to drink clear fluids up until 
two hours prior to induction of anaesthesia. Endotracheal intubation is performed in 
the anaesthetic room. Pre-operative sedative mediation is routinely avoided. 
Monitoring is performed invasively with a central venous line to assess CVP and an 
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invasive blood pressure monitor via the radial artery. Oxygen saturation levels, end 
tidal CO2, heart rate, blood pressure and urine output are monitored continuously 
throughout the procedure. Patients received peri-operative antibiotic prophylaxis, 
low molecular weight heparin and pneumatic calf compression as 
thromboprophylaxis. Warming blankets are applied to the patient for the duration of 
surgery. 
 
Liver resection is performed from either a bilateral subcostal incision or right 
subcostal incision, extended to the midline if required. Full laparotomy is performed 
to establish any contra-indication to resection. Intra-operative ultrasound is 
performed by the operating surgeon to determine the location and extent of disease 
and confirm the operative approach. Transection is performed with the Cavitron 
Ultrasonic Aspirator (CUSA) device, with or without hepatic in-flow occlusion and 
under hypovolaemic conditions via CVP monitoring. Routine NG tube and peritoneal 
drainage are avoided. 
 
Post-operatively patients are transferred to the recovery unit where they are 
extubated and monitored for immediate complications. They are subsequently 
transferred to the High Dependency Unit and then the general ward after 
approximately 48 hours. Patients are managed according to unit protocol until 
medically fit for discharge and capable of self care. Pain control is routinely 
managed with a thoracic epidural and then oral analgesia as coordinated by a 
specialist pain team. Patients are encouraged to eat and drink from the first post-
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operative day and mobilised daily from post-operative day one. Venous and arterial 
cannulae and urinary catheters are removed from post-operative day one. 
 
The patients are routinely reviewed in the out-patient clinic approximately four 
weeks post discharge and discussed in the MDT meeting where pathological analysis 
of the specimen was reported and follow up and adjuvant chemotherapy decided 
upon. 
 
8.3.2 Data Collection  
 
Demographic details, namely age, gender and comorbidities were collected from the 
patient case files. Presence of co-morbidity was determined as positive when at least 
one co-morbidity was described in the pre-operative clinic assessment. 
 
Pre-operative oncological data were obtained from the transcription of the Multi-
Disciplinary Team (MDT) meeting prior to resection. From this report performance 
of portal vein embolization (PVE) and neoadjuvant chemotherapy data were 
obtained. Confirmation of PVE was obtained from the CT report. Neoadjuvant 
chemotherapy was also confirmed from the MDT report and deemed to be positive if 
chemotherapy was commenced prior to resection. Pre-operative blood tests were 
obtained from the laboratory investigations contained within the electronic case 
records. 
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The extent of the procedure and use of in-flow occlusion were determined with major 
resection being defined as resection of three or more segments. Extended resection 
was defined as resection of five or more segments as per the Brisbane criteria. [91]  
 
Intra-operative and post-operative blood transfusion information was obtained from 
the Blood Transfusion Service database of prospectively collected data. Day of 
operation from the operation note and admission dates were linked with the dates of 
transfusion of blood and reported as receiving transfusion accordingly. 
 
Admission data were gained from the patient case records and clinical course, 
complications and length of stay were documented. Post-operative complications 
were also gathered from the patent records, namely the discharge letter from the 
discharging surgeon. Complication type was recorded as it was reported in the case 
documentation.  
 
Pathology data were gained from the original pathology report. Underlying tumour 
pathology, size and number were recorded. Underlying liver parenchyma was also 
confirmed from the pathology report as was resection margin with a R1 resection 
being confirmed if the tumour edge was within 1 mm of the resection margin. 
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Peri-operative mortality was confirmed if patients were reported to have died in 
hospital or within thirty days after operation. Thirty and ninety day mortality was 
confirmed by data from the Information and Statistics Department (Scotland).  
 
8.3.3 Statistical Analysis 
 
Continuous data were expressed as median and interquartile range (IQR) and 
compared using the Mann Whitney U test when not normally distributed. If normal 
distribution was observed a mean and standard deviation were presented and 
unpaired t-tests performed to determine differences in means. Categorical data were 
assessed with Chi squared test or Fishers exact test where appropriate. Multivariable 
logistic regression analysis was performed to assess for independent predictors of 
morbidity. Factors were entered into the multivariable analysis if they were clinically 
relevant or achieved significance at the 10% level. P values were two-tailed and 
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8.4 Results 
During the study period 603 patients underwent liver resection for malignant (n=540) 
and benign (n=63) disease (Table 24).  
 
The mean age of the cohort was 60.5±13.4 years with 41.8% having at least one co-
morbidity. The main malignant indications for resection were Colorectal Liver 
Metastasis (CLM) (n=381), Hepatocellular Carcinoma (HCC) (n=75) and 
cholangiocarcinoma (n=50). 
 
As the majority of patients had resection for CLM, data were gathered on 
neoadjuvant chemotherapy and chemotherapy related liver injury. 168 (27.9%) 
patients received neoadjuvant chemotherapy. The precise chemotherapeutic regimen 
was not available on all patients and so only the presence or absence of 
chemotherapy administration recorded in the patients records was reported.  
 
55.7% of patients underwent a major resection, defined as resection of greater than or 
equal to three segments with patients undergoing resection for cholangiocarcinoma 
having predominantly major resections (92.0%). Cholangiocarcinoma resections 
were also associated with a greater number of patients receiving intra-operative 
blood transfusions (Table 25).  
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Age (years) 60.5±13.4 60.1±11.8 63.0±15.0 62.4±11.8 66.0±12.0 48.8±15.6 
Female 253(42.0) 21(42) 20(26.7) 150(39.4) 19(55.9) 43(68.3) 
Comorbidities  252 (41.8) 18(36) 64(85.3) 139 (36.5) 12 (35.3) 19(30.2) 
Baseline bloods       
  WCC (x109/L) 7.3±2.3 8.4±2.8 6.9±2.3 7.1±2.1 7.3±2.6 8.3±2.4 
  Haemoglobin (g/L) 132±17 128±16 135±17 133±17 129±15 134±15 
  Platelets (x109/L) 252±92 310±100 225±109 244±83 281±128 271±70 
  Creatinine (μmol/L) 79±32 76±49 81±23 81±33 79±24 71±19 
  Albumin (g/L) 41±4 39±5 41±5 42±4 41±4 42±5 
  Bilirubin (μmol/L) 15±27 57±77 12±7 10±5 12±8 15±18 
  ALT (U/L) 41±59 84±68 50±44 30±29 29±24 68±144 
  Prothrombin Time (secs) 11±2 11±2 12±2 11±2 10±2 11±2 
Neoadjuvant chemotherapy  168 (27.9) 0 (0) 0 (0) 158(41.5) 9(26.5) 1(1.6) 
PVE  41(6.8) 6(12) 4(5.3) 28(7.3) 2(5.9) 1(1.6) 
WCC – White Cell Count, PVE – Portal Vein Embolisation, ALT – Alanine Transaminase. CLM – Colorectal Liver Metastasis, HCC 
Hepatocellular Carcinoma.  Data presented as mean±sd or n (%). 
Table 24. Patient characteristics 
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Pringle  157(26.0) 5 (10.0) 20(26.7) 110(28.9) 8(23.5) 14(22.2) 
Blood transfusion  
  Intra-operative  
  No. of units 
  Rest of admission  































Redo procedure  41(6.8) 2(4.0) 3(4.0) 34(8.9) 1(2.9) 1(1.6) 
Laparoscopic resection  33(5.5) 0(0) 12(16.0) 17(4.5) 1(2.9) 3(4.8) 
CLM – Colorectal Liver Metastasis, HCC Hepatocellular Carcinoma. Data are presented as n(%) or median (IQR)  
Table 25. Operative details 
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Pathological analysis of the resected specimen revealed that resection was carried out 
for two or fewer tumours in 81.9% of patients and the mean diameter of the largest 
tumour was 40.9±33.6 mm. Cirrhosis was predominantly confined to patients 
undergoing resection for HCC (38.7%). CRLI was mainly manifested as steatosis, 
which, although greatest in the CLM group, was evident across all sub-groups. 
Perineural and vascular invasion was predominantly evident in the 
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Data are presented as n(%) or mean±s.d. 
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Size of largest tumour (mm) 40.9±33.6 34.9±19.9 53.7±41.8 36.9±27.3 46.9±45.6 51.4±50.5 
Cirrhosis 34(5.6) 1(2.0) 29(38.7) 1(0.3) 1(2.9) 2(3.2) 
Steatosis 252(41.8) 6(12.0) 22(29.3) 200(52.5) 12(35.3) 12(19.0) 
Steatohepatitis 43(7.1) 1(2.0) 16(21.3) 22(5.8) 2(5.9) 2(3.2) 
Sinusoidal obstruction syndrome 67(11.1) 1(2.0) 4(5.3) 55(14.4) 1(2.9) 6(9.5) 
Microvascular invasion 83(13.8) 16(32.0) 24(32.0) 37(9.7) 6(17.6) 0(0) 
Perineural invasion 35(5.8) 25(50.0) 1(1.3) 9(2.4) 0(0) 0(0) 
R1 resection 95(15.8) 15(30.0) 7(9.3) 71(18.6) 2(5.9) 0(0) 
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Nine patients died in hospital over the review period. This equated to a mortality rate 
of 1.5%. All nine patients died in the intensive care unit having suffered a major 
post-operative complication. Six of these patients died of multi-organ failure 
secondary to hepatic failure, one died after complications following significant post-
operative bleeding and two died following prolonged respiratory failure. Two further 
patients died within 90 days or surgery, resulting in a ninety day mortality of 1.8% 
(n=11). Due to the small numbers of patients in this group, mortality as an individual 
outcome was not able to be meaningfully assessed and so these patients were 
included in the “major morbidity” group. Major morbidity was assessed separately 
from all morbidity in an effort to differentiate between severity of post-operative 
morbidity.  
 
Overall morbidity rate (inclusive of patients who died within 30 days) following a 
complication) was analysed and the composite all cause rate is reported as 34.3%. 
Cholangiocarinoma had the highest morbidity rate of 54.0% whereas those patients 
undergoing resection for benign pathology had the lowest morbidity rate of all the 
subgroups at 25.4%. Patients having resection for cholangiocarcinoma also had the 
highest major morbidity rates (26.0%) as defined as morbidity relating to a Clavien 
Dindo classification of three and above (Table 27).  
 
Individual morbidity types were also reported. The morbidity corresponding to the 
highest Clavien Dindo classification was reported and only this morbidity was 
reported in patients who had more than one morbidity. Bile leak (5.0%) and intra-
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abdominal abscess (5.1%) were the two most frequent intra-abdominal morbidities. 
(Table 28). LRTI (4.5%) was the most frequently reported non-abdominal morbidity 
(Table 29). Cholangiocarcinoma resection was associated with higher rates of liver 
failure (10.0%) and intra-abdominal abscess (14.0%).
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Table 27. Post-operative outcomes 












Overall Complications  207(34.3) 27(54.0) 28(37.3) 124(32.5) 12(35.3) 16(25.4) 
Major complication  72(11.9) 13(26.0) 9(12.0) 42(11.0) 1(2.9) 7(11.1) 
Minor complication  135(22.4) 14(28.0) 19(25.3) 82(21.5) 11(32.4) 9(14.3) 
Clavien Dindo Classification 
  V 9(1.5) 3 (6.0) 2(2.7) 4(1.0) 0(0) 0(0) 
  IVa 2(0.3) 1(2.0) 0(0) 1(0.3) 0(0) 0(0) 
  IVb 6(1.0) 0(0) 1(1.3) 4(1.0) 0(0) 1(1.6) 
  IIIb 19(3.2) 3(6.0) 3(4.0) 11(2.9) 0(0) 2(3.2) 
  IIIa 36(6.0) 6(12.0) 3(4.0) 22(5.8) 1(2.9) 4(6.3) 
  II 57(9.5) 7(14.0) 11(14.7) 32(8.4) 6(17.6) 1(1.6) 
  I 78(12.9) 7(14.0) 8(10.7) 50(13.1) 5(14.7) 8(12.7) 
Length of stay (days) 7 (5-10) 12 (7-21) 7 (5-9) 7(5-10) 7(6-9) 7 (5-9) 
Readmission  45(7.5) 8(16.0) 2(2.7) 26(6.8) 4(11.8) 5(7.9) 
30 day mortality  9 (1.5) 3(6.0) 2(2.7) 4(1.0) 0(0) 0(0) 
Overall and major complications are inclusive of nine patients who suffered mortality. Data are presented as n (%) or median (IQR). 
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Table 28. Surgical morbidity 
 












Bile leak 30(5.0) 3(6.0) 1(1.3) 19(5.0) 2(5.9) 5(7.9) 
Liver failure 15(2.5) 5(10.0) 2(2.7) 6(1.6) 1(2.9) 1(1.6) 
Bleeding  11(1.8) 0(0) 3(4.0) 8(2.1) 0(0) 0(0) 
IAA 31(5.1) 7(14.0) 3(4.0) 16(4.2) 3(8.8) 2(3.2) 
Wound infection 24(4.0) 3(6.0) 2(2.7) 16(4.2) 2(5.9) 1(1.6) 
MOF 6(1.0) 3(6.0) 1(1.3) 2(0.5) 0(0) 0(0) 
Bowel ischaemia  2(0.3) 0(0) 1(1.3) 1(0.3) 0(0) 0(0) 
Anastomotic 
leak 
1(0.2) 0(0) 0(0) 1(0.3) 0(0) 0(0) 
Other hepatic  3(0.5) 1(2.0) 1(1.3) 1(0.3) 0(0) 0(0) 
Ileus 13(2.2) 0(0) 2(2.7) 11(2.9) 0(0) 0(0) 
IAA – Intra-abdominal abscess, MOF – Multi-organ failure. Data are presented as n(%). 
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AKI 8(1.3) 0(0) 1(1.3) 6(1.6) 1(2.9) 0(0) 
Thromboembolism 5(0.8) 1(2.0) 1(1.3) 3(0.8) 0(0) 0(0) 
LRTI 27(4.5) 2(4.0) 5(6.7) 16(4.2) 2(5.9) 2(3.2) 
ARDS 4(0.7) 0(0) 0(0) 4(1.0) 0(0) 0(0) 
Atelectasis 5(0.8) 0(0) 1(1.3) 1(0.3) 0(0) 3(4.8) 
Confusion 4(0.7) 1(2.0) 0(0) 2(0.5) 0(0) 1(1.6) 
Cardiac 8(1.3) 0(0) 3(4.0) 4(1.0) 0(0) 1(1.6) 
UTI 1(0.2) 0(0) 1(1.3) 0(0) 0(0) 0(0) 
Pleural effusion 3(0.5) 0(0) 0(0) 2(0.5) 1(2.9) 0(0) 
Pneumothorax 1(0.2) 0(0) 0(0) 1(0.3) 0(0) 0(0) 
Electrolyte  
derangement 
2(0.3) 0(0) 0(0) 2(0.5) 0(0) 0(0) 
Diarrhoea 3(0.5) 1(2.0) 0(0) 2(0.5) 0(0) 0(0) 
AKI – Acute Kidney Injury; LRTI – Lower Respiratory Tract Infection; ARDS – Adult Respiratory Distress Syndrome; UTI – Urinary tract 
Infection. Data are presented as n(%). 
Table 29. General morbidity 
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After these data were gathered, univariate analyses were performed to identify 
significant independent factors associated with morbidity. These are highlighted in 
Table 30.  
 
Predictors of all adverse outcomes, including death, were identified. After 
multivariate analysis age, major and extended resection and pre-operative 
thrombocytopenia, hypoalbuminaemia and hyperbilirubinaemia were significantly 
predictive of adverse outcome (Table 30). 
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OR 95%CI Multivariate 
analysis 
P value 
Age - 60.5±13.4 62.7(±12.9) 0.004a 1.022 1.007-1.037 0.03 
Female (n=253) 77 (30.4) 0.09b 1.203 0.83-1.746 0.329 
Re-do procedure (n=41)  12(29.3) 0.48b    
Neoadjuvant 
chemotherapy (n=168) 
62(36.9) 0.41b    
EHD (n=61) 19 (31.1) 0.58b    
Co-morbidities (n=252) 99 (39.3) 0.03b 1.421 0.974-2.072 0.068 
Major resection (n=336) 139(41.4) <0.0001b 1.835 1.224-2.751 0.003 
Extended resection 
(n=96) 
54(56.2) <0.0001b 2.443 1.475-4.047 0.001 
Steatosis (n=252) 86(34.1) 0.93b    
Steatohepatitis (n=43) 17(39.5) 0.46b    
Sinusoidal dilatation 
(n=67) 
21(31.3) 0.59b    
Cirrhosis (n=34) 15(44.1) 0.22b    
Blood transfusion (n=88) 31(35.2) 0.85b    
Albumin < 35 g/L(n=31) 18(58.1) 0.004b 2.224 1.009-4.901 0.047 
Platelets < 150  x109/L  
(n=51) 
25(49.0) 0.02b 2.289 1.233-4.249 0.009 
Bilirubin ≥ 20 μmol/L  
(n=63) 
32(50.8) 0.004b 1.781 1.016-3.119 0.044 
EHD – Extra hepatic disease. a Unpaired t-test, b χ2 test. Data are presented as n(%) or mean ±sd. 
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A further analysis was performed to identify independent predictors of major 
morbidity. This was specified as Clavien Dindo grade of three and above including 
death (Table 31). Extended resection was the only factor independently predictive of 
major adverse outcome. A further analysis of complication types following extended 
resection was performed and significantly higher levels of liver failure, intra-
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OR 95%CI Multivariate 
analysis 
P value 
Age - 60.5±13.4 62.6±14.0 0.15a    
Female (n= 253) 26(10.3) 0.28b    
Re-do (n= 41) 5(12.2) 1.0c     
Primarily resectable (n=512) 61(11.9) 0.96b    
Neoadjuvant chemo (n=168) 20(11.9) 0.99b    
EHD (n=61) 6(9.8) 0.59b    
Co-morbidities (n=252) 30(11.9) 0.98b    
Major resection (n=336) 51(15.2) 0.006b 1.122 0.597-2.109 0.720 
Extended resection (n=96) 30(31.2) <0.0001b 4.079 2.177-7.642 0.000 
Steatosis (n=252) 24(9.5) 0.12b    
Steatohepatitis (n=43) 5(11.6) 1.0c    
Sinusoidal dilatation (n=67) 4(6.0) 0.16c     
Cirrhosis (n=34) 4(11.8) 1.0c    
Blood transfusion (n=88) 10(11.4) 0.86b    
Albumin ≤ 30g/L (n=31) 8(25.8) 0.01b 2.420 0.989-5.922 0.053 
Platelets ≤ 150 x109/L  
(n=51) 
8(15.7) 0.39b    
Bilirubin ≥ 20 μmol/L  
(n=63) 
15(23.8) 0.002b 1.850 0.931-3.676 0.079 
EHD – Extra hepatic disease.  a Unpaired t-test, b χ2 test, c Fisher’s exact test. Data are presented as n 
(%) or mean ±sd 
Table 31. Univariate and multivariate analysis of factors associated with major morbidity (CD grade III-V) 
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 Extended resection 
(n=96) 
Major, minor resection 
(n=507) 
P value 
Liver failure 6 (6.2) 9 (1.8) 0.01a  
Bile leak 13 (13.5) 17 (3.4) <0.0001a 
Bleeding 4 (4.2) 7 (1.4) 0.08b  
Intra-abdominal abscess 10 (10.4) 21 (4.1) 0.01a  
Mortality 6 (6.2) 3 (0.6) 0.0008b  
a χ2 test, b Fishers exact test. Data are presented as n(%). 
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8.5 Discussion 
 
This study reports complication and mortality rates of 34.3% and 1.5% respectively. 
Mortality rates have been shown by several studies to be reduced in the more recent 
data presentations. Generally mortality rates of less than 5% are accepted but rates 
have decreased steadily from 4.9% [117], 3.1% [71] and 2.3% [81] when compared to 
more historical data. The present study represents data from 2006-2012, some of the 
most recent outcome data and continues this trend of steadily improving mortality 
rates after liver resection.  
 
Morbidity rates after liver surgery have been reported in several large database studies 
at between 22 and 45%. [71, 73, 81, 117] A recent meta-analysis of ERAS liver 
surgery identified overall morbidity rates of between 11% and 46% [172] following 
resection managed with enhanced recovery principles. Morbidity rates remain high 
and do not seem to be shown to have improved significantly despite awareness of 
techniques to reduce post-operative liver failure, [76] intra-operative bleeding [180] 
and improvements in peri-operative care. [172]  
 
Significant independent predictors identified in this study were increased age, 
extended hepatic resection, thrombocytopenia, hypoalbuminaemia and 
hyperbilirubinaemia. Although the literature has identified risk factors following liver 
resection, as discussed below, the impact of enhanced recovery care on factors 
determining outcome has not been explored before. 
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Haematological and biochemical markers of biliary obstruction and advanced liver 
disease were observed in this study to be predictors of morbidity and major morbidity. 
These factors are well established [72, 117] and these findings add further evidence 
supporting the pre-operative relief of biliary obstruction and optimisation of hepatic 
function prior to liver resection.  
 
However, this study also identified factors associated with morbidity that are less 
universally acknowledged. Increasing age is associated with poorer long term survival 
[220] as well as higher post-operative mortality. [220, 221] However, a significant 
proportion of the literature, in contrast to the current findings, advocates that age is 
not associated with increased morbidity [71, 117, 220, 222, 223] and so is not a 
contra-indication to resection. These studies all dichotomised age to “old” versus 
“young” cohorts and failed to show a significant difference in all levels of morbidity. 
This methodology is potentially flawed if sample size is not adequate. However 
further studies assessing morbidity risk per year also did not find age as a linear 
variable to be an independent predictor of morbidity. [73, 80, 221] One study, Mullen 
et al [72] did, and, with the present study represent the minority view in the literature 
that with increasing age comes increased overall morbidity after liver resection. 
However Mullen et al reported only major resections and so differs slightly from the 
current cohort.  
 
When predictors of major complications only were assessed in the present study, age 
was not an independent predictor. This is again in contrast to the majority of 
published studies that have reported age to be associated with mortality, or major 
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morbidity. [72, 73, 220, 221] These studies differ slightly from the present study in 
that Reddy et al [221] and Mullen et al [72] exclusively looked at major resections 
and so represent a slightly different population at a higher risk than the more 
heterogeneous cohort examined in the current study (in terms of extent of resection) 
and Sulpice et al [220] reported higher levels of cirrhosis and primary liver tumours 
than the current study, therefore again reporting a higher risk group where increased 
age is reported to be associated with poor outcome.   
 
Therefore the current results are at odds with the general accepted wisdom that 
morbidity is not influenced by age but mortality is, which suggested that 
complications in the elderly tend to be severe when they occur.  
 
Traditionally age related morbidity following liver resection is associated with the 
decreased capacity of the liver to regenerate (and altered hepatic perfusion). [224] 
Moreover, higher rates of cirrhosis associated with old age can all adversely affect the 
post-operative course. [220] However with increased accuracy of pre-operative 
volume assessment, the ability to effectively increase the future liver remnant size 
with PVE, major liver related complications can be anticipated and minimised even in 
the most elderly patients. [225] 
 
Due to the presence of reduced cardiorespiratory reserve, decreased baseline mobility 
and decreased muscle mass, the potential for increased “general” post-operative 
morbidity is evident. Improvements in perioperative care such as high dependency 
level care, prophylactic measures against chest and line sepsis and early nutrition can 
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all reduce potentially major cardiorespiratory and infective complications in the most 
vulnerable patients. This has been shown convincingly in the general ERAS literature 
[58] as well as, to a lesser extent, the liver ERAS data. [172] 
 
However we found age to be an independent predictor of adverse outcome when 
looking at all levels of complication severity, i.e. when minor complications were 
included. This suggests that elderly patients are more likely to develop a complication 
than young patients, although the consequences are not likely to be severe. A recent 
review of ERAS protocols in the elderly found evidence of higher morbidity rates and 
reduced achievement of recovery milestones in elderly patients. [226] An inability to 
adhere to such protocols is likely to result in a failure to prevent general post-
operative morbidity. Therefore when trying to minimise morbidity and formulating 
ERAS protocols, advanced age must be taken into consideration in order to increase 
adherence and minimise post-operative complications. 
 
The other factor found to be an independent predictor of all complications as well as, 
specifically, major complications after liver resection was extended resection, i.e. 
resection of five or more segments.  
 
The majority of large cohort studies assessing post resectional outcomes have not 
reported extended hepatic resection to be predictive of all morbidity. [71, 72, 80, 117] 
These investigators either did not report extended resection separately [117] or 
reported small percentages of extended resection, [80] thus unlikely to prove 
independently significant following univariate or indeed multivariate analysis. 
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However, extended resection, [71] right hepatectomy [221] and number of segments 
resected [73] have been reported as independently predictive of mortality after 
resection in concordance with the findings of our study.   
 
Extent of resection has been associated with increased rates of bile leak [81] and liver 
failure post-operatively. [227] We observed significantly higher rates of liver 
impairment after extended resection compared to major and minor hepatic resections 
however the liver failure rate of 6.2% is comparable or lower than other quoted rates 
when looking at extended resections only - 15% [227] and 13.8%. [228] Despite the 
use of advanced techniques to prevent liver failure (PVE, neoadjuvant chemotherapy 
and two stage procedures), and decreased levels of hepatic insufficiency compared 
with previous studies, this complication remains an on going concern for major 
resections and continued investigation and implementation of techniques such as 
ALLPS and PVE is critical to reducing post-operative morbidity after liver resection.  
 
The present study also observed significantly higher rates of bile leak  (13.5% v 3.4%) 
and abscess formation (10.4% v 4.1%) after extended resections compared to non-
extended resections. Our overall bile leak rate of 5% compares slightly higher than 
other published rates - 4.8% [81]; 1% [229], 4.7% [80] and 3.7%. [71] It appears that 
the majority of these complications occurred following extended hepatic resection.  
 
Complex resections and post-operative morbidity must however be considered in the 
context of the survival benefit following major resection for, in many cases, colorectal 
liver metastases. Increasingly favourable long-term outcomes are being achieved 
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following complex, extensive resection for advanced disease, justifying an aggressive 
surgical approach. [230] The present study suggests that such morbidity will continue 
to be evident as a result of curative resectional surgery.  
 
Current techniques to reduce post-operative bleeding and bile leak have not routinely 
been incorporated in ERAS protocols [172] and hepatic specific morbidity has not 
been affected by ERAS care. [172] CVP minimisation to reduce intra-operative blood 
loss has been included in only two liver ERAS trials. [88, 122] Therefore further 
avenues of investigative pursuit to develop methods to reduce such complications 
after extended resection are mandated.  
 
However, the current study, in contrast to the published literature, also found that 
extended resection was predictive of developing any type of complication, including 
minor complications, implying that careful consideration of all aspects of post-
operative care is required after extended resection. Not only must key surgical factors 
be addressed such as prevention of bile leak, bleeding or liver failure, but also 
appreciation of the susceptibility to more minor complications such as confusion, UTI 
and wound infection.  
 
This can have implications when considering analgesia, particularly paracetamol that 
is often contra-indicated following extended liver resection, therefore requiring 
suitable substitutes, most often opiates or NSAIDS, both associated with post-
operative infective complications. These include chest sepsis related to decreased 
mobilisation secondary to opiate use [45] and increased risk of peptic ulceration and 
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perforation related to NSAIDs. The evidence behind this practice is minimal and an 
evidence base for optimum multimodal analgesic regimen following major liver 
resection is lacking. [198]  
 
Nutrition post-operatively is also an important consideration after extended liver 
resection due to potential nutritional insufficiency related to the increased surgical 
insult and increased risk of sepsis. [231] Further work is required to investigate the 
effects of small liver remnant volume on outcome after liver resection and how ERAS 
protocols need to accommodate this unique aspect of liver surgery that is not 
translatable from other areas of abdominal surgery. 
 
These results should be taken in context of the limitations of the study. Firstly this 
was a retrospective study and as a result is susceptible to the various problems 
associated with this methodology. Specifically for this study the limitations with 
regard to this aspect were as follows. 
 
The completeness of the patient records introduces reporter bias into the analysis. If 
complications were not recorded they were not included into the database. We did not 
have access to the original clinical notes from the time of the admission, but referred 
to the discharge letter for complications. If the complication was not reported then it 
was not included and there is a possibility that some complications were missed, most 
likely minor complications and so the outcomes could be biased towards 
complications of a higher Clavien Dindo classification. A similar picture is also true 
for reporting of co-morbidities. As this was a retrospective study, no pre-operative 
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study assessment was made and only the clinic letter was scrutinised for co-
morbidities. If no mention of co-morbidities was made then the assumption was made 
that no significant co-morbidities were present. Therefore, it is possible that some 
comorbidities were missed from the data collection. 
 
Intra-operative data were not universally available, in particular estimated blood loss. 
We dealt with this by looking at those patients who had received a blood transfusion, 
however the findings are likely to be less discriminatory.  
 
In summary, the implications of this study are as follows. The post-operative care of 
older patients, even without co-morbidities, is critical and any post-operative protocol 
should accommodate this key difference to ensure compliance and minimise post-
operative morbidity. Patients undergoing extended resections are susceptible to 
increased complication rates of all levels as well as major morbidity and future 
research should focus on areas that can improve the post-operative outcomes 
following resection of five or more segments.  
 
8.6 Research Requirements identified 
 
Extended hepatic resection is becoming an increasingly performed operation. The 
above study has identified its association with overall and severe morbidity. The 
following two chapters will investigate two key issues impacting on the peri-operative 
care of patients who have a small liver remnant, namely analgesia and energy 
requirements.
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Ensuring adequate post-operative nutrition relies on replacing energy expended. 
Resting energy expenditure (REE) is the major component of total energy 
expenditure.  REE after liver surgery is not well investigated and measurement, 
performed by indirect calorimetry (IC), is challenging. A mobile device (SenseWear 
Armband) (SWA) has been validated when measuring REE in other clinical settings 
but not liver resection. The aims of this study are to validate SWA versus IC, quantify 
REE change following liver resection and determine factors associated with REE 
change. Patients listed for open liver resection prospectively underwent IC and SWA 
REE measurements pre- and post-operatively. Additionally the SWA was worn 
continuously post-operatively to record daily REE for the first five post-operative 
days. To determine acceptability of the SWA, validation analysis was performed. To 
assess REE change, peak post-operative REE was compared to pre-operative levels. 
Factors associated with REE change were also analysed. SWA showed satisfactory 
validity compared with IC when measuring REE although the post-operative 95% 
levels of agreement (-5.56-3.18 kcal/kg/day) may introduce error. Post-operative REE 
(median 23.5 (IQR 22.6-25.7) kcal/kg/day) was significantly higher than predicted 
REE (median 19.7 (IQR 19.1-21.0) kcal/kg/day; p<0.0001). Median REE rise was 
11% (IQR -1-25%). Factors associated with REE rise of >11% were age (p=0.017) 
and length of operation (p=0.03).  SWA offers a suitable alternative to IC when 
measuring post-operative REE however the magnitude of the error (8.74 kcal/kg/day) 
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could hinder its accuracy. REE quantification after liver resection is important to 
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9.2 Introduction 
 
Adequate nutrition is a vital component of post-operative management following 
major surgery. Complications of under-nourishment include increased incidence of 
infection, poor wound healing and reduced mobility. [231] Similarly, over feeding, 
particularly with parenteral nutrition, can result in increased energy expenditure [232] 
and even fatty liver induction. [233] Conversely if calorie requirements are met it has 
been found to reduce mortality in critically ill patients. [234] Therefore an accurate 
assessment of nutritional requirement is crucial when attempting to optimise patient 
recovery and minimise morbidity following major abdominal surgery. 
 
Nutritional requirements are calculated by quantifying the total calories used over a 
specified period. Total energy expenditure is made up of the resting energy 
expenditure, energy of physical activity and the energy used to digest food. Resting 
energy expenditure is the major component of total energy expenditure. It can be 
summarised as the amount of calories used by the body in a 24 hour period of rest and 
represents the fuel sources needed to provide energy for metabolic processes involved 
in maintaining the function and integrity of cells and body organs. It accounts for 60-
70% of total expenditure. [235] 
 
Resting energy expenditure traditionally is measured by indirect calorimetry. This 
technique measures the volume of O2 consumed and CO2 produced whilst at rest. 
Indirect calorimetry, despite being acknowledged as a gold standard for measuring 
resting energy expenditure, is often criticised for being error prone, operator 
dependent and impractical.  
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A simpler method of estimation of energy expenditure is the SenseWear Armband 
device (SWA; Bodymedia, Pittsburgh, PA). The SWA is worn on the upper arm and 
collects a variety of physiological data through multiple sensors - a three-axis 
accelerometer, heat flux sensor, skin temperature sensor, near-body ambient 
temperature sensor, and galvanic skin response sensor. The sensor data is combined 
with gender, age, height and weight to calculate total and resting energy expenditure.  
It has been validated against indirect calorimetry for determining resting energy 
expenditure in various settings including healthy adults, [236] stroke victims [237] 
and cancer patients. [238] It has not been validated when assessing resting energy 
expenditure in patients following liver resection or any other type of abdominal 
surgery. 
 
Liver surgery is often performed on patients following chemotherapy, which is 
associated with muscle loss [239] making them vulnerable to the effects of inadequate 
post-operative nutrition. Furthermore, after partial resection of the liver, regeneration 
occurs – an energy dependent process [240] – potentially adding to the burden of 
energy requirements.  
 
Outcomes following liver surgery have improved and mortality rates are less than 5% 
in high volume centres. However, complication rates remain high at up to 45%. [73] 
Therefore optimisation of post-operative care is vital. 
 
There is no evidence assessing the effects of liver surgery on resting energy 
expenditure. Hendry et al [219] assessed the administration of oral nutritional 
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supplements following liver resection and found no difference in surgical outcomes 
between those receiving supplements and those receiving standard care. However, if 
the underlying magnitude of resting energy expenditure change is not known it is 
impossible to know if calorific targets are being met.  
 
Therefore the aims of this study are to 1) assess the validity of SWA compared to IC, 
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9.3 Methods 
 
The trial protocol was prospectively published on clinicaltrials.gov (NCT02031094). 
After gaining approval from the South East Scotland Research Ethics Committee 
patients undergoing liver resection at the Royal Infirmary of Edinburgh, UK, were 
approached and given written information regarding the trial after an initial discussion 
at the pre-admission clinic. Written informed consent was obtained on the day of 




Patients were not recruited if they were to undergo a laparoscopic procedure, a liver 
resection combined with a further procedure, had abnormal liver function tests, were 
below the age of 18 years of age or did not have capacity to provide informed consent 
to enter the trial. Patients were excluded from the validation analysis if respiratory 
quotient (RQ) variability exceeded 10% during the IC assessment or if the armband 
was not worn for at least 95% of the study period. 
 
9.3.2 Peri-operative care 
 
Patients were admitted on the morning of surgery having fasted for six hours and 
taken clear fluids up to two hours prior to surgery. All patients underwent induction of 
anaesthesia with propofol, atracurium and fentanyl (1-2 microg/kg). Maintenance of 
anaesthesia was achieved by desflurane or sevoflurane. At induction patients routinely 
received a central venous catheter in the right internal jugular vein, radial arterial 
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cannulation and a urethral catheter. Routine monitoring of central venous pressure 
(CVP), invasive continuous blood pressure and mean arterial pressure, end tidal CO2, 
heart rate, oxygen saturations and urine output was performed throughout the 
operation.  
 
The peritoneal cavity was entered via a right subcostal incision that was extended 
superiorly in the midline if required. A full laparotomy was performed to ensure no 
contra-indications to resection were evident. Intra-operative ultrasound was 
undertaken by the operating surgeon to establish resectability and to formulate a final 
operative approach. Transection of the liver parenchyma was performed with 
Cavitron Ultrasonic Aspirator (CUSA, ValleyLab, Boulder, Colorado, USA) and 
monopolar diathermy. Transection was performed in accordance with the patient’s 
pathological, oncological and physiological requirements to ensure optimum short and 
long term outcome. 
 
Routine thromboprophylaxis and peri-operative antibiotics were administered 
immediately prior to incision. Intra-operative warming was routinely performed. 
Intra-peritoneal drains and NG tubes were not routinely administered and intra-
operative fluid management was restricted to 80-100 mls/hour. 
 
Patients were transferred from theatre to the recovery ward where they were extubated 
and monitored until observations and pain scores were satisfactory according to the 
unit protocol. They were subsequently transferred to the high dependency ward where 
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they remained until they achieved discharge criteria and could be transferred to the 
general ward.  
 
9.3.3 SWA Validation 
 
The first aim of the study was to assess the validity of the SWA when measuring 
REE. Prior to resection patients underwent a pre-operative measurement of their 
resting energy expenditure. This was performed by both methods simultaneously: 
SWA and IC. In order to achieve optimum conditions patients underwent IC between 
0800hrs and 1000hrs prior to eating breakfast so they had fasted for approximately 12 
hours.  
 
Patients underwent 30 minutes of indirect calorimtery (GEMnutrition, Cheshire, UK) 
under standardised conditions. This technique measures the volume of O2 consumed 
and the volume of CO2 produced whilst at rest. This is achieved by comparing the 
concentrations of O2 and CO2 in the air inspired by the participant with the 
concentrations in the air expired. The Weir equation [241] is used to convert the 
volume of O2 consumed and the volume of CO2 produced per minute into a value for 
resting energy expenditure expressed in calories. 
 
The Weir Equation: 
Energy expenditure (kcal) = [(VO2 L/min) (3.941) + (VCO2 L/min)(1.11)] x 1.44 
 
The tests were performed in the same room maintained at 24 degrees centigrade. 
Patients were advised to lie semi-reclined on a bed and to achieve a relaxed state 
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without sleeping. No physical exercise was permitted on the morning of the test. The 
IC was performed for 30 minutes after the first 10 minutes were discounted until a 
steady state had been achieved. RQ variation of more than 10 per cent was an 
indication to exclude the result. 
 
During this period patients wore the SWA simultaneously and therefore under 
identical conditions. This resulted in a REE quantity for 30 minutes. This result was 
then multiplied up to give a kcal/day reading similar to the IC. To eliminate the 
influence of fat free mass REE was presented as kcal/kg/day. The same protocol was 
repeated post-operatively between POD3-5.  
 
9.3.4 REE Change After Liver Resection 
 
The second aim of the study was to evaluate the effect of liver resection on REE.  
This was performed in two parts. The first part assessed the effect of liver resection 
itself on REE change. Secondly, factors associated with increased REE rise were 
investigated. 
 
Patients underwent a pre-operative measurement of REE with the SWA, either in 
combination with IC or in isolation. Prior to assessment, all participants had 
measurement of anthropometric and body fat percentage measurements to determine 
overall body composition. In addition, REE prediction by the Harris Benedict 
equation was calculated. Patients subsequently underwent liver resection according to 
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their oncological requirements. Post-operatively the SWA was placed on the patient’s 
arm at the mid-humerus level. This remained in situ until POD 5.  
 
REE was downloaded on a daily basis. REE was obtained by recording a period of 
time where no active energy expenditure was evident and the value multiplied to 
achieve a daily REE of kcal/day. To eliminate the influence of fat free mass REE was 
presented as kcal/kg/day. To determine patients’ maximum metabolic state the peak 
REE observed was recorded and referred to as peak REE. Changes in REE from 
baseline were reported as either percentage rise or absolute values. 
 
9.3.5 Data Collected 
 
Demographic patient data were collected including age, sex, ASA, weight, height and 
BMI. Pre-operatively anthropometric data were collected. Mid upper arm 
circumference (MUAC) and waist circumference were obtained with a tape measure. 
Skin fold thickness (SFT) of the biceps, triceps and subscapular region were obtained 
with skin fold callipers (Harpenden Calliper, West Sussex, UK). SFT measurement 
was performed according to a standardised protocol by a single investigator (MH) as 
described by Rona et al. [242] Body fat percentage (BF%) and fat mass (FM) were 
obtained by using bio-impedance analysis (Omron Healthcare, Milton Keynes, UK).  
Fat free mass (FFM) was subsequently obtained from these data. 
 
Intra-operative data were collected. Operation performed, length of operation and 
estimated blood loss (EBL) were prospectively recorded. Extent of resection was 
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assessed in two ways. The first was to report the number of segments resected, and 
secondly estimated residual liver volume (RLV) was obtained by estimating the liver 
volume based on a formula from Chouker et al [243] and subtracting the percentage 
of liver resected according to pre-determined values as described by Schindl et al. 
[244] 
 
The pathology of the resected specimen was also obtained and details of background 
liver parenchyma, size and pathology of tumour were obtained directly from the 
original pathology report. 
 
Post-operatively clinical data were collected. Length of stay, i.e. length of time spent 
in hospital and morbidity rate was recorded. Patients were observed for complications 
on a twice daily basis by the researcher. Complications were classified according to 
pre-determined definitions, [202] diagnosed and managed by the clinical team and 
morbidity rates reported accordingly. Routine post-operative blood tests were 
recorded daily from POD 1-4.  
 
Resting energy expenditure (REE) was calculated by the two methods as described 
above.  REE was reported as kcal/kg/day. The effect of resection extent, and therefore 
regeneration, was investigated. Patients were initially divided according to extent of 
resection: either resections of more than three segments or less than or equal to three 
segments. After that patients were divided according to RLV with the median RLV 
forming the cut off point between groups. Furthermore the percentage rise in REE 
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from baseline was used to split the cohort between the median percentage rise in REE 
to determine factors associated with REE rise. 
 
9.3.6 Statistical Analysis 
 
All statistical analysis was performed using SPSS version 19.0 (IBM, Armonk, New 




The validation of the SWA compared to IC was performed via linear regression 
analysis to determine relationship of the REE measurement between the two 
techniques. Bland Altman charts were plotted to further investigate the validity and 
agreement of the SWA compared with IC. [245] Pre- and post-operative REE was 
compared between modalities with Wilcoxon signed-rank test for comparison of 
different measuring techniques on the same patients. 
 
9.3.6.2 Assessment Of Effect Of Resection On REE 
 
Pre- and post-operative REE was compared with Wilcoxon signed-rank test for 
comparison of REE on the same patients. When assessing for factors associated with a 
rise in REE, univariate analysis was performed to assess any differences in baseline 
characteristic between the two groups. For dichotomous data Chi square or Fishers 
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exact tests were performed. Continuous independent data were compared with Mann 
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9.4 Results 
 
The trial was conducted between February and August 2014 at the Royal Infirmary of 
Edinburgh, UK. 28 patients undergoing open liver resection were recruited into the 
trial. 
 
9.4.1 Patients  
 
The consort diagram is shown in Figure 20. Seven patients pre-operatively did not 
undergo IC as they were unable to attend for the assessment prior to their operation 
due to logistical difficulties. Of the 21 patients who underwent pre-operative IC, post-
operatively one patient died on the third post-operative day, one refused post-
operative IC and one patient was contra-indicated to IC due to infection control 
restrictions. 
 
Therefore for the validation analysis, 21 patients underwent a pre-operative 
assessment with IC. Of these 21 patients, 18 underwent post-operative IC. Four 
patents had two recordings and three patients were excluded due to high RQ 
variability leading to unreliable IC recordings. Therefore a total of 21 pre-operative 
and 19 post-operative recordings of IC and SWA were made on which the validation 
analysis was performed.  
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For the REE SWA assessment all 28 patients commenced the study. Five patients 
were excluded. One patient died on POD 3 and four patients did not wear the SWA 
for over 95% of the time and so were excluded from the analysis.  23 patients were  
therefore included for this analysis. Table 33 shows the baseline characteristics of the 
patients included in the pre-operative and post-operative validation analysis and the 













Figure 20. CONSORT diagram. 
Validation analysis  
Pre-operative IC and SWA  
- Unable to attend pre-operatively 
(n=7) 
- Total (n=21) 
Post-operative IC and SWA  
- High RQ variability (n=3) 
- Refused (n=1) 
- Died (n=1) 
- CI to IC (n=1) 
- Total (n=15) 
o 2 recordings (n=4) 
o Total recordings (n=19) 
 
Effect of resection on REE  
SWA assessment (n=28) 
- Died (n=1) 
- <95% of time SWA worn (n=4) 





Refused to participate (n=8) 
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Patient Variable IC/SWA validation 
(n=21) 
SWA REE analysis 
(n=23) 
Age (years) 64 (55-71.5) 64 (53-70) 
Male  17 (81.0) 17 (73.9) 
Weight (kg) 84 (70-94.4) 84 (70-96) 
BMI (kg/m2) 28 (25.4-31.6) 27.4 (25.0-30.9) 
EBL(ml) 750 (350-1100) 750 (300-1500) 
Length of operation (mins) 216 (178-255) 225 (160-285) 
Pringle time (mins) 19 (0-29) 10 (0-28) 
Biceps SFT (mm) 10.2 (7-12.6) 11 (7.4-12.2) 
Triceps SFT (mm) 15.4 (8.5-21.0) 15.5 (9.0-19.0) 
Subscapular SFT  (mm) 17.5 (15-23.5) 17 (15.0-24.0) 
MUAC (cm) 29 (27-30.2) 29.0 (27.0-30.0) 
Waist circumference (cm) 98 (93-102.5) 97 (93.0-102.0) 
FM (kg) 24.9 (20.1-35.0) 24.4 (18.8-30.7) 




























CLM – Colorectal liver metastasis, HCC – Hepatocellular Carcinoma, EBL – 
Estimated Blood Loss, SFT –Skin fold thickness, MUAC – Mid upper arm 
circumference, FM – Fat mass, BF – Body fat. Data are presented as median (IQR) 
or n (%) 
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Post-operative Factor IC/SWA validation (n=21) SWA REE analysis (n=23) 
LOS (days) 6 (5-10) 7 (5-10) 
Complications  8 (38.1) 9 (39.1) 
Segments resected 3 (2-5) 4 (2-4) 
Peak ALT (U/L) 258 (109-484) 258 (162-534) 
Peak bilirubin (μmol/L) 24 (16-56) 28 (23-38) 
Peak WCC (x109/L) 12.8 (11.5-15.6) 12.8 (11.4-15.4) 
Peak temp (degrees C) 38.0 (37.8-38.4) 38.0 (37.8-38.4) 
Peak PT (secs) 17 (14-20) 18 (15-19) 
LOS – Length of stay, ALT – Alanine Transaminase, WCC – White cell count, PT – 
Prothrombin Time. Data are presented as median (IQR). 
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9.4.2 Validation 
 
A validation analysis was performed of SWA compared to IC. Both instruments were 
used to measure REE simultaneously pre- and post-operatively (Figures 21 and 22). 
The pre-operative analysis is shown in Figure 21A and 21B (n=21). The Bland-
Altman analysis is shown below (Figure 21A) and shows a 95% limits of agreement 
of -4.042-3.968 kcal/kg/day. Significant linear regression analysis was observed 
(p=0.003) between the two measuring techniques (Figure 21B). 
  
The same comparison between IC and SWA was made post-operatively (n=19). The 
IC measurement was performed between POD 3 and 5 depending on the clinical 
condition of the patient. A similar significant linear regression analysis was observed 
(Figure 22B) as were the 95% limits of agreement (-5.56-3.18 kcal/kg/day) after the 
Bland Altman analysis (Figure 22A).  
 
No significant differences were seen (after assessment with Wilcoxon-ranked sum 
test) between the median values of REE measured by IC and SWA on the same 
patients both pre-operatively (IC 20.6 kcal/kg/day IQR 18.8 – 21.8; SWA 20.8 
kcal/kg/day IQR 19.6-22.0) (Figure 23A) and post-operatively (IC median 22.2 
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Figure 21A. Bland Altman comparing IC to SWA pre-operatively when measuring 
REE. 
Figure 21B. Linear regression analysis of pre-operative IC versus SWA REE 
measurement. 
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Figure 22A. Bland Altman plot comparing IC to SWA post-operatively when 
measuring REE. 
Figure 22B. Linear regression analysis of post-operative IC versus SWA REE 
measurement. 

































Post-operative IC versus SWA
95% limits of agreement -5.56-3.18
Figure 22A
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Figures 23A and 23B. Comparison of REE measurements obtained by IC and SWA 
pre- (n=21) and post-operatively (n=19). No significant difference was observed 
between the two methodologies. Both REE measuring techniques were performed 
simultaneously under standardised conditions. 









































Enhanced Recovery After Liver Surgery 
Energy Expenditure After Liver Resection  224 
9.4.3 The Effect Of Liver Resection On REE 
 
In order to assess the effect of liver resection over the whole post-operative period the 
SWA was placed on the patient’s arm and worn continuously for the first five days 
after surgery (n=23) to assess REE change. Daily REE was calculated and the 
percentage change from the pre-operative baseline was recorded below. Minimal 
median change was observed, however the magnitude of the inter-individual variance 
was high (Figure 24).  
 
Therefore, to determine if liver resection had an effect on REE beyond predictable 
levels, an analysis was performed comparing the Harris Benedict (HB) equation to the 
REE recorded by the SWA pre-operatively and the post-operative peak REE.  When 
compared to the predictive Harris Benedict formula, SWA recorded hypermetabolic 
states in both the post-operative patients and pre-operative recordings (Figure 25, 
n=23). SWA pre-operative (median 21.3 (IQR 20.3-23.5) kcal/kg/day) and post-
operative (median 23.5 (IQR 22.6-25.7) kcal/kg/day) measurements were 
significantly higher than the predicted HB REE (median 19.7 (IQR 19.1-21.0) 
kcal/kg/day). Post-operative peak REE was also significantly higher than the pre-
operative SWA REE measurement (p=0.01). 
 
The peak post-operative REE recorded for each patient over the five post-operative 
days was calculated. The percentage peak rise in REE over the 5 post-operative days 
from pre-operative baseline was then calculated. The median rise from baseline 
observed in the peak REE was 11 per cent (IQR -1-25 per cent) (Figure 26). 
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Serial REE measurement with SWA (n=23). Daily post-operative REE was compared 
with pre-operative REE and the difference recorded from DOS to POD5. Error bars 
indicate median (IQR). 

































































SWA REE measurement 
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Comparison of pre and post-operative REE measurement  (median and IQR) by SWA 
(n=23). SWA REE measurements were significantly higher pre- and post-operatively 
than the HB REE estimation. 
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Post-operative change in REE.  
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9.4.4 Factors Associated With REE Rise 
 
A further aim of the study was to assess if the extent of resection had an effect on 
post-operative REE. The cohort was divided into those patients who had resections of 
greater than three segments and those who had three or fewer segments resected.  
 
When REE was compared for the first five post-operative days REE was significantly 
greater in the group who underwent resection of > 3 segments when assessing 
kcal/day directly. However when REE was compared per kg of mass, this effect was 
negated and no difference was seen between the two groups (Figures 27A and 27B). 
A similar picture was observed when RLV was calculated. The median RLV was 
1164g and the two groups above and below this median were compared for repeated 
measures of REE. Again, this did not show a significant difference (Figure 28). 
 
The cohort was subsequently divided to compare those whose REE increased to a 
greater extent to those whose REE rose less or decreased post-operatively. The group 
that had a median rise of over 11% compared to baseline REE had significantly 
greater age and length of operation after univariate analysis (Table 35). No 
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Figures 27A-B. The effect of the extent of resection on REE. Figure 27A compares 
daily REE (median, IQR) between patients as measured by kcal/day. Figure 27B 
compares the same factor but assessed kcal/kg/day.  
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Data presented as median (IQR) 
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Patient Variable ≤11% REE rise 
(n=12) 
>11% REE rise  
(n=11) 
P value 
Age (years) 56.5 (53.0-64.8) 70 (56.0-74.0) 0.017a 
Male 9 (75) 8 (72.7) 1.0b 
Weight (kg) 78 (67.2-91.2)  89 (77.4-101.0) 0.17a 
BMI (kg/m2) 25.4 (22.6-29.35) 28 (25.9-34.3) 0.08a 
EBL (ml) 675 (325-975) 1500 (250-2000) 0.2a 
Length of operation 
(mins) 
207 (141-229) 255 (210-388) 0.03a 
Pringle (mins) 0 (0-25) 27 (0-60) 0.13a 
RLV (g) 1059 (859-1739) 1590 (951-2018) 0.25a 
Neoadjuvant 
Chemotherapy 
9 (75) 5 (45) 0.2b 
Biceps (mm) 8.8 (7-12.8) 11.2 (10-14.1) 0.17a 
Triceps (mm) 17.6 (10.0-19.0) 15 (8.0-17.0) 0.28a 
Subscapular (mm) 16 (14.2-18.9) 18.0 (16.0-25.8) 0.14a 
MUAC (cm) 27.5 (24.8-29.8) 29 (27.0-30.5) 0.4a 
Waist (cm) 96 (92.2-101.8) 98.0 (94.0-114.0) 0.35a 
FFM (kg) 58.0 (44.6-65.3) 63.4 (51.0-69.1) 0.44a 
BF%  26.2 (22.8-32.1) 29.6 (28.4-35.3) 0.2a 
Pathology 
  CLM 
  HCC 
  Cholangiocarcinoma 

















  I 
  II 













CLM – Colorectal liver metastasis, HCC – Hepatocellular carcinoma. EBL – 
Estimated Blood Loss, SFT –Skin fold thickness, MUAC – Mid upper arm 
circumference, FM – Fat mass, BF – Body fat.  a Mann Whitney U test, bFishers exact 
test. Data are presented as median (IQR) or n (%). 
Table 35. Baseline characteristics of two groups divided according to REE rise 
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Post-operative Factor ≤11% REE rise (n=12) >11% REE rise (n=11) P value 
LOS (days) 7 (5-10) 7 (5-10) 0.87a 
Complications 5 (41.7) 4 (36.4) 0.8b  
Segments resected 4 (1-5) 3 (2-4) 0.45b 
Peak ALT (U/L) 286 (169-504.5) 258 (82-534) 1.0a 
Peak Bilirubin (μmol/L) 28 (23.2-46.2) 26 (16-38) 0.51a 
Peak WCC (x109/L) 13.65 (11.6-17.7) 12.5 (9.5-14.1) 0.24a 
Peak temp (degrees C) 37.9 (37.8-38.3) 38.2 (37.5-38.4) 0.92a 
Peak PT (seconds) 17 (14-21.5) 18 (16-19) 0.75a 
LOS – Length of stay, ALT – Alanine Transaminase, WCC – White cell count, PT – 
Prothrombin Time. a Mann Whitney U test, bFisher’s exact test. Data are presented as 
median (IQR) or n(%) 
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9.5 Discussion 
 
This study attempted to validate the measurement of REE with a mobile device after 
liver resection. We were able to show validation and agreement of the two methods 
although the 95% limits of agreement were wide. 
 
No significant difference was observed between the pre and post-operative REE 
recorded by the two methods. Pre- and post-operatively the IC and SWA showed 
significant regression coefficients, providing evidence that the two methods of 
measuring REE are in agreement with each other. However it is crucial when 
validating a measuring device to establish the accuracy with which it is measuring the 
intended outcome and to what degree the two devices are reaching the same 
measurement. For this reason the Bland Altman plots were performed.  
 
In this study pre-operative REE measurement between IC and SWA showed 95% 
limits of agreement of 8.01 kcal/kg/day. Post-operatively, similar significant 
correlation coefficients were seen, and the 95% limits of agreement were 8.74 
kcal/kg/day. This means that any measurement of REE by SWA could be erroneous 
by as much as 8.74 kcal/kg/day. And so, for a 70kg man this would equate to a 
potential error of up to 611 kcal/day when compared to indirect calorimetry, the gold 
standard REE measuring device. The acceptability of this is challenging to determine 
definitively and it is the clinical relevance of the potential error that is important to 
consider.  
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The SenseWear Armband has been validated in healthy adults. [236] It has also been 
validated in patients with underlying disease including malignancy [238] and chronic 
respiratory disease. [246] Magnitudes of between 444kcal/day and 572kcal/day were 
seen in these studies when assessing the limits of agreement. In our study the post-
operative limits of agreement are comparable to these findings. This difference is 
unlikely to represent a significant clinical compromise but this is important to 
consider when measurements are performed.  
 
The SWA has never been validated with IC in patients who have recently undergone 
abdominal surgery. The SWA detects movement, temperature change and heat flux to 
estimate the REE based on proprietary logarithms. The influence of the host post-
operative response to trauma on resting energy expenditure is unpredictable. Crisafulli 
et al [246] found the SWA to underestimate REE in patients with chronic respiratory 
failure when compared to the IC measurement. Factors such as post-operative 
infection and respiratory dysfunction may affect REE and not be detected by the 
SWA. In this study, an overall under-estimation of REE by the SWA is suggested and 
is therefore a potential disadvantage of the SWA in this set of circumstances.  
 
The second focus of the study was to establish the effects of liver resection on REE. 
Initially an assessment was made with pre- and peak post-operative REE 
measurements with SWA and these were compared with the Harris Benedict equation.  
 
SWA pre- and post-operative REE measurements were significantly higher than REE 
predicted by the HB formula. This suggests that pre-operative patients with liver 
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tumours are actually hypermetabolic. Okamoto et al [247] found patients with 
oesophageal carcinoma to have higher measured REE when compared to healthy 
controls. Conversely, in patients undergoing Whipples procedure, Sasaki et al [248] 
and Vaismon et al [249] found that measured REE by IC was no different to REE 
predicted by the Harris Benedict equation, suggesting that these patients, with mainly 
cholangiocarcinomas and pancreatic tumours, were not in a hypermetabolic state. The 
potential explanation for high pre-operative metabolic rate in the current study is the 
presence of advanced malignancy, and subsequently, cachexia that is not necessarily a 
contra-indication to surgery, therefore allowing inclusion into the study. This is unlike 
other malignancies, where patients with advanced disease, associated with 
hypermetabolic states, are often deemed irresectable and therefore not put forward for 
surgery or included in similar studies. [249] 
 
Post-operatively, there were significantly higher REE recordings for the SWA REE 
groups when compared to HB prediction of REE and when compared to pre-operative 
levels as measured by SWA. This suggests that post-operatively, patients become 
even more hypermetabolic, as a result of the surgery, in a manner that is not predicted 
by formulaic equations. 
  
Several studies have assessed REE after abdominal surgery. As mentioned above 
Okomato et al [247] and Sasaki et al  [248] looked at oesophagectomies and 
Whipples procedure respectively and both reported a significant post-operative REE  
rise (as measured by IC and compared to HB and pre-operative values).  Fredrix et al 
[235] also reported a 10% rise in REE following major gastrointestinal surgery.  
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The current study is in agreement with these findings with a median rise of 11% being 
reported in patients after liver resection. One investigator [250] found patients who 
had undergone liver resection had significantly higher REE post-operatively 
compared to those who had undergone gastrointestinal surgery. This may indeed be 
the case, however the crucial factor when determining the effect of a procedure on 
REE is the change in REE above pre-operative baseline rather than an isolated 
measurement. 
 
The likely reason for the post-operative rise in REE is related to the inflammatory 
response to the trauma of surgery. [250] The resultant increase in muscle catabolism, 
gluconeogenesis and lipolysis as a result of endocrine, immune and sympathetic 
response to tissue injury, requires calories as part of the energy dependent processes. 
The current study, in agreement with previous work suggests this is, on average about 
11 per cent rise from baseline after liver resection. 
 
However the range of change of REE from baseline was wide, with some patients 
actually dropping REE post-operatively and others increasing much beyond eleven 
per cent. Previous investigators have addressed post-operative REE rise by adding a 
stress factor to the Harris Benedict equation to account for the post-operative rise. 
[248] However the ability to measure REE on a real time basis and tailor nutritional 
input according to REE is preferable and is associated with improved mortality rates 
in critically ill patients. [234] Optimisation of nutritional status in the critically ill or 
post-operative patient is increasingly viewed as a key care component. [251] This is a 
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therapeutic area where the SWA could provide benefit. In light of the practical 
difficulties associated with IC measurement, notably the fact that it can only be used 
for short periods and is not particularly comfortable for patients, SWA use post-
operatively can provide individualised REE updates to guide nutritional input, based 
on the validated findings of this study. 
 
The final focus of the study was to determine if any factors were associated with a 
greater rise in REE. After we had divided the cohort into two groups based on their 
rise in REE from baseline, factors associated with the rise were sought. Surprisingly 
the group with a higher rise in REE were significantly older. This is surprising 
because REE decreases with age. [252, 253] However the effects of age on REE post-
operatively are not well investigated with no previous study assessing age and REE 
after liver surgery.  
 
Ishikawa et al [250] found hypermetabolic changes in elderly patients undergoing 
gastrointestinal surgery compared to younger patients.  Older patients have been 
shown to have an exaggerated post-operative inflammatory response [254] and this is 
likely to contribute to REE increase. Aging is however associated with a decreased 
sympathetically mediated component of REE [255] and so other factors are likely to 
contribute to the rise beyond merely age. The length of operation was also 
significantly longer in patients experiencing a greater REE rise. Blood loss was also 
higher in this group, but this was not statistically significant. A combination of these 
factors is likely to result in an increased surgical insult and corresponding 
inflammatory surge, which could all manifest in an increased post-operative REE rise.  
Enhanced Recovery After Liver Surgery 
Energy Expenditure After Liver Resection  238 
Body composition is another important variant when predicting REE. In this study the 
BMI was higher in the group with an increased rise (although not significantly so), yet 
the FFM was not significantly different. Lean body tissue is known to consume a 
greater proportion of oxygen than adipose tissue [256] and is a predictor of REE. 
However the effect of body composition on REE change after surgery is not well 
known and our study suggests that patients with a high BMI, may have a greater 
magnitude of REE rise compared to their baseline REE, and could represent those at 
greatest risk of post-operative malnutrition secondary to inadequate replacement of 
calories expended. 
 
The volume of liver resected was not associated with a significant rise in REE. This 
had previously been speculated due to the effect of liver regeneration on metabolic 
rate. This did not affect REE rise, indeed the residual liver volume was lower in the 
group with a smaller rise in REE. Therefore other factors should be considered 
following liver resection when determining nutritional requirements, namely, length 
of procedure itself. 
 
The small number of participants in the study prevented meaningful multivariate 
analysis to be performed thus preventing independent predictors of REE rise to be 
fully identified. 
 
The findings of this prospective observational study suggest that the effects of liver 
resection on post-operative REE are variable and not necessarily predictable. Current 
literature has a large evidence base on REE and particularly, predictors of baseline 
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REE. However the effects of surgery on REE are less well investigated. No previous 
study has investigated the effects of liver surgery on REE change or factors associated 
with REE rise.  
 
The implications of these findings are that certain patients are likely to have 
unpredictable nutritional requirements. Measurement of REE pre- and post-
operatively could be a useful adjunct to dietician care in order to screen for those who 
might benefit from additional nutritional support as a result of an increased REE rise. 
The use of SWA to assist with this would allow an acceptable, lightweight monitoring 
device to provide updated REE measurement.  
 
The results of this study should be interpreted in light of the following limitations. 
First of all it is a small sample size. This therefore potentially allows type two error to 
be introduced to the analysis. Moreover, the small cohort reduces the potential power 
of the validation of the two methods of REE measurement and prevented meaningful 
multivariate analysis. 
 
Secondly the IC assessment was only able to be performed once the patients were able 
to be mobilised to the clinical research facility where the IC was housed. This meant 
that they were free of oxygen requirements and well enough to be off the general 
ward for one hour. This meant that the first two post-operative days were not 
assessed. However the primary purpose of the IC was to validate the SWA that was 
worn continuously to review POD 1 and 2 REE.  
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In conclusion, the SWA provides a validated alternative to IC in measuring REE after 
liver resection. REE increases after liver resection and certain factors, namely age, 
and operative time are associated with an increased rise in REE. The use of SWA to 
determine REE after liver resection could guide post-operative nutritional input.
 
9.6 Chapter Publication 
Energy Expenditure After Liver Resection: Validation of a mobile device for 
estimating resting energy expenditure and an investigation of energy expenditure 
change after liver resection. Hughes MJ, Harrison EM, Wigmore SJ. Accepted for 
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10 Acetaminophen Metabolism After Liver Resection: A Prospective 




Acetaminophen has an important role as part of a multimodal analgesic regimen 
following major surgery. Little is known about acetaminophen metabolism after liver 
resection, in particular if it is affected by residual liver volume (RLV). This study 
aims to investigate the effects of major liver resection on acetaminophen metabolism. 
Patients undergoing liver resection were administered post-operative oral 
acetaminophen at a therapeutic dose. Urinary acetaminophen metabolites were 
prospectively measured by High Pressure Liquid Chromatography (HPLC) over the 
first three post-operative days following liver resection. Whole blood glutathione was 
also measured pre-operatively and the first and third post-operative days. A subgroup 
analysis was performed to assess the effect of therapeutic acetaminophen on patients 
with low RLV. Two way repeated measures ANOVA was used to compare metabolite 
levels between groups over three days. 41 patients completed the study. For the whole 
cohort, the glutathione dependent metabolites (cysteine and mercapturate) increased 
over the study period. Glutathione significantly reduced by POD3. Group A (n=11) 
had a median RLV of 876g (IQR 708-892) and was compared with a matched control 
group B (n=11) with median RLV of 2434g (IQR 2305-2493). Group A had 
significantly higher levels of cysteine (p=0.048) and sulphate (p=0.047). No 
difference was observed in glutathione or 5-oxoproline levels over three post-
operative days between the groups suggesting replete glutathione levels despite low 
RLV. In conclusion, low RLV results in altered acetaminophen metabolism, however, 
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in this study, no evidence of glutathione deficiency was evident, suggesting that 
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10.2 Introduction 
 
Liver resection is now an established surgical treatment for both primary and 
secondary liver tumours. The most common indication in the UK is for colorectal 
liver metastases, and it can offer long term survival for these patients of up to 60% 
over five years. [257] Although contemporary approaches aim to minimise the 
resection volume, extended resections remain necessary, depending on the bulk and 
distribution of the disease. The limits of resectability centre on the future liver 
remnant (FLR), and in patients with normal liver parenchyma, up to 75% of the liver 
can be removed. [258] 
 
Liver resection is a major procedure with mortality rates of up to five per cent and 
morbidity rates of up to 45 per cent. [73] Common complications include biliary 
leaks, liver remnant failure and infective complications including intra-abdominal 
abscess and respiratory infections. [81] 
 
Following liver resection enhanced recovery care protocols have contributed to 
improving post-operative recoveries by reducing overall morbidity rate and lengths of 
hospital stay. [172] Optimum pain control is an essential component of the enhanced 
recovery post-operative care pathway. Multimodal analgesia is used involving a 
combination of simple analgesia and regional techniques in an attempt to minimise 
opiate consumption. High opiate use is associated with reduced mobility, respiratory 
infections, post-operative nausea, vomiting and prolonged hospital stay. [45] The 
combination of analgesic techniques allows a reduction in the use of opiate analgesia. 
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Therefore a good basis of simple analgesia at the appropriate dose is required when 
attempting to control post-operative pain with more advanced techniques, enhance 
recovery and reduce complications. [259] 
 
Acetaminophen is the mainstay of simple analgesia and is given routinely to patients 
following liver resection in doses of up to four grammes per 24 hours. Dosing guides 
have been established based on use of the drug in healthy individuals. Acetaminophen 
taken in excess can lead to hepatotoxicity. This has been observed in healthy 
individuals at doses of less than twice the recommended limit. [260] The appropriate 
dose to use following liver resection is unclear. Hepatotoxicity in patients following 
liver resection results in the increased risk of liver remnant failure, which is a major 
cause (18%) of post-operative mortality following liver resection. [261]  
 
Acetaminophen is metabolised by the liver (Figure 29). Glucuronidation and 
sulphation produces non-toxic end products. In normal individuals, approximately 
five per cent of acetaminophen is metabolised via the cytochrome P450 pathway 
producing the toxic metabolite N-acetyl-p-benzoquinone imine (NAPQI). If NAPQI is 
not metabolised by glutathione to cysteine or mercapturate it binds to hepatocytes and 
leads to cell death. [262] In acetaminophen overdose, the cytochrome P450 pathway 
is overwhelmed and glutathione rapidly depleted, resulting in a toxic accumulation of 
NAPQI. Clinically this may manifest with fulminant hepatic failure, multi-organ 
failure and death. 
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5-oxoproline is produced as a result of disordered glutathione metabolism or 
glutathione deficiency. Glutathione is produced by the gamma-glutamyl cycle. In this 
cycle, formation of glutathione leads to a negative feedback inhibition of G-
glutamylcysteine synthase therefore stopping further production of glutathione. When 
glutathione is deficient, g-glutacysteine synthase is not inhibited by g-glutacysteine. 
High levels of g-glutamylcysteine leads to formation of 5-oxoproline. [263] 
 
Figure 29. Acetaminophen metabolism 
 
Liver resection results in a predictable reduction in liver remnant volume. [244] The 
clinical concern is that following a significant reduction in liver volume inadvertent 
acetaminophen overdose could occur following therapeutic dosage. To use 
acetaminophen safely in these patients it is imperative to know if therapeutic doses 
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Currently, due to a lack of evidence, acetaminophen is either administered in a 
reduced dose or avoided entirely in patients following extended liver resection, 
particularly in patients of low body weight. This is empirical and dose reduction or 
avoidance is instituted at the discretion of the operating surgeon. Whilst this concern 
is often expressed in patients who have had an extended resection (70-75% of liver 
excised), those patients undergoing a hemihepatectomy (40 or 60% of liver excised) 
are usually administered full dose acetaminophen. It is not known if this may 
contribute to the postoperative liver impairment that can be seen in these patients. 
 
Therefore this study prospectively analysed the acetaminophen metabolism of patients 
undergoing liver resection, and related this to liver remnant volume. Acetaminophen 
levels and the markers of hepatotoxic risk, mercapturate and cysteine, were quantified 
in all patients.  Metabolites of patients who had small RLV were compared to patients 
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10.3 Methods 
 
The trial protocol was prospectively published on clinicaltrials.gov (NCT01770041). 
After gaining approval from the South East Scotland Research Ethics Committee 
patients undergoing liver resection at the Royal Infirmary of Edinburgh, UK, were 
approached and given written information regarding the trial after an initial discussion 
at the pre-admission clinic. Written informed consent was obtained on the day of 




Patients undergoing liver resection were approached to enter the study.  The exclusion 
criteria were: contra-indication to acetaminophen administration, inability to give 
written, informed consent, jaundice (Bilirubin > 100 μmol/L), liver resection 
combined with secondary surgical procedure, age < 18 years and pregnancy. 
 
10.3.2 Perioperative Care 
 
Patients were admitted on the morning of surgery having fasted for six hours and 
taken clear fluids up to two hours prior to surgery. Patients underwent induction of 
anaesthesia with propofol, atracurium and fentanyl (1-2 microg/kg). Maintenance of 
anaesthesia was achieved by desflurane or sevoflurane. At induction patients routinely 
received a central venous catheter in the right internal jugular vein, radial arterial 
cannulation and a urethral catheter. Routine monitoring of CVP, invasive continuous 
Enhanced Recovery After Liver Surgery 
Acetaminophen Metabolism After Liver Resection: A Prospective Case Control Study  248
blood pressure and mean arterial pressure, end tidal CO2, heart rate, oxygen 
saturations and urine output were performed throughout the operation.  
 
The peritoneal cavity was entered via a right subcostal incision that was extended if 
required superiorly in the midline. A full laparotomy was performed to ensure no 
contra-indications to resection were evident. Intra-operative ultrasound was 
performed by the operating surgeon to establish resectability and to formulate a final 
operative approach. Transection of the liver parenchyma was performed with 
Cavitron Ultrasonic Aspirator (CUSA, ValleyLab, Boulder, Colorado, USA) and 
monopolar diathermy. Transection was performed in accordance with the patient’s 
pathological, oncological and physiological requirements to ensure optimum short and 
long term outcome. 
 
Routine thromboprophylaxis and peri-operative antibiotics were administered 
immediately prior to incision. Intra-operative warming was routinely performed. 
Intra-peritoneal drains and NG tubes were not routinely administered and intra-
operative fluid management was restricted to 80-100mls/hour. 
 
10.3.3 Acetaminophen Administration 
 
Patients were administered 1g of acetaminophen every six hours with a maximum of 
four grammes per 24 hours. The first dose was administered intravenously at the end 
of the operation prior to extubation. Subsequent doses were administered orally. 
Acetaminophen administration continued to at least the fourth post-operative day as 
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per unit protocol. Patients were excluded from analysis if they did not receive 
complete administration of acetaminophen from day of surgery to the end of post-
operative day three. 
 
10.3.4 Sample Collection 
 
24 hour urine collections were performed daily until the morning of the fourth post-
operative day. From this, 20ml aliquots of urine were taken on each post-operative 
day and stored at -20 degrees centigrade for subsequent analysis of acetaminophen 
metabolites. 
 
Blood tests were obtained by venepuncture pre-operatively and on the morning of 
post-operative days one and three. Collection of 10mls of whole blood was obtained 
in one heparinised tube and one EDTA tube. Whole blood aliquots were obtained 
from the EDTA tube and transferred to 1.5ml polypropylene Eppendorf tubes and 
stored at -80 degrees centigrade until batch analysis was performed.   
 
10.3.5 Data Collection 
 
Demographic patient data were collected including age, sex, ASA and weight.  Intra-
operative data were collected. Operation performed, length of operation and estimated 
blood loss (EBL) were prospectively recorded. Extent of resection was assessed in 
two ways. The first was to report the number of segments resected, and secondly we 
calculated the residual liver volume (RLV) by calculating the liver volume based on 
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Chouker et al [243] and subtracting the percentage of liver resected according to pre-
determined values. [244] 
 
The pathology of the resected specimen was also obtained and details of background 
liver parenchyma and pathology of tumour were obtained directly from the original 
pathology report. 
 
Post-operatively clinical data were collected. Length of stay, i.e. length of time spent 
in hospital, and morbidity rate were recorded. Patients were observed for 
complications on a twice daily basis by the researcher. Complications were diagnosed 
and managed by the clinical team and morbidity rates reported accordingly. Routine 
post-operative blood tests were taken daily from POD 1-4.  
 
10.3.6 Primary Outcome 
 
The primary outcome assessed was the urinary metabolite levels of the glutathione 
dependent mercapturate and cysteine.  
 
10.3.7 Secondary Outcomes 
 
Further metabolites were assessed: 5-oxoproline, glucuronamide and sulphate. 
Glutathione and plasma acetaminophen levels were obtained pre-operatively and on 
POD 1 and POD 3.  
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10.3.8 Groups 
 
A comparison of metabolite levels was made between groups of differing residual 
liver volume. Predicted RLV of <35.5% was determined to be a volume at risk of 
therapeutic acetaminophen overdose. [244] This was combined with a weight based 
estimation of liver volume [243] and a group was populated with the patients with 
estimated RLV of <1000g and estimated remaining volume of <35.5% (group A). A 
matched comparison group of patients who had undergone minimal or no liver 
resection was also created to provide a control group. Patients with a resection volume 
of <10% and with the largest estimated RLV were observed to act as a control group 





It was hypothesised that the glutathione dependent metabolites (cysteine and 
mercapturate) would be greater in Group A when compared to the control group B 
when measured repeatedly over three post-operative days following liver resection. 
 
10.3.10  Analysis 
 
Plasma acetaminophen levels were analysed in the biochemistry laboratory of the 
Royal Infirmary of Edinburgh. Levels of urinary mercapturate, cysteine, 5-oxoproline, 
sulphate and glucuronamide were quantified by High Pressure Liquid 
Chromatography (HPLC). This is a well-validated technique and has been used to 
establish urinary acetaminophen metabolite levels in other clinical settings including 
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major surgery [264] and acute liver failure. [265] Glutathione levels were obtained 
from samples of whole blood via enzymatic recycling method as described by 
Rahman et al. [266] 
 
10.3.11 Statistical Analysis 
 
All statistical analysis was performed using SPSS version 19.0 (IBM, Armonk, New 
York, USA). A p value of <0.05 was adjudged to represent statistical significance. 
Assessment of the entire cohort was performed initially and then the patients were 
divided into two groups depending on residual liver volume (RLV). T-test or Mann-
Whitney U test was used to assess differences between independent continuous data. 
Linear regression analysis was performed to assess the relationship between RLV and 
logged concentration of the urinary metabolite levels. Paired t-test or Wilcoxon 
signed-rank analysis was performed to assess differences between dependent 
continuous data. Chi square analysis was performed to compare dichotomous data. 
Two way repeated measures ANOVA test was performed to compare differences 
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10.4 Results 
 
The trial was conducted between March 2013 and March 2014. 79 patients were 
recruited initially. Of these, 37 were subsequently excluded because they did not 
compete the full course of acetaminophen. Of these, 17 patients had a reduced dose of 
acetaminophen due to concern over liver function and so were excluded from the 
analysis. A further 20 patients were excluded because they did not complete the 
acetaminophen administration over the first three post-operative days because of 
either refusing acetaminophen or missing a dose therefore not receiving the standard 
full administration. 42 patients completed the acetaminophen administration. One 
patient did not comply with urine collection and so was unable to be included. 41 
patients were included in the final analysis. 
 
10.4.1 Demographic Characteristics 
 
The baseline data of the whole patient cohort are shown in Table 37. The patients 
received resection for colorectal liver metastases (CLM) in the majority of cases. 19 
(46.3%) patients underwent a major resection (more than or equal to three segments 
resected) with the remainder undergoing minor resection. The majority of patients had 
evidence of chemotherapy related liver injury with 15 (36.6%) patients having normal 
background liver parenchyma after pathological examination. Post-operative 
morbidity is reported in Table 38. 
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Variable Total cohort (n=41) 
Female 17 (41) 
Age 62 (53-72) 
ASA 
  I 
  II 





Weight (kg) 78.0 (72.4-86.5) 
Operation length (mins) 180 (135-250) 
EBL (mls) 600 (378-1124) 
Pringle time (mins) 0 (0-21) 
Segments resected 
  5 
  4 
  3 
  2 
  1 








Pathology of tumour 
  CLM 
  HCC 
  Cholangiocarcinoma 






Background liver  
  Steatosis 22 (53.7) 
  Steatohepatitis 7 (17.1) 
  Sinusoidal dilatation 9 (22.0) 
  Fibrosis 9 (22.0) 
  Cirrhosis 
  Normal liver 
4 (9.8) 
15 (36.6) 
CLM – Colorectal liver metastasis, HCC – 
Hepatocellular Carcinoma. Data are presented as n(%) 
or median (IQR). 
Table 37. Patient characteristics 
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Data are presented as n (%). 











Intra-abdominal abscess 3 (7.3) 
Pneumothorax 1 (1.7) 
Bile leak 1 (1.7) 
Confusion 1 (1.7) 
Lower respiratory tract infection 2 (4.9) 
Cardiac 1 (1.7) 
Wound infection 2 (4.9) 
Ileus 1 (1.7) 
Acute urinary retention 1 (1.7) 
Nausea and vomiting 2 (4.9) 
Acute kidney injury 4 (9.8) 
Sepsis 1 (1.7) 
Hypotension 1 (1.7) 
Total 21 (51.2) 
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10.4.2 Urinary Metabolites After All Liver Resections 
 
Figure 30 shows the urinary metabolites quantified over the first three post-operative 
days after liver resection. Urine collection was performed from the morning of POD1 
to the morning of POD 4.  
 
The glutathione dependent pathway metabolites were quantified. Cysteine was 
significantly raised on POD 2 compared to POD 1 however a drop from POD 2 to 
POD 3 was observed. The other glutathione dependent metabolite, mercapturate, 
increased over the measuring period although statistical significance was not reached 
(p=0.06) (Figure 30). 
 
The normal metabolic pathway results in glucuronidation and sulphation of 
acetaminophen to produce the end products of glucuronamide and sulphate. 
Glucuronamide levels did not change over the three post-operative days with no 
significant difference observed between POD1 and POD3. In contrast sulphate levels 
were seen to decrease over the three post-operative days with significantly lower 
levels observed on POD3 when compared to POD1 (Figure 30). 
 
Gluthathione levels dropped significantly post-operatively when compared to pre-
operative levels. 5-oxoproline levels, a marker of glutathione deficiency, rose post-
operatively but a statistically significant rise was not observed (Figure 30). 
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Data are presented as mean (95%CI) 
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10.4.3 Residual Liver Volume And Acetaminophen Metabolites 
 
The glutathione dependent metabolites are shown in Figures 31A-F. The relationship 
between volume and the glutathione dependent metabolites – cysteine (Figures 31A-
C) and mercapturate (Figures 31D-F) – changed over the study period. On POD 2 a 
significant linear regression analysis between each of these metabolites and RLV was 
observed suggesting increased metabolite levels in lower volume livers. This was not 
evident on the other post-operative days. 
 
When the non-glutathione metabolite levels were assessed, the same pattern of 
relationship between RLV and urinary levels of glucuronamide from days 1-3 was 
not observed (Figures 32A-C). Conversely, sulphate levels were seen to be 
significantly related to RLV on POD 2 representing higher urinary levels of sulphate 
in the patients with a smaller volume of remaining liver (Figures 32 D-F). This 
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Figure 31. Glutathione dependent metabolites and RLV 
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Figure 32. Non glutathione dependent metabolites and RLV 
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Figure 33. 5-oxoproline and RLV 
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10.4.4 Extent Of Liver Resection And Urinary Acetaminophen Metabolites 
 
For the final stage of the analysis the cohort was split into two groups. The case 
group was comprised of patients who had low RLV, as defined as having less than or 
equal to 35.5% of their pre-operative volume and less than 1000g of residual liver 
remaining (group A; n=11). This group was matched with those with the highest 
RLV and less than 10% of liver resected (group B; n=11).  
 
The demographic, operative and pathological characteristics of the two groups are 
reported in Table 39. As might be expected, median weight was higher in group B 
due to liver volume estimation being weight based. Group A had a greater number of 
segments resected and the greater length of operation observed reflecting the greater 
complexity of surgery in this group.  
 
Plasma acetaminophen levels were significantly higher in group A over the study 
period and rose significantly from baseline in both groups (Figure 34). No difference 
was observed in post-operative ALT (Figure 34). Post-operatively group A were 
reported to have significantly higher levels of bilirubin over the three post-operative 
days (Figure 34).  
 
Urinary acetaminophen metabolites were compared between groups. The glutathione 
dependent metabolites are reported in Figure 35. In group A, both cysteine and 
mercapturate levels rose significantly after POD 1 whereas the same metabolites in 
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group B did not. Moreover group A cysteine levels were significantly higher over all 
three post-operative days after two way RM ANOVA analysis. 
 
Metabolites produced as a result of the “normal” acetaminophen breakdown 
pathway, glucuronamide and sulphate, were also assessed. No difference was 
observed in glucuronamide between the groups over the three days (Figure 35), but 
sulphate levels were significantly higher in group A compared to group B although 
no rise from POD 1 was observed in either group (Figure 35). 
 
Glutathione levels however, dropped significantly from pre-operative levels but were 
not altered between the two groups (Figure 35) and no difference in post-operative 5-
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Table 39. Patient characteristics 
Variable  Group A ( n=11) Group B (n=11) P value 
Female 4 (36.4) 0 (0) 0.09a 
Age (years) 67 (56-77) 62 (57-70) 0.66b 
ASA 
  I 
  II 













Weight (kg) 75.0 (63.6-79.1) 87 (79.0-94.0) 0.002b 
Operation length (mins) 250 (180-330) 135 (116-150) 0.0015b 
Pringle (mins) 0(0-23) 0(0-22) 0.8b 
Segments resected 
  5 
  4 
  1 












RLV (g) 876 (708-892) 2434 (2305-2493) <0.0001b 
RLV (%) 35.5 (35.5-35.5) 90.3 (90.3-90.3) <0.0001b 
Pathology of tumour 
  CLM 
  HCC 
  Cholangiocarcinoma 
















Background liver    
  Steatosis 4 (36.4) 7 (63.6) 0.39a 
  Sinusoidal dilatation 5 (45.5) 0 (0) 0.04a 
  Steatohepatitis 1 (9.1) 2 (18.2) 1.0a 
  Fibrosis 3 (27.3) 2 (18.2) 1.0a 
  Cirrhosis 







CLM – Colorectal liver metastasis, HCC – Hepatocellular Carcinoma. a Fishers exact test, b 
Mann Whitney U test. Data are presented as n(%) or median (IQR). 
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Data are presented as median (IQR) 
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Figure 35. Comparison of metabolite levels between groups.  
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10.5 Discussion 
 
This trial has shown that glutathione dependent metabolites are raised to a greater 
extent in patients with smaller volumes of remaining liver after liver resection 
however, no evidence of glutathione deficiency was observed in this group when 
compared to those with minimal volumes of liver resected. 
 
Acetaminophen metabolism is a concern following liver resection however no 
previous evidence exists to guide clinicians when attempting to implement a 
multimodal analgesic regimen. Galinski et al [136] showed increased levels of 
plasma acetaminophen being evident after liver resection compared with non-liver 
resections. In our study acetaminophen levels rose significantly above baseline, and 
were significantly higher in the patients who had undergone the greatest volume of 
resection, thus corroborating Galinski’s findings and also suggesting a volume 
related component to acetaminophen metabolism. 
 
However the clinical significance of a raised plasma acetaminophen level is not 
immediately clear as it is the depletion of glutathione that precipitates the 
accumulation of hepatotoxic end-products. Therefore assessment of the urinary 
acetaminophen metabolites has gained increased importance when determining the 
effect of acetaminophen on liver function.  
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When the whole cohort was assessed the “normal” metabolic pathway metabolite 
glucuronamide remained static over the post-operative period, but sulphate levels 
were seen to decrease significantly from the high early post-operative levels. The 
glutathione dependent metabolites, namely cysteine and mercapturate, increased over 
the study period. Glutathione was also seen to decrease significantly. This suggests 
involvement of the cytochrome P450 pathway after therapeutic acetaminophen 
administration and utilisation of glutathione stores.  
 
However, again, the significance of liver resection specifically on these results is not 
certain. These findings are similar to those of Pickering et al [264] who quantified 
the levels of urinary metabolites after major abdominal (aortic) surgery. In this study, 
as in ours, a rise in the glutathione dependent metabolites cysteine and mercapturate 
was observed when compared to early post-operative levels. They also observed a 
reduction in glucuronamide and sulphate. This finding may therefore reflect normal 
post-operative therapeutic acetaminophen administration that is unaltered by liver 
resection. Furthermore the clinical significance of this finding is not immediately 
obvious as liver damage occurs after depletion of glutathione with a rise in 
glutathione dependent metabolites not necessarily corresponding to subsequent liver 
damage. 
 
Until now, very little evidence is available looking at the effect of liver resection on 
acetaminophen metabolism.  Galinski et al [267] looked at five patients who 
underwent liver resection and did not identify an increase in the levels of a NAPQI 
Enhanced Recovery After Liver Surgery 
Acetaminophen Metabolism After Liver Resection: A Prospective Case Control Study  269 
related metabolite, indicative of NAPQI accumulation, however the small sample 
size may have contributed to the negative finding. Acetaminophen administration 
after liver transplant was investigated by Park et al. [268] They too measured NAPQI 
accumulation but reported a rise in NAPQI of up to 10 per cent in the early post-
operative period as well as a decrease in glucuronamide and sulphate, which 
recovered over follow up.  
 
Our study differed to these in that we assessed the change in glutathione dependent 
metabolites and evidence of glutathione deficiency - the precursor to liver damage as 
NAPQI accumulation is an end stage process and unlikely to occur unless 
acetaminophen is administered to a failing resected liver. Furthermore our study 
continued observation of acetaminophen administration and metabolism until the 
morning of the fourth post-operative day allowing for full assessment of any liver 
damage.  
 
In the current study we observed 5-oxoproline levels, as a marker of glutathione 
deficiency, which is likely to be evident prior to the hepatotoxic NAPQI. Clinically 
5-oxoproline is evident when glutathione is deficient and is used selectively in 
acetaminophen overdose, is indicative of high anion gap metabolic acidosis as well 
as a marker of glutathione metabolic dysfunction in children. [263] When looking at 
the whole cohort of liver resections 5-oxoproline was observed to increase, although 
not significantly, over the study period, indicative of potential glutathione deficiency 
in some patients. This has not been assessed before.  
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The aim of the current study was to assess the effect that the extent of resection had 
on acetaminophen metabolism and to see if those patients with the least volume of 
liver remaining showed evidence of altered acetaminophen metabolism. Low 
residual liver volumes are associated with increased morbidity after liver resection 
and are vulnerable to liver failure due to inadequate liver remnant. [244] This study 
compared the patients with the smallest estimated residual liver volume with a 
control group that was populated with patients with low volume resections (mainly 
less than one segment) and high estimated pre-operative liver volumes. This 
represented a convenient control group with functioning livers, with the advantage of 
having had otherwise identical procedures. 
 
In the literature assessing liver failure and transplantation after acetaminophen 
overdose, risk factors for poor outcome after overdose have been investigated. 
Although controversy remains, several factors are suggested as being associated with 
increased rates of liver failure, transplant or death, including increased age, tobacco 
smoking, alcohol use, being in a fasted state [269] or elderly. [270] 
 
The effect on liver volume has not been investigated before. Reduced acetaminophen 
administration in patients under 50kg is advised to prevent unintentional therapeutic 
overdose. Patients with low body mass have been reported as suffering fatal 
hepatotoxicity after receiving therapeutic acetaminophen doses. [271] Liver volume 
is predictable when considering age, weight and sex [243] and low liver volume is 
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suspected as a risk factor for acetaminophen related liver injury after overdose. 
Although this is key for post-operative care of the patient undergoing liver resection, 
this has not been formally assessed before. 
 
We observed significant differences in the glutathione dependent metabolites 
between those who had higher and lower RLVs. This seemed to peak during the 
collection over the second post-operative day. Furthermore we showed a change in 
the relationship between the glutathione dependent metabolites and RLV on post-
operative day two with an inverse relationship being observed between RLV and 
cysteine and mercapturate that was not evident before or after this time point.  
Bilirubin was also significantly higher in patients with lower RLVs in the post-
operative study period.  
 
Davern et al [265] assessed acetaminophen metabolites in patients with acute liver 
failure following supra-therapeutic acetaminophen ingestion and observed high 
initial cysteine levels and then a fall in cysteine levels with a fall in ALT levels. This 
however was not the case for our patients where the ALT peaked early and decreased 
on a daily basis, in contrast to the metabolite levels that peaked at POD 2 or 
continued to rise until POD 3. A potential explanation for the higher levels of 
glutathione dependent metabolites on POD 2 and 3 is the lag time between high ALT 
and deranged acetaminophen metabolism that likely corrects itself as liver function 
normalises post-operatively. 
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No difference was observed in glutathione or 5-oxoproline when considering volume 
of remaining liver. This has not been assessed before and suggests that extensive 
liver resectional surgery is associated with a shift in the metabolism of 
acetaminophen, but not to the extent that a corresponding depletion of glutathione 
occurs at this level of administration. 5-oxoproline levels were seen to rise after all 
liver resections compared to baseline suggesting some patients exhibited glutathione 
depletion. However, residual liver volume per se did not seem to be associated with 
this finding. Potentially, other risk factors are responsible for this rise and this should 
be considered in all patients undergoing liver resection. 
 
A possible conclusion from this study is that in view of the rise in the glutathione 
dependent metabolites after major resection, acetaminophen metabolism is altered 
with a greater proportion of metabolism being performed via the cytochrome P450 
mediated pathway. However, in a healthy liver remnant that is functioning 
adequately, therapeutic acetaminophen does not deplete the glutathione levels to a 
degree to precipitate hepatotoxicity, regardless of the size of the remaining liver 
assessed in this cohort. However, in view of the increased rise observed in 
glutathione dependent metabolites, these patients are potentially at risk of liver 
damage and consideration of other risk factors should be made, for example 
underlying liver disease, intra-operative liver ischaemia, age and nutritional status 
when prescribing acetaminophen and adjustment made accordingly if such factors 
are evident. 
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A potential limitation of this study is that we, for ethical reasons, excluded patients 
whose liver function deteriorated over their post-operative course as they had their 
acetaminophen treatment withheld due to concern for their liver function. This means 
that the patients included in this study all had good or improving liver function and 
so adequate glutathione stores would perhaps be expected, so evidence of glutathione 
depletion and subsequent hepatotoxicity were de-selected from this population. 
Furthermore, the majority of patients in group A had 35.5% of their liver remaining 
which corresponds to a right hepatectomy. [244] Therefore these results are not 
directly translatable to those who have had extended right hepatectomies, as only two 
patients in group A had such resections.  
 
Further limitations to this study are as follows. The relationship between 
acetaminophen ingestion and 5-oxoproline is not well established. It is not specific to 
acetaminophen toxicity and its clinical usage is not routine and evidence supporting 
its use is limited. [263] However when attempting to assess for evidence of 
glutathione deficiency and alteration of the metabolic pathway, its inclusion offers a 
degree of completeness to the analysis. 
 
Due to the exclusion of several patients who underwent extended resection due to 
lack of acetaminophen administration, only 11 patients were included in the 
comparative analysis. Therefore this may have been too small a sample to effectively 
show a difference between the two groups. 
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Radiological assessment of future liver volume was not performed and predictive 
formulae were used to estimate the remaining liver volume. Although this method 
has been shown to be accurate, it remains an estimation based on population studies 
and not an assessment of the individual patient and potential errors may have been 
introduced. 
 
The results of this trial therefore mandate that acetaminophen administration in 
patients after liver resection is carefully considered. There does appear to be a shift in 
the metabolic pathway after liver resection and potential evidence of glutathione 
depletion. There were also significantly higher levels of glutathione dependent 
metabolites in the major resection group however no evidence of glutathione 
deficiency was observed after extended liver resections.  Therefore, we advocate 
acetaminophen administration in patients who have undergone a major resection so 
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11 Discussion 
This thesis has identified several key areas when considering recovery after liver 
resection. Evidence assessing post-operative ERAS care protocols after liver 
resection is limited and there is often considerable influence from the colorectal 
ERAS literature. The current thesis has identified areas unique to hepatic resection 
that can be incorporated into ERAS protocols in an attempt to improve outcomes 
after liver resectional surgery. 
 
The idea that extensive liver resection is not only associated with major morbidity 
but also increased minor complications highlights the need for a multi-disciplinary 
approach to post-operative care. In order to achieve the optimum post-operative 
outcome, all aspects of care need to be scrutinised.  
 
When considering post-operative analgesia, opiate minimisation is often possible 
with the implementation of a multimodal analgesic regimen. The avoidance of 
acetaminophen in patients with major resections can result in increased opiate 
consumption. The findings of this thesis suggest that acetaminophen administration 
at therapeutic doses is safe after major resection if the liver is functioning 
satisfactorily and as such can play an important role in post-operative analgesia 
following live resection. 
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Post-operative analgesia advice from the colorectal literature advocates post-
operative epidural. However the generalisability of this evidence to liver surgery is 
debatable. Aspects unique to liver surgery demand consideration of individualised 
peri-operative care. No significant advantage was seen when using epidural analgesia 
after liver resection when compared to CWI. The main delays to recovery for the 
TEA group were the increased requirement for HDU care, increased vasopressor 
requirement and poor pain control once epidural had been removed. The high 
hypotension rate is symptomatic of the requirement for mid thoracic epidural due to 
adequate coverage of the dermatomes affected by the subcostal incision, not always 
encountered in other fields of abdominal surgery. The comparable pain scores, not 
seen before in similar studies, suggests a CWI protocol capable of providing 
adequate analgesia without these disadvantages of TEA and rather than epidurals 
being considered routine, as is often advocated, the current study suggests an 
alternative, CWI, is suitable as a first line analgesic. 
 
Nutritional requirements after liver resection are not well investigated. Extent of 
resection and subsequently liver regeneration was hypothesised as being integral to 
nutritional requirements after major liver resection. This hypothesis was not 
supported by the study findings. However the requirements for nutrition were seen to 
be wholly unpredictable with significant variation between subjects. The validation 
of a mobile device to monitor energy expenditure and therefore nutritional 
requirements by this thesis will potentially provide increased insight into this aspect 
of care. 
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Conversely, there are universal areas that apply to all aspects of peri-operative care. 
Adherence to ERAS protocols is also important as is determining streamlined 
implementation policy. The current investigation has shown universal support for 
ERAS care components but challenges with daily implementation of ERAS care 
observed, in common with other ERAS trials, highlighted the inherent difficulties in 
ensuring ERAS protocols reach the bedside and patients benefit from evidence based 
care. 
 
The future research that will be of benefit should aim to continue the scrutiny of 
individual peri-operative care components and ascertain their interaction on liver 
surgery. The employment of wound infiltration devices is not limited to open surgery 
and assessment of their application to laparoscopic liver surgery is an area of 
potential development and investigation. A major advantage of CWI is its low 
nursing requirements and simplistic design. It is conceivable that they could be 
utilised in an ambulatory setting and could potentially facilitate 24 hour stay 
laparoscopic liver resection. No previous trial has examined CWI in laparoscopic 
liver resection or determined if an advantage exists to conventional analgesia 
however this is an area to investigate in the future. 
 
The results of the two exploratory observational studies could be exploited to provide 
safety data on which to base randomised trials. The trial assessing acetaminophen 
metabolism suggested small remnant volume was not associated with glutathione 
deficiency or liver damage and this knowledge could be utilised to compare formally 
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low and normal doses of acetaminophen following extended resection. Such data 
were not available prior to this investigation and so exploratory investigation was 
mandated. Similarly the trial assessing energy expenditure after liver resection 
provided results that could conceivably link into a comparison of nutrition guided by 
energy expenditure as measured by SWA compared with standard nutritional care. 
SWA was not validated prior to this investigation and so any such trial would have 
relied on IC, which is not practical for daily, real time assessment of energy 
expenditure in the clinical setting. 
 
In summary, the current thesis identified areas of peri-operative care that were 
lacking in sufficient evidence to guide practice. As a result of the described studies, 
several areas of care, namely analgesia and nutrition, have been clarified and provide 
a basis on which to establish future practice and investigation.
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